Voya Financial (VOYA) 10-Q 2 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - $ / shares	9 Months Ended
	Sep. 30, 2023	Oct. 27, 2023	Dec. 31, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-35897
Entity Registrant Name	Voya Financial, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-1222820
Entity Address, Address Line One	230 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10169
City Area Code	212
Local Phone Number	309-8200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		104,468,001
Common stock, par value (usd per share)	$ 0.01		$ 0.01
Entity Central Index Key	0001535929
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock, $.01 par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	VOYA
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/40th
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/40th
Trading Symbol	VOYAPrB
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 903	$ 1,179
Accrued investment income	446	425
Premiums Receivable And Reinsurance Recoverables, Including Reinsurance Premium Paid	11,765	12,426
Deferred policy acquisition costs and Value of business acquired	2,278	2,363
Deferred income taxes	2,438	2,223
Goodwill	748	327
Other Intangible Assets, Net	900	631
Assets held in separate accounts	85,491	80,174
Total assets	149,265	146,606
Liabilities:
Future policy benefits	9,371	9,719
Contract owner account balances	40,135	42,455
Payables under securities loan and repurchase agreements, including collateral held	1,190	1,302
Short-term debt	2	141
Long-term debt	2,095	2,094
Derivatives	373	389
Liabilities related to separate accounts	85,491	80,174
Total liabilities	144,306	141,609
Commitments and Contingencies (Note 17)
Mezzanine equity:
Redeemable noncontrolling interest	173	166
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2023 and 2022)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 109,500,599 and 97,789,852 shares issued as of 2023 and 2022, respectively; 105,074,021 and 97,186,970 shares outstanding as of 2023 and 2022, respectively)	1	1
Treasury stock (at cost; 4,426,578 and 602,882 shares as of 2023 and 2022, respectively)	(307)	(39)
Additional paid-in capital	6,664	6,643
Accumulated other comprehensive income (loss)	(3,533)	(3,055)
Retained earnings (deficit):
Unappropriated	302	(201)
Total Voya Financial, Inc. shareholders' equity	3,127	3,349
Noncontrolling interest	1,659	1,482
Total shareholders' equity	4,786	4,831
Total liabilities, mezzanine equity and shareholders' equity	149,265	146,606
Consolidated Entity, Excluding Consolidated VIE
Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	24,663	27,044
Fixed maturities, at fair value using the fair value option	1,955	2,151
Equity securities, at fair value	301	336
Short-term investments	297	356
Mortgage loans on real estate, net	5,344	5,427
Policy loans	358	363
Limited partnerships/corporations	1,792	1,781
Derivatives	482	422
Other investments	63	68
Securities pledged (amortized cost of $1,157 as of 2023 and $1,303 as of 2022)	1,002	1,162
Total investments	36,257	39,110
Cash and cash equivalents	829	919
Other assets (net of allowance for credit losses of $1 as of 2023 and 2022)	2,579	2,625
Liabilities:
Other liabilities	3,024	2,901
VIEs
Investments:
Limited partnerships/corporations	3,079	2,802
Cash and cash equivalents	88	88
Other assets (net of allowance for credit losses of $1 as of 2023 and 2022)	36	21
Financing Receivable, after Allowance for Credit Loss	1,428	1,293
Liabilities:
Other liabilities	1,296	1,200
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,329	$ 1,234

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Fixed maturities, amortized cost	$ 28,409	$ 30,202
Fixed maturities, allowance for credit losses	19	12
Mortgage loans, allowance for credit losses	29	18
Securities pledged, amortized costs	1,157	1,303
Premium receivable and reinsurance recoverable, allowance for credit losses	25	32
Other assets, allowance for credit losses	$ 1	$ 1
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, aggregate liquidation preference	$ 625	$ 625
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares outstanding (in shares)	900,000,000	900,000,000
Common stock, shares issued (in shares)	109,500,599	97,789,852
Common stock, shares outstanding (in shares)	105,074,021	97,186,970
Treasury stock (in shares)	4,426,578	602,882

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Net investment income	$ 547	$ 522	$ 1,637	$ 1,733
Fee income	489	445	1,427	1,291
Premiums	682	606	2,044	1,811
Net gains (losses)	(7)	(125)	(79)	(639)
Other revenue	81	33	245	117
Income (loss) related to CIEs:
Net investment income	31	(136)	255	62
Total revenues	1,823	1,345	5,529	4,375
Benefits and expenses:
Policyholder benefits	471	297	1,419	1,119
Interest credited to contract owner account balances	328	240	813	716
Operating expenses	717	632	2,323	1,869
Net amortization of Deferred policy acquisition costs and Value of business acquired	57	60	173	184
Interest expense	31	31	102	104
Operating expenses related to CIEs:
Interest expense	45	12	116	31
Other expense	2	2	7	7
Total benefits and expenses	1,651	1,274	4,953	4,030
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	172	71	576	345
Income tax expense (benefit)	(74)	29	(34)	49
Net income (loss)	246	42	610	296
Less: Net income (loss) attributable to noncontrolling interest	(16)	(138)	107	(20)
Net income (loss) available to Voya Financial, Inc.	262	180	503	316
Less: Preferred stock dividends	14	14	32	32
Net income (loss) available to Voya Financial, Inc.'s common shareholders	$ 248	$ 166	$ 471	$ 284
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 2.35	$ 1.70	$ 4.62	$ 2.79
Diluted (usd per share)	$ 2.29	$ 1.57	$ 4.31	$ 2.55

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 246	$ 42	$ 610	$ 296
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	(23)	93	7	289
Other comprehensive income (loss), before tax:
Unrealized gains (losses) on securities	(916)	(1,685)	(612)	(6,757)
Other Comprehensive Income (Loss), before Tax, Total	(939)	(1,592)	(605)	(6,468)
Income tax expense (benefit) related to items of other comprehensive income (loss)	(197)	(334)	(127)	(1,358)
Other Comprehensive Income (Loss), Net of Tax, Total	(742)	(1,258)	(478)	(5,110)
Comprehensive income (loss)	(496)	(1,216)	132	(4,814)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	(16)	(138)	107	(20)
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ (480)	$ (1,078)	$ 25	$ (4,794)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Total Voya Financial, Inc. Shareholders' Equity	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Deficit), Unappropriated	Noncontrolling Interest
Beginning balance at Dec. 31, 2021	$ 9,668	$ 8,100	$ 1	$ (80)	$ 7,542	$ 1,807	$ (1,170)	$ 1,568
Increase (Decrease) in Stockholders' Equity
Interest in VIM Holdings LLC	412	412			412
Comprehensive income (loss):
Net income (loss)	289	316	0	0	0	0	316	(27)
Other comprehensive income (loss), after tax	(5,110)	(5,110)	0	0	0	(5,110)	0	0
Total comprehensive income (loss)	(4,814)	(4,794)
Total comprehensive income (loss)	(20)							(27)
Total comprehensive income (loss)	(4,821)
Net consolidations (deconsolidations) of consolidated investment entities	3							3
Common stock issuance	7	7	0	0	7	0	0	0
Common stock acquired - Share repurchase	(750)	(750)	0	(750)	0	0	0	0
Dividends on preferred stock	(32)	(32)	0	0	(32)	0	0	0
Dividends on common stock	(61)	(61)	0	0	(61)	0	0	0
Share-based compensation	34	34	0	(43)	77	0	0	0
Contributions from (Distributions to) noncontrolling interest, net	46	0	0	0	0	0	0	46
Ending Balance at Sep. 30, 2022	4,506	2,916	1	(873)	7,945	(3,303)	(854)	1,590
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Dec. 31, 2021	0
Increase (Decrease) in Temporary Equity [Roll Forward]
Interest in VIM Holdings LLC	148
Net income (loss)	7
Total comprehensive income (loss)	7
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2022	155
Beginning balance at Jun. 30, 2022	5,298	3,601	1	(821)	7,500	(2,045)	(1,034)	1,697
Increase (Decrease) in Stockholders' Equity
Interest in VIM Holdings LLC	412	412			412
Comprehensive income (loss):
Net income (loss)	35	180	0	0	0	0	180	(145)
Other comprehensive income (loss), after tax	(1,258)	(1,258)	0	0	0	(1,258)	0	0
Total comprehensive income (loss)	(1,216)	(1,078)
Total comprehensive income (loss)	(138)							(145)
Total comprehensive income (loss)	(1,223)
Net consolidations (deconsolidations) of consolidated investment entities	3							3
Common stock issuance	5	5	0	0	5	0	0	0
Common stock acquired - Share repurchase	0	0	0	(50)	50	0	0	0
Dividends on preferred stock	(14)	(14)	0	0	(14)	0	0	0
Dividends on common stock	(20)	(20)	0	0	(20)	0	0	0
Share-based compensation	10	10	0	(2)	12	0	0	0
Contributions from (Distributions to) noncontrolling interest, net	35	0	0	0	0	0	0	35
Ending Balance at Sep. 30, 2022	4,506	2,916	1	(873)	7,945	(3,303)	(854)	1,590
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Jun. 30, 2022	0
Increase (Decrease) in Temporary Equity [Roll Forward]
Interest in VIM Holdings LLC	148
Net income (loss)	7
Total comprehensive income (loss)	7
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2022	155
Beginning balance at Dec. 31, 2022	4,831	3,349	1	(39)	6,643	(3,055)	(201)	1,482
Comprehensive income (loss):
Net income (loss)	590	503	0	0	0	0	503	87
Other comprehensive income (loss), after tax	(478)	(478)	0	0	0	(478)	0	0
Total comprehensive income (loss)	132	25
Total comprehensive income (loss)	107							87
Total comprehensive income (loss)	112
Common stock acquired - Share repurchase	(216)	(216)	0	(216)	0	0	0
Dividends on preferred stock	(32)	(32)	0	0	(32)	0	0
Dividends on common stock	(83)	(83)	0	0	(83)	0	0
Share-based compensation	84	84	0	(52)	136	0	0
Contributions from (Distributions to) noncontrolling interest, net	90	0	0	0	0	0	0	90
Ending Balance at Sep. 30, 2023	4,786	3,127	1	(307)	6,664	(3,533)	302	1,659
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Dec. 31, 2022	166
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	20
Total comprehensive income (loss)	20
Contributions from (Distributions to) noncontrolling interest, net	(13)
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2023	173
Beginning balance at Jun. 30, 2023	5,357	3,697	1	(248)	6,695	(2,791)	40	1,660
Comprehensive income (loss):
Net income (loss)	237	262	0	0	0	0	262	(25)
Other comprehensive income (loss), after tax	(742)	(742)	0	0	0	(742)	0	0
Total comprehensive income (loss)	(496)	(480)
Total comprehensive income (loss)	(16)							(25)
Total comprehensive income (loss)	(505)
Common stock acquired - Share repurchase	(54)	(54)	0	(54)	0	0	0	0
Dividends on preferred stock	(14)	(14)	0	0	(14)	0	0	0
Dividends on common stock	(42)	(42)	0	0	(42)	0	0	0
Share-based compensation	20	20	0	(5)	25	0	0	0
Contributions from (Distributions to) noncontrolling interest, net	24	0	0	0	0	0	0	24
Ending Balance at Sep. 30, 2023	4,786	$ 3,127	$ 1	$ (307)	$ 6,664	$ (3,533)	$ 302	$ 1,659
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Jun. 30, 2023	171
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	9
Total comprehensive income (loss)	9
Contributions from (Distributions to) noncontrolling interest, net	(7)
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2023	$ 173

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net cash provided by operating activities	$ 1,274	$ 1,133
Proceeds from the sale, maturity, disposal or redemption of:
Fixed maturities	5,578	5,165
Equity securities	31	0
Mortgage loans on real estate	447	733
Limited partnerships/corporations	124	158
Acquisition of:
Fixed maturities	(3,655)	(6,653)
Equity securities	(25)	(76)
Mortgage loans on real estate	(376)	(511)
Limited partnerships/corporations	(131)	(225)
Short-term investments, net	60	66
Derivatives, net	54	157
Sales from CIEs	652	702
Purchases within CIEs	(780)	(1,688)
Collateral received (delivered), net	166	149
Receipts on deposit asset contracts	208	91
Payments for business acquisitions, net of cash acquired	(584)	(2)
Net cash provided by (used in) investing activities	(70)	(12)
Net cash provided by (used in) investing activities	1,699	(1,946)
Cash Flows from Financing Activities:
Deposits received for investment contracts	1,718	5,039
Maturities and withdrawals from investment contracts	(4,460)	(4,736)
Proceeds from issuance of long-term debt	388	0
Repayments of long-term debt, including current maturities	(539)	(365)
Borrowings of CIEs	232	1,094
Repayments of borrowings of CIEs	(388)	(309)
Contributions from (distributions to) participants in CIEs, net	385	358
Proceeds from issuance of common stock, net	0	7
Common stock acquired - Share repurchase	(212)	(750)
Dividends paid on preferred stock	(32)	(32)
Dividends paid on common stock (includes $2 of dividend equivalent payments in 2023)	(85)	(63)
Other, net	(70)	(68)
Net cash provided by (used in) financing activities	(3,063)	175
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	(90)	(638)
Cash and cash equivalents, including cash in CIEs, beginning of period	1,007	1,573
Cash and cash equivalents, including cash in CIEs, end of period	917	$ 935
Total cash and cash equivalents, including cash in CIEs	917
Consolidated Entity, Excluding Consolidated VIE
Cash and cash equivalents	829
VIEs
Cash and cash equivalents	$ 88

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Business Description and Basis of Presentation	Business, Basis of Presentation and Significant Accounting Policies Business Voya Financial, Inc. and its subsidiaries (collectively, the "Company") is a financial services organization that offers a broad range of retirement services, investment management services, mutual funds, group insurance and supplemental health products primarily in the United States. P roducts and services are provided by the Company through three segments: Wealth Solutions, Health Solutions and Investment Management . Activities not directly related to the Company's segments and certain run-off activities that are not meaningful to the Company's business strategy are included within Corporate. See the Segments Note to these Condensed Consolidated Financial Statements. On July 25, 2022, the Company completed a series of transactions pursuant to a Combination Agreement dated as of June 13, 2022 (the "AllianzGI Agreement") with Voya Investment Management LLC ("Voya IM") and VIM Holdings LLC ("VIM Holdings"), both indirect subsidiaries of the Company, Allianz SE ("Allianz") and Allianz Global Investors U.S. LLC ("AllianzGI"), an indirect subsidiary of Allianz, which combined Voya IM with assets and teams comprising specified transferred strategies managed by AllianzGI. The transaction increases the international scale and distribution of the Company’s investment products and provides diverse investment strategies that meet the needs of a larger and more global client base. Under the terms of the AllianzGI Agreement, AllianzGI transferred to VIM Holdings the rights to certain assets and liabilities related to specified investment teams and strategies and the associated assets under management (the "AllianzGI Transferred Business"). The Company transferred all of the limited liability company interests in Voya IM to VIM Holdings and in exchange, received a 76% economic stake in VIM Holdings. Pursuant to the Amended and Restated Limited Liability Company Agreement of VIM Holdings entered into at the closing date ("A&R VIM Holdings Operating Agreement"), the Company now holds, indirectly, a 76% economic stake in VIM Holdings and Allianz holds, indirectly, a 24% economic stake in VIM Holdings. In accordance with the A&R VIM Holdings Operating Agreement, the Company has full operational control of VIM Holdings, Voya IM and the transferred assets and investment teams. The AllianzGI Agreement was executed for noncash consideration and accounted for under the acquisition method of accounting. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the closing date. The 24% economic stake in VIM Holdings shares is reflected on the Condensed Consolidated Balance Sheets under Redeemable noncontrolling interests within Mezzanine equity. On November 1, 2022, Voya Investment Management Alternative Assets, LLC ("VIMAA"), one of the Company’s indirect subsidiaries, acquired all of the issued and outstanding equity interests of Czech Asset Management, L.P., a private credit asset manager dedicated to the U.S. middle market pursuant to a sales and purchase agreement ("SPA") entered into on August 1, 2022 with Czech Management GP, LLC, and Czech Holdings, LLC. The purchase consideration for the acquisition included cash paid upon close and contingent consideration that is based on revenues that will be earned during the earnout period and capital raised in the underlying funds and is subject to conditions as defined in the SPA. The acquisition expands VIMAA's private and leveraged credit business. On January 24, 2023, the Company acquired all outstanding shares of Benefitfocus, Inc. ("Benefitfocus"), pursuant to an agreement and plan of merger (the "Merger Agreement") entered into on November 1, 2022. The acquisition expands the Company’s capacity to meet the growing demand for comprehensive benefits and savings solutions and increases its ability to deliver innovative solutions for employers and health plans. The total purchase consideration for the acquisition was $595, of which $583 was paid in cash ($558 paid by the Company and $25 of the cash acquired was used to fund the transaction). Net assets acquired as part of this transaction included cash of $49, goodwill of $319, intangible assets of $275, deferred tax assets of $45 and assumed lease liabilities of $91. This represents the best estimate of fair value of net assets acquired at the transaction date and will continue to be revised during the remeasurement period as further information becomes available. Intangible assets primarily include customer relationships of $190 with a useful life of 15 years, and software of $70 with a useful life of 5 years. The estimated amortization expense of the acquired intangible assets for the next five years is approximately $29 annually. The revenues, expenses, assets and liabilities of the business acquired are reported in the Health Solutions segment. On August 1, 2023, the Company acquired all remaining equity interest in VFI SLK Global Services Private Limited previously held by SLK Software Private Limited ("SLK") and renamed the entity as Voya Global Services Private Limited ("Voya India"). Voya India was a private limited company in India formed pursuant to a joint venture agreement between the Company and SLK on August 1, 2019, with the Company and SLK holding 49% and 51% of ownership shares, respectively. The purpose of Voya India is to provide technology and business operation services to the Company. As a result of the acquisition, Voya India has become a wholly owned subsidiary of the Company and provides the Company with improved strategic and operational flexibility. As part of the purchase consideration, an upfront payment of approximately $53 was made at closing. The Company recorded a gain of $45 in relation to revaluation of the existing investment in Voya India which was recorded in Net gains (losses) in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023. Net assets acquired as part of this transaction included goodwill of $102. The revenues, expenses, assets and liabilities of the business acquired are reported in Corporate. Intercompany balances between Voya India and other Voya subsidiaries are eliminated in the Condensed Consolidated Financial Statements. Basis of Presentation The accompanying Condensed Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are unaudited. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. The accompanying Condensed Consolidated Financial Statements are unaudited and reflect adjustments (including normal, recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented in conformity with U.S. GAAP. Interim results are not necessarily indicative of full year performance. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. On January 1, 2023, the Company adopted Accounting Standard Update (“ASU”) 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts ("ASU 2018-12"), under the modified retrospective adoption method. ASU 2018-12 provided new authoritative guidance impacting the accounting and disclosure requirements for long-duration insurance and investment contracts issued by the Company. The unaudited Condensed Consolidated Financial Statements are presented under the new guidance for reporting periods beginning January 1, 2021. See “Adoption of New Pronouncements” below for additional information regarding this adoption and the transition impacts recorded as of January 1, 2021. See "Significant Accounting Policies" below for additional details regarding the key policy changes effected by this ASU and updated accounting policies resulting from the adoption of this ASU for all periods presented in the unaudited Condensed Consolidated Financial Statements. This section is meant to serve as an update to, and should be read in conjunction with, the Business, Basis of Presentation and Significant Accounting Policies Note to the Consolidated Financial Statements in Part II, Item 8. of the Company's Annual Report on Form 10-K for the year ended December 31, 2022. Significant Accounting Policies Effective January 1, 2023, the Company adopted ASU 2018-12, as amended. As a result, the Company made changes to the following significant accounting policies: Estimates and Assumptions Upon adoption of ASU 2018-12, deferred policy acquisition costs ("DAC") and value of business acquired ("VOBA") were no longer considered significant estimates by the Company, as the amortization methodology is no longer subject to a significant degree of variability and does not require a high degree of judgment. Deferred Policy Acquisition Costs and Value of Business Acquired DAC represents policy acquisition costs that have been capitalized and are subject to amortization. Capitalized costs are incremental, direct costs of contract acquisition and certain other costs related directly to successful acquisition activities. Such costs consist principally of commissions, underwriting, sales and contract issuance and processing expenses directly related to the successful acquisition of new and renewal business. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. VOBA represents the outstanding value of in-force business acquired and is subject to amortization. The value is based on the present value of estimated net cash flows embedded in the insurance contracts at the time of the acquisition and increased for subsequent deferrable expenses on purchased policies. DAC/VOBA amortization is recorded in Net amortization of Deferred policy acquisition costs and Value of business acquired in the Condensed Consolidated Statements of Operations. Amortization Methodologies The Company amortizes DAC/VOBA related to certain traditional life insurance contracts, certain accident and health insurance contracts, and deferred annuity contracts on a constant level basis over the expected term of the related contracts. Contracts are grouped for amortization purposes by product or market type and issue year cohort using assumptions on a basis consistent with those used in estimating the associated liability or other related balance, where applicable. The principal assumption deemed critical to the DAC/VOBA amortization is the estimated contract term, which incorporates mortality and persistency, and represents management’s best estimate of future outcome. The Company periodically reviews this assumption against actual experience and, based on additional information that becomes available, updates the assumption. Changes in contract term estimates are reflected prospectively in amortization expense as of the beginning of the reporting period in which the change is made. VOBA is subject to recoverability testing; DAC is not. The Company performs testing to assess the recoverability of VOBA on an annual basis, or more frequently if circumstances indicate that a potential loss recognition issue exists. If VOBA is not deemed recoverable, charges will be applied against the VOBA balance before an additional reserve is established. Future Policy Benefits Future Policy Benefits The Company establishes and carries actuarially-determined reserves that are calculated to meet its future obligations, including estimates of unpaid claims and claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. • Reserves for long-duration traditional life insurance contracts (term insurance, participating and non-participating whole life insurance and traditional group life insurance) and accident and health insurance represent the present value of future benefits to be paid to or on behalf of contract owners and related expenses, less the present value of future net premiums. • Reserves for payout contracts with life contingencies are equal to the present value of future payments. Principal assumptions used to establish liabilities for future policy benefits include interest rate, mortality, morbidity, policy lapse, contract renewal, payment of subsequent premiums or deposits by the contract owner, retirement, inflation, and benefit utilization. Other than interest rate assumptions, these assumptions are based on Company experience and periodically reviewed against industry standards. The Company reviews these assumptions at least annually and updates them if necessary. In addition to assumption updates, the Company adjusts reserves for actual experience in the period in which the experience occurs. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Remeasurements of the reserves as a result of assumption updates and adjustments for actual experience are recognized in Policyholder benefits in the Condensed Consolidated Statements of Operations. Interest rates used in discounting the reserves are based on an upper-medium grade (low credit risk) fixed income instrument yield derived from observable market data. A 30-year forward rate is used for periods beyond the last observable market point. Reserves are remeasured quarterly to reflect changes in the discount rate, with the resulting change recorded in Accumulated other comprehensive income ("AOCI"). Locked-in interest rates used to determine interest accretion on reserves for new contracts sold after January 1, 2021 are based on the upper-medium grade (low credit risk) fixed income instrument yield applicable at the time the contract was issued. Locked-in interest accretion rates for contracts in-force as of the January 1, 2021 transition date for ASU 2018-12 are based on the locked-in interest rates in effect for those contracts immediately before the transition date. Interest accretion is recorded in Policyholder benefits on the Condensed Consolidated Statements of Operations. Product Guarantees and Additional Reserves The Company calculates additional reserve liabilities for certain universal life-type products and certain variable annuity guaranteed benefits and variable funding products. The Company periodically evaluates its estimates and adjusts the additional liability balance, with a related charge or credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions should be revised. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Universal and Variable Universal Life : The Company establishes additional reserves on universal life ("UL") and variable universal life ("VUL") contracts, primarily related to secondary guarantees and paid-up guarantees, for the portion of contract assessments received in early years that will be used to compensate the Company for benefits provided in later years. These reserves are calculated by estimating the expected value of benefits payable and recognizing those benefits ratably over the accumulation period based on total expected assessments, using interest rates consistent with the underlying contracts' interest crediting rates. Included are contracts where the Company contractually guaranteed a death benefit even when there is insufficient value to cover monthly mortality and expense charges, whereas otherwise the contract would typically lapse ("no lapse guarantee"), and other provisions that would produce expected gains from the insurance benefit function followed by losses from that function in later years. Additional reserves for UL and VUL contracts are recorded in Future policy benefits on the Condensed Consolidated Balance Sheets. Stabilizer and MCG : Guaranteed credited rates give rise to an embedded derivative in the stabilizer ("Stabilizer") products and a stand-alone derivative for managed custody guarantee products ("MCG"). These derivatives are measured at estimated fair value and recorded in Contract owner account balances. Changes in estimated fair value that are not related to attributed fees collected or payments made are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The estimated fair value of the Stabilizer embedded derivative and MCG stand-alone derivative is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. The liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative include a risk margin to capture uncertainties related to policyholder behavior assumptions. The margin represents additional compensation a market participant would require to assume these risks. The discount rate used to determine the fair value of the liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). Reinsurance The Company utilizes reinsurance agreements in most aspects of its insurance business to reduce its exposure to large losses. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not discharge the primary liability of the Company as direct insurer of the risks reinsured. For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk. The Company reviews contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. The assumptions used to account for both long and short-duration reinsurance agreements are consistent with those used for the underlying contracts, with the exception of the interest accretion rate on reinsurance recoverable assets associated with in-force business reinsured. Ceded Future policy benefits and Contract owner account balances are reported gross on the Condensed Consolidated Balance Sheets. Long-duration : For reinsurance of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid and benefits received related to the underlying contracts is included in the expected net cost of reinsurance, which is recorded in Premiums receivable and reinsurance recoverable or Other liabilities, as appropriate, on the Condensed Consolidated Balance Sheets. Short-duration : For prospective reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid are recorded as ceded premiums and ceded unearned premiums and are reflected as a component of Premiums in the Condensed Consolidated Statements of Operations and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets, respectively. Ceded unearned premiums are amortized through premiums over the remaining contract period in proportion to the amount of protection provided. For retroactive reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid in excess of the related insurance liabilities ceded are recognized immediately as a loss. Any gains on such retroactive agreements are deferred in Other liabilities and amortized over the remaining life of the underlying contracts. Accounting for reinsurance requires use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company reviews assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance at least annually and updates them if necessary. In addition to the assumption updates, the Company adjusts these assets or liabilities for actual experience in the period in which the experience occurs. The Company also evaluates the financial strength of potential reinsurers and continually monitors the financial condition of reinsurers. Reinsurance recoverable balances are reported net of the allowance for credit losses on the Company’s Condensed Consolidated Balance Sheets. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Included in the factor-based method are the consideration of capital market factors, counterparty financial information and ratings, and reinsurance agreement-specific risk characteristics such as collateral type, collateral size, and covenant strength. The allowance for credit losses is a valuation account that is deducted from the reinsurance recoverable balance to present the net amount expected to be collected on the reinsurance recoverable. The change in the allowance for credit losses is recorded in Policyholder benefits in the Condensed Consolidated Statements of Operations. Current reinsurance recoverable balances deemed probable of recovery and payable balances under reinsurance agreements are included in Premium receivable and reinsurance recoverable and Other liabilities, respectively. Such assets and liabilities relating to reinsurance agreements with the same reinsurer are recorded net on the Condensed Consolidated Balance Sheets if a right of offset exists within the reinsurance agreement. Premiums, Fee income and Policyholder benefits are reported net of reinsurance ceded. The Company has entered into coinsurance funds withheld reinsurance arrangements that contain embedded derivatives for which carrying value is estimated based on the change in the fair value of the assets supporting the funds withheld payable under the agreements. Significant accounting policies that were unchanged from those included in the Company’s December 31, 2022 Annual Report on Form 10-K as a result of the adoption of ASU 2018-12 have not been repeated. These policies include Internal Replacements, Contract Owner Account Balances, and Separate Accounts. Adoption of New Pronouncements Long-Duration Contracts The following section provides a description of the Company's adoption of ASU 2018-12 issued by the Financial Accounting Standards Board ("FASB") and the impact of the adoption on the Company's financial statements: This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and DAC for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts, measured on a retrospective catch-up basis and recognized in the period the update is made. The rate used is required to be updated quarterly, with related changes in the liability recorded in AOCI. • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits ("MRB"), with changes in fair value recognized in the Statements of Operations. Changes in the instrument-specific credit risk will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. An accounting election may be made to apply the DAC requirements to VOBA. • Insurance entities may make an accounting policy election to exclude contracts from application of the requirements in ASU 2018-12 when those contracts have been derecognized because of a sale or disposal of a legal entity before the effective date of ASU 2018-12. The Company adopted ASU 2018-12 on January 1, 2023, on a modified retrospective basis for the liability for future policy benefits and DAC and on a full retrospective basis for MRBs. The January 1, 2021 transition impact increased Total shareholders’ equity. This increase was primarily driven by the removal of DAC/VOBA and Premium deficiency reserve adjustment balances, and partially offset by the impact of remeasurement of Future policy benefits and Reinsurance recoverable using the discount rate at January 1, 2021. Total shareholders’ equity was also impacted by the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. The Company elected the option to exclude contracts reported as discontinued operations in 2021. Disclosures and post-transition comparative information have been restated to conform to the requirements of ASU 2018-12. The following tables provide additional information related to the transition adjustments: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses Exited (1) Balance, December 31, 2020 $ 119 $ 1,186 $ 70 Adjustment for removal of related balances in AOCI 571 104 635 Balance, January 1, 2021 $ 690 $ 1,290 $ 705 Liability for Future Policy Benefits Health Solutions Group (2) Health Solutions Voluntary (3) Businesses Exited (1) Balance, December 31, 2020 $ 822 $ 188 $ 5,448 Adjustment for reversal of related balances in AOCI — — (386) Adjustment for loss contracts under the modified retrospective approach 7 3 3 Effect of remeasurement of liability at current discount rate 118 83 1,362 Balance, January 1, 2021 $ 947 $ 274 $ 6,427 (1) Includes long duration retail individual life and annuity business exited via reinsurance (2) Includes long duration employee-sponsored group life and health products (3) Includes long duration employee-paid whole life products The following table presents information on transition adjustments, net of tax, related to the adoption of ASU 2018-12 for retained earnings and AOCI to arrive at the opening balances as of January 1, 2021: Total Shareholders' equity December 31, 2020 $ 11,178 AOCI Reversal of AOCI adjustments 1,328 Effect of remeasurement of liability at current discount rate (1,065) Total AOCI adjustments $ 263 Retained Earnings Establishment of MRBs $ (132) Other adjustments 27 Total Retained earnings $ (105) Total adjustment for the adoption of ASU 2018-12 $ 158 Total Shareholders' equity January 1, 2021 $ 11,336 The following table provides a description of the Company’s adoption of other new ASUs issued by the FASB and the impact of adoption on the Company’s financial statements: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. January 1, 2023 on a prospective basis. Adoption of the ASU did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements . ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments were effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2024. The Company has elected to apply the optional expedient provided in ASU 2020-04 for qualifying contract modifications. To date, adoption of the guidance has not had a material impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as the project nears completion. Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.

Investments (excluding Consolid

Investments (excluding Consolidated Investment Entities)	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Investments (excluding Consolidated Investment Entities)	50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 89 $ 255 $ — $ — $ — $ 344 2022 243 342 65 — — 650 2021 247 224 230 — — 701 2020 161 145 — 10 16 332 2019 234 74 29 — — 337 Prior 2,603 359 6 — 41 3,009 Total $ 3,577 $ 1,399 $ 330 $ 10 $ 57 $ 5,373 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 Prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 168 $ 109 $ 67 $ — $ 344 2022 229 56 203 162 650 2021 262 14 77 348 701 2020 225 25 5 77 332 2019 204 26 86 21 337 Prior 2,243 315 261 190 3,009 Total $ 3,331 $ 545 $ 699 $ 798 $ 5,373 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 Prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 70 $ 55 $ 7 $ 99 $ 39 $ 42 $ 3 $ 26 $ 3 $ 344 2022 140 131 48 99 113 93 5 1 20 650 2021 99 63 126 148 111 94 10 49 1 701 2020 73 156 17 10 12 40 — 7 17 332 2019 53 101 10 75 46 4 14 13 21 337 Prior 778 620 777 202 217 202 47 146 20 3,009 Total $ 1,213 $ 1,126 $ 985 $ 633 $ 538 $ 475 $ 79 $ 242 $ 82 $ 5,373 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 Prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 110 $ 157 $ 26 $ 19 $ 32 $ — $ — $ 344 2022 79 264 253 34 10 10 — 650 2021 36 151 363 124 — 18 9 701 2020 57 59 73 143 — — — 332 2019 46 83 161 36 11 — — 337 Prior 800 768 668 491 67 165 50 3,009 Total $ 1,128 $ 1,482 $ 1,544 $ 847 $ 120 $ 193 $ 59 $ 5,373 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 Prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: September 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded 2 3 Increase (decrease) on mortgage loans with an allowance recorded in a previous period 9 — Provision for expected credit losses 29 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 29 $ 18 The following table presents past due commercial mortgage loans as of the dates indicated: September 30, 2023 December 31, 2022 Delinquency: Current $ 5,335 $ 5,445 30-59 days past due 38 — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,373 $ 5,445 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of September 30, 2023, the Company had $38 of matured loans not paid off or extended, with an LTV ratio of 100%. As of December 31, 2022, the Company had no commercial mortgage loans in non-accrual status. The amount of interest income recognized on loans in non-accrual status for the nine months ended September 30, 2023 was immaterial. There was no interest income recognized on loans in non-accrual status for the year ended December 31, 2022. Net Investment Income The following table summarizes Net investment income by investment type for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Fixed maturities $ 438 $ 483 $ 1,336 $ 1,457 Equity securities 3 (3) 17 6 Mortgage loans on real estate 64 58 187 177 Policy loans 5 5 16 16 Short-term investments and cash equivalents 10 3 28 6 Limited partnerships and other 44 (10) 106 115 Gross investment income 564 536 1,690 1,777 Less: Investment expenses 17 14 53 44 Net investment income $ 547 $ 522 $ 1,637 $ 1,733 As of September 30, 2023 and December 31, 2022, the Company had $18 and $11, respectively, of investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Net Gains (Losses) Net gains (losses) were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (24) $ 8 $ (41) $ (71) Fixed maturities, at fair value option (135) (294) (243) (844) Equity securities, at fair value (3) (7) (6) (39) Derivatives 134 174 199 300 Embedded derivatives - fixed maturities (3) (2) (4) (8) Other derivatives — 2 — — Standalone derivatives 1 (3) 1 (2) Managed custody guarantees (15) (6) (12) (8) Stabilizer (9) — (9) 19 Mortgage loans (1) (1) (11) 4 Other investments 48 4 47 10 Net gains (losses) $ (7) $ (125) $ (79) $ (639) The Company recorded a gain of $45 in relation to its revaluation of the existing investment in Voya India which was recorded in Net gains (losses) in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023. Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Proceeds on sales $ 862 $ 1,138 $ 4,499 $ 3,358 Gross gains 11 30 54 60 Gross losses 14 19 69 63 " id="sjs-B4" xml:space="preserve">Investments (excluding Consolidated Investment Entities) Fixed Maturities Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of September 30, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 458 $ — $ 40 $ — $ — $ 418 U.S. Government agencies and authorities 54 1 2 — — 53 State, municipalities and political subdivisions 881 — 155 — — 726 U.S. corporate public securities 8,554 57 1,436 — — 7,175 U.S. corporate private securities 5,114 10 521 — — 4,603 Foreign corporate public securities and foreign governments (1) 2,974 10 431 — 6 2,547 Foreign corporate private securities (1) 3,111 10 241 — 1 2,879 Residential mortgage-backed securities 3,710 28 340 (1) — 3,397 Commercial mortgage-backed securities 4,226 2 739 — 10 3,479 Other asset-backed securities 2,439 11 105 — 2 2,343 Total fixed maturities, including securities pledged 31,521 129 4,010 (1) 19 27,620 Less: Securities pledged 1,157 — 155 — — 1,002 Total fixed maturities $ 30,364 $ 129 $ 3,855 $ (1) $ 19 $ 26,618 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 590 $ 12 $ 21 $ — $ — $ 581 U.S. Government agencies and authorities 58 3 2 — — 59 State, municipalities and political subdivisions 978 1 134 — — 845 U.S. corporate public securities 9,343 97 1,239 — — 8,201 U.S. corporate private securities 5,087 14 409 — — 4,692 Foreign corporate public securities and foreign governments (1) 3,343 18 403 — 9 2,949 Foreign corporate private securities (1) 3,254 7 225 — 2 3,034 Residential mortgage-backed securities 4,230 34 290 3 — 3,977 Commercial mortgage-backed securities 4,466 2 585 — — 3,883 Other asset-backed securities 2,307 3 173 — 1 2,136 Total fixed maturities, including securities pledged 33,656 191 3,481 3 12 30,357 Less: Securities pledged 1,303 3 144 — — 1,162 Total fixed maturities $ 32,353 $ 188 $ 3,337 $ 3 $ 12 $ 29,195 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The amortized cost and fair value of fixed maturities, including securities pledged, as of September 30, 2023, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Cost Fair Value Due to mature: One year or less $ 831 $ 812 After one year through five years 3,890 3,663 After five years through ten years 4,091 3,738 After ten years 12,334 10,188 Mortgage-backed securities 7,936 6,876 Other asset-backed securities 2,439 2,343 Fixed maturities, including securities pledged $ 31,521 $ 27,620 As of September 30, 2023 and December 31, 2022, the Company did not have any investments in a single issuer, other than obligations of the U.S. Government and government agencies, with a carrying value in excess of 10% of the Company’s Total shareholders' equity. Repurchase Agreements and Securities Pledged As of September 30, 2023 and December 31, 2022, the Company did not have any securities pledged in dollar rolls or reverse repurchase agreements. The Company engages in securities lending whereby the initial collateral is required at a rate of at least 102% of the market value of the loaned securities. The lending agent retains the collateral and invests it in high quality liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. In the normal course of business, the Company receives cash collateral and non-cash collateral in the form of securities. If cash is received as collateral, the lending agent retains the cash collateral and invests it in short-term liquid assets on behalf of the Company. Securities retained as collateral by the lending agent may not be sold or re-pledged, except in the event of default, and are not reflected on the Company’s Condensed Consolidated Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and MBS pools. The following table presents Securities pledged as of the dates indicated: September 30, 2023 December 31, 2022 Securities pledged/obligations under repurchase agreements (1) $ 112 $ 113 Securities loaned to lending agent (2) 682 907 Securities pledged as collateral (2)(3) 208 142 Total $ 1,002 $ 1,162 (1) Comprised of other asset-backed securities and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. (2) Included in Securities pledged on the Condensed Consolidated Balance Sheets. (3) See Collateral within the Derivatives Note to these Condensed Consolidated Financial Statements for more information. The following table presents collateral held by asset class that the Company pledged under securities lending as of the dates indicated: September 30, 2023 December 31, 2022 U.S. Treasuries $ 19 $ 53 U.S. corporate public securities 494 604 Short-term investments 1 — Foreign corporate public securities and foreign governments 193 285 Total (1) $ 707 $ 942 (1) As of September 30, 2023 and December 31, 2022, liabilities to return cash collateral were $560 and $807, respectively, and included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. The Company's securities lending activities are conducted on an overnight basis, and all securities loaned can be recalled at any time. The Company does not offset assets and liabilities associated with its securities lending program. Allowance for credit losses The following tables presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Nine Months Ended September 30, 2023 U.S. corporate public securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded — 10 — — 1 11 Reductions for securities sold during the period — — (2) — — (2) Increase (decrease) on securities with allowance recorded in previous period — — (1) (1) — (2) Balance as of September 30 $ — $ 10 $ 6 $ 1 $ 2 $ 19 Year Ended December 31, 2022 Residential mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 1 $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded — 9 — — 9 Reductions for securities sold during the period — — (57) — (57) Increase (decrease) on securities with allowance recorded in previous period (1) — 3 — 2 Balance as of December 31 $ — $ 9 $ 2 $ 1 $ 12 For additional information about the Company’s methodology and significant inputs used in determining whether a credit loss exists, see the Business, Basis of Presentation and Significant Accounting Policies Note to the Consolidated Financial Statements in Part II, Item 8. of the Annual Report on Form 10-K . Unrealized Capital Losses The following tables present available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by investment category and duration as of the dates indicated: As of September 30, 2023 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 276 $ 11 $ 99 $ 29 $ 375 $ 40 U.S. Government agencies and authorities 13 1 3 1 16 2 State, municipalities and political subdivisions 28 1 682 154 710 155 U.S. corporate public securities 1,375 97 4,761 1,339 6,136 1,436 U.S. corporate private securities 967 39 3,249 482 4,216 521 Foreign corporate public securities and foreign governments 565 25 1,670 406 2,235 431 Foreign corporate private securities 437 18 2,101 223 2,538 241 Residential mortgage-backed 349 17 1,307 323 1,656 340 Commercial mortgage-backed 84 4 3,234 735 3,318 739 Other asset-backed 110 5 1,618 100 1,728 105 Total $ 4,204 $ 218 $ 18,724 $ 3,792 $ 22,928 $ 4,010 As of December 31, 2022 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 197 $ 19 $ 9 $ 2 $ 206 $ 21 U.S. Government agencies and authorities 21 2 — — 21 2 State, municipalities and political subdivisions 751 121 30 13 781 134 U.S. corporate public securities 5,479 792 1,137 447 6,616 1,239 U.S. corporate private securities 3,569 322 458 87 4,027 409 Foreign corporate public securities and foreign governments 2,050 260 391 143 2,441 403 Foreign corporate private securities 2,728 211 65 14 2,793 225 Residential mortgage-backed 1,538 128 562 162 2,100 290 Commercial mortgage-backed 2,628 390 1,133 195 3,761 585 Other asset-backed 1,430 104 578 69 2,008 173 Total $ 20,391 $ 2,349 $ 4,363 $ 1,132 $ 24,754 $ 3,481 As of September 30, 2023, the average duration of our fixed maturities portfolio, including securities pledged, is between 6 and 6.5 years. As of September 30, 2023 and December 31, 2022, the Company concluded that an allowance for credit losses was not warranted for the securities above because the unrealized losses are interest rate related. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. Evaluating Securities for Impairments The Company performs a regular evaluation, on a security-by-security basis, of its available-for-sale securities holdings, including fixed maturity securities, in accordance with its impairment policy in order to evaluate whether such investments are impaired. For the three and nine months ended September 30, 2023, intent impairments included in the Condensed Consolidated Statements of Operations, but excluding impairments included in Other comprehensive income (loss), were $18 and $25, respectively. For the three and nine months ended September 30, 2022, intent impairments were $12 and $21, respectively. The Company may sell securities during the period in which fair value has declined below amortized cost for fixed maturities. In certain situations, new factors, including changes in the business environment, can change the Company’s previous intent to continue holding a security. Accordingly, these factors may lead the Company to record additional intent related capital losses. Debt Restructuring Upon the adoption of ASU 2022-02 as of January 1, 2023, the Company no longer identifies certain debt modifications as troubled debt restructuring, but instead evaluates all debt modifications to determine whether a modification results in a new loan or a continuation of an existing loan. Disclosures are required for loan modifications with borrowers experiencing financial difficulty. For the three and nine months ended September 30, 2023, the Company had no material debt modifications that require such disclosure. Mortgage Loans on Real Estate The Company diversifies its commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates mortgage loans based on relevant current information including a review of loan-specific performance, property characteristics and market trends. Loan performance is monitored on a loan specific basis through the review of submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review ensures properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk. Loan-to-value ("LTV") and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. These ratios are utilized as part of the review process described above. The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 89 $ 255 $ — $ — $ — $ 344 2022 243 342 65 — — 650 2021 247 224 230 — — 701 2020 161 145 — 10 16 332 2019 234 74 29 — — 337 Prior 2,603 359 6 — 41 3,009 Total $ 3,577 $ 1,399 $ 330 $ 10 $ 57 $ 5,373 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 Prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 168 $ 109 $ 67 $ — $ 344 2022 229 56 203 162 650 2021 262 14 77 348 701 2020 225 25 5 77 332 2019 204 26 86 21 337 Prior 2,243 315 261 190 3,009 Total $ 3,331 $ 545 $ 699 $ 798 $ 5,373 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 Prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 70 $ 55 $ 7 $ 99 $ 39 $ 42 $ 3 $ 26 $ 3 $ 344 2022 140 131 48 99 113 93 5 1 20 650 2021 99 63 126 148 111 94 10 49 1 701 2020 73 156 17 10 12 40 — 7 17 332 2019 53 101 10 75 46 4 14 13 21 337 Prior 778 620 777 202 217 202 47 146 20 3,009 Total $ 1,213 $ 1,126 $ 985 $ 633 $ 538 $ 475 $ 79 $ 242 $ 82 $ 5,373 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 Prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 110 $ 157 $ 26 $ 19 $ 32 $ — $ — $ 344 2022 79 264 253 34 10 10 — 650 2021 36 151 363 124 — 18 9 701 2020 57 59 73 143 — — — 332 2019 46 83 161 36 11 — — 337 Prior 800 768 668 491 67 165 50 3,009 Total $ 1,128 $ 1,482 $ 1,544 $ 847 $ 120 $ 193 $ 59 $ 5,373 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 Prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: September 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded 2 3 Increase (decrease) on mortgage loans with an allowance recorded in a previous period 9 — Provision for expected credit losses 29 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 29 $ 18 The following table presents past due commercial mortgage loans as of the dates indicated: September 30, 2023 December 31, 2022 Delinquency: Current $ 5,335 $ 5,445 30-59 days past due 38 — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,373 $ 5,445 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of September 30, 2023, the Company had $38 of matured loans not paid off or extended, with an LTV ratio of 100%. As of December 31, 2022, the Company had no commercial mortgage loans in non-accrual status. The amount of interest income recognized on loans in non-accrual status for the nine months ended September 30, 2023 was immaterial. There was no interest income recognized on loans in non-accrual status for the year ended December 31, 2022. Net Investment Income The following table summarizes Net investment income by investment type for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Fixed maturities $ 438 $ 483 $ 1,336 $ 1,457 Equity securities 3 (3) 17 6 Mortgage loans on real estate 64 58 187 177 Policy loans 5 5 16 16 Short-term investments and cash equivalents 10 3 28 6 Limited partnerships and other 44 (10) 106 115 Gross investment income 564 536 1,690 1,777 Less: Investment expenses 17 14 53 44 Net investment income $ 547 $ 522 $ 1,637 $ 1,733 As of September 30, 2023 and December 31, 2022, the Company had $18 and $11, respectively, of investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Net Gains (Losses) Net gains (losses) were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (24) $ 8 $ (41) $ (71) Fixed maturities, at fair value option (135) (294) (243) (844) Equity securities, at fair value (3) (7) (6) (39) Derivatives 134 174 199 300 Embedded derivatives - fixed maturities (3) (2) (4) (8) Other derivatives — 2 — — Standalone derivatives 1 (3) 1 (2) Managed custody guarantees (15) (6) (12) (8) Stabilizer (9) — (9) 19 Mortgage loans (1) (1) (11) 4 Other investments 48 4 47 10 Net gains (losses) $ (7) $ (125) $ (79) $ (639) The Company recorded a gain of $45 in relation to its revaluation of the existing investment in Voya India which was recorded in Net gains (losses) in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023. Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Proceeds on sales $ 862 $ 1,138 $ 4,499 $ 3,358 Gross gains 11 30 54 60 Gross losses 14 19 69 63

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of September 30, 2023 and December 31, 2022. The notional amounts and fair values of derivatives were as follows as of the dates indicated: September 30, 2023 December 31, 2022 Notional Asset Fair Value Liability Notional Asset Fair Value Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 105 $ 6 $ — $ 81 $ — $ 6 Cash flow hedges: Interest rate contracts 22 — — 22 — — Foreign exchange contracts 736 60 2 718 71 2 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 17,996 408 353 18,304 341 376 Foreign exchange contracts 219 6 7 160 9 2 Equity contracts 241 2 8 248 1 1 Credit contracts 157 — 3 174 — 2 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A — 1 N/A 3 — Within reinsurance agreements (4) N/A 101 41 N/A 95 46 Managed custody guarantees (3) N/A — 18 N/A — 6 Stabilizers (3) N/A — 9 N/A — — Total $ 583 $ 442 $ 520 $ 441 (1) Open derivative contracts are reported as Derivatives assets or liabilities at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, Other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable The Company does not offset any derivative assets and liabilities in the Condensed Consolidated Balance Sheets. The disclosures set out in the table below include the fair values of Over-The-Counter (“OTC”) and cleared derivatives excluding exchange traded contracts subject to master netting agreements or similar agreements as of the dates indicated: Gross Amount Recognized (1) Counterparty Netting (2) Cash Collateral Netting (2) Securities Collateral Netting (2) Net receivables/ payables September 30, 2023 Derivative assets $ 482 $ (328) $ (145) $ (6) $ 3 Derivative liabilities 373 (328) (26) (9) 10 December 31, 2022 Derivative assets 420 (295) (64) (6) 55 Derivative liabilities 389 (295) (88) (1) 5 (1) As of September 30, 2023, gross amounts do not exclude asset and liability exchange traded contracts. As of December 31, 2022, gross amounts exclude asset and liability exchange traded contracts of $2 and $0, respectively. (2) Represents the netting of receivable with payable balances, net of collateral, for the same counterparty under eligible netting agreements. Collateral Under the terms of the OTC Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties collateral to assure that terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. To the extent cash collateral is received and delivered, it is included in Payables under securities loan and repurchase agreements, including collateral held and Short-term investments under securities loan agreements, including collateral delivered, respectively, on the Condensed Consolidated Balance Sheets and is reinvested in short-term investments. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported in Securities pledged on the Condensed Consolidated Balance Sheets. As of September 30, 2023, the Company held $133 and pledged $11 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. As of December 31, 2022, the Company held $56 and pledged $79 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. In addition, as of September 30, 2023, the Company delivered $208 of securities and held $6 of securities as collateral. As of December 31, 2022, the Company delivered $142 of securities and held $7 of securities as collateral. The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Three Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ 7 $ — $ 64 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 3 — 4 Nine Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (11) $ (2) $ 126 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 8 — 9 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Three Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 547 $ (7) $ 522 $ (125) Fair value hedges: Foreign exchange contracts: Hedged items — (3) — (6) Derivatives designated as hedging instruments (1) — 4 — 6 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 3 — 4 — Nine Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 1,637 $ (79) $ 1,733 $ (639) Fair value hedges: Foreign exchange contracts: Hedged items — (1) — (13) Derivatives designated as hedging instruments (1) — 3 — 14 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 8 — 9 — (1) For the three months and nine months ended September 30, 2023, $1 and $2 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning, respectively. For the three months ended September 30, 2022, an immaterial amount of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the nine months ended September 30, 2022, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) on Derivative Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 138 $ 176 $ 196 $ 328 Foreign exchange contracts Net gains (losses) (2) — (1) (2) Equity contracts Net gains (losses) (7) (8) 1 (36) Credit contracts Net gains (losses) 1 — — (4) Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) (3) (2) (4) (8) Within reinsurance agreements (1) Policyholder benefits 29 57 11 233 Managed custody guarantees Net gains (losses) (15) (6) (12) (8) Stabilizers Net gains (losses) (9) — (9) 19 Total $ 132 $ 217 $ 182 $ 522 (1) For the three months and nine months ended September 30, 2023, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Net gains (losses). For the three months an d nine months ended September 30, 2022, the amount excluded gains (losses) of $(3) and $(2), respectively, from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (exclud

Fair Value Measurements (excluding Consolidated Investment Entities)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements (excluding Consolidated Investment Entities)	Fair Value Measurements (excluding Consolidated Investment Entities) Fair Value Measurement The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of September 30, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 366 $ 52 $ — $ 418 U.S. Government agencies and authorities — 52 1 53 State, municipalities and political subdivisions — 726 — 726 U.S. corporate public securities — 7,157 18 7,175 U.S. corporate private securities — 3,135 1,468 4,603 Foreign corporate public securities and foreign governments (1) — 2,547 — 2,547 Foreign corporate private securities (1) — 2,404 475 2,879 Residential mortgage-backed securities — 3,334 63 3,397 Commercial mortgage-backed securities — 3,479 — 3,479 Other asset-backed securities — 2,293 50 2,343 Total fixed maturities, including securities pledged 366 25,179 2,075 27,620 Equity securities 111 — 190 301 Derivatives: Interest rate contracts 1 407 — 408 Foreign exchange contracts — 72 — 72 Equity contracts — 2 — 2 Embedded derivative on reinsurance — 101 — 101 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,016 13 — 2,029 Assets held in separate accounts 79,775 5,375 341 85,491 Total assets $ 82,269 $ 31,149 $ 2,606 $ 116,024 Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 27 27 Derivatives: Interest rate contracts 11 342 — 353 Foreign exchange contracts — 9 — 9 Equity contracts — 8 — 8 Credit contracts — 3 — 3 Embedded derivative on reinsurance — (16) (2) 57 (3) 41 Total liabilities $ 11 $ 346 $ 196 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 433 $ 148 $ — $ 581 U.S. Government agencies and authorities — 58 1 59 State, municipalities and political subdivisions — 845 — 845 U.S. corporate public securities — 8,181 20 8,201 U.S. corporate private securities — 2,891 1,801 4,692 Foreign corporate public securities and foreign governments (1) — 2,946 3 2,949 Foreign corporate private securities (1) — 2,602 432 3,034 Residential mortgage-backed securities — 3,949 28 3,977 Commercial mortgage-backed securities — 3,883 — 3,883 Other asset-backed securities — 2,072 64 2,136 Total fixed maturities, including securities pledged 433 27,575 2,349 30,357 Equity securities 140 — 196 336 Derivatives: Interest rate contracts 2 339 — 341 Foreign exchange contracts — 80 — 80 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 95 — 95 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,430 24 — 2,454 Assets held in separate accounts 74,600 5,227 347 80,174 Total assets $ 77,605 $ 33,341 $ 2,892 $ 113,838 Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 6 6 Derivatives: Interest rate contracts 3 373 — 376 Foreign exchange contracts — 10 — 10 Equity contracts — 1 — 1 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 58 (3) 46 Total liabilities $ 3 $ 374 $ 176 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative. Valuation of Financial Assets and Liabilities at Fair Value Certain assets and liabilities are measured at estimated fair value on the Company's Condensed Consolidated Balance Sheets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The exit price and the transaction (or entry) price will be the same at initial recognition in many circumstances. However, in certain cases, the transaction price may not represent fair value. The fair value of a liability is based on the amount that would be paid to transfer a liability to a third-party with an equal credit standing. Fair value is required to be a market-based measurement that is determined based on a hypothetical transaction at the measurement date, from a market participant’s perspective. The Company considers three broad valuation approaches when a quoted price is unavailable: (i) the market approach, (ii) the income approach and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given the instrument being measured and the availability of sufficient inputs. The Company prioritizes the inputs to fair valuation approaches and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Company utilizes a number of valuation methodologies to determine the fair values of its financial assets and liabilities in conformity with the concepts of exit price and the fair value hierarchy as prescribed in ASC Topic 820. Valuations are obtained from third-party commercial pricing services, brokers and industry-standard, vendor-provided software that models the value based on market observable inputs. The valuations obtained from third-party commercial pricing services are non-binding. The Company reviews the assumptions and inputs used by third-party commercial pricing services for each reporting period in order to determine an appropriate fair value hierarchy level. The documentation and analysis obtained from third-party commercial pricing services are reviewed by the Company, including in-depth validation procedures confirming the observability of inputs. The valuations are reviewed and validated monthly through the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. When available, the fair value of the Company's financial assets and liabilities are based on quoted prices of identical assets in active markets and therefore, reflected in Level 1. The valuation approaches and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy are presented below. For fixed maturities classified as Level 2 assets, fair values are determined using a matrix-based market approach, based on prices obtained from third-party commercial pricing services and the Company’s matrix and analytics-based pricing models, which in each case incorporate a variety of market observable information as valuation inputs. The market observable inputs used for these fair value measurements, by fixed maturity asset class, are as follows: U.S. Treasuries: Fair value is determined using third-party commercial pricing services, with the primary inputs being stripped interest and principal U.S. Treasury yield curves that represent a U.S. Treasury zero-coupon curve. U.S. government agencies and authorities, State, municipalities and political subdivisions: Fair value is determined using third-party commercial pricing services, with the primary inputs being U.S. Treasury yield curves, trades of comparable securities, credit spreads off benchmark yields and issuer ratings. U.S. corporate public securities, Foreign corporate public securities and foreign governments: Fair value is determined using third-party commercial pricing services, with the primary inputs being benchmark yields, trades of comparable securities, issuer ratings, bids and credit spreads off benchmark yields. U.S. corporate private securities and Foreign corporate private securities: Fair values are determined using a matrix and analytics-based pricing model. The model incorporates the current level of risk-free interest rates, current corporate credit spreads, credit quality of the issuer and cash flow characteristics of the security. The model also considers a liquidity spread, the value of any collateral, the capital structure of the issuer, the presence of guarantees, and prices and quotes for comparably rated publicly traded securities. RMBS, CMBS and ABS: Fair value is determined using third-party commercial pricing services, with the primary inputs being credit spreads off benchmark yields, prepayment speed assumptions, current and forecasted loss severity, debt service coverage ratios, collateral type, payment priority within tranche and the vintage of the loans underlying the security. Generally, the Company does not obtain more than one vendor price from pricing services per instrument. The Company uses a hierarchy process in which prices are obtained from a primary vendor and, if that vendor is unable to provide the price, the next vendor in the hierarchy is contacted until a price is obtained or it is determined that a price cannot be obtained from a commercial pricing service. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Fair values of privately placed bonds are determined primarily using a matrix-based pricing model and are generally classified as Level 2 assets. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees and the Company’s evaluation of the borrower’s ability to compete in its relevant market. Using this data, the model generates estimated market values, which the Company considers reflective of the fair value of each privately placed bond. Equity securities: Level 2 and Level 3 equity securities, typically private equities or equity securities not traded on an exchange, are valued by other sources such as analytics or brokers. Derivatives: Derivatives are carried at fair value, which is determined using the Company’s derivative accounting system in conjunction with observable key financial data from third-party sources, such as yield curves, exchange rates, S&P 500 Index prices, London Interbank Offered Rates ("LIBOR"), Overnight Index Swap ("OIS") rates, and Secured Overnight Financing Rate ("SOFR"). The Company uses SOFR discounting for valuations of interest rate derivatives; however, certain legacy positions may continue to be discounted on OIS. The Company uses OIS for valuations of collateralized interest rate derivatives, which are obtained from third-party sources. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third-party brokers. Counterparty credit risk is considered and incorporated in the Company’s valuation process through counterparty credit rating requirements and monitoring of overall exposure. It is the Company’s policy to transact only with investment grade counterparties with a credit rating of A- or better. The Company’s nonperformance risk is also considered and incorporated in the Company’s valuation process. The Company also has certain credit default swaps and options that are priced by third party vendors or by using models that primarily use market observable inputs, but contain inputs that are not observable to market participants, which have been classified as Level 3. The remaining derivative instruments are valued based on market observable inputs and are classified as Level 2. Contingent consideration: The fair value of the contingent consideration liability associated with the Company’s acquisitions uses unobservable inputs and as such are reported as Level 3. Unobservable inputs include projected revenues, duration of earnouts and other metrics as well as discount rate. Changes in the fair value of the contingent consideration are recorded in Operating expenses in the Company’s Condensed Consolidated Statements of Operations. Stabilizer and MCGs : The Company records reserves for Stabilizer and MCG contracts containing guaranteed credited rates. The guarantee is treated as an embedded derivative or a stand-alone derivative (depending on the underlying product) and is required to be reported at fair value. The estimated fair value is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using relevant actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. These derivatives are classified as Level 3 liabilities. The discount rate used to determine the fair value of the Company's Stabilizer embedded derivative liabilities and MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). The nonperformance risk adjustment incorporates a blend of observable, similarly rated peer holding company credit spreads, adjusted to reflect the credit quality of the individual insurance subsidiary that issued the guarantee, as well as an adjustment to reflect the non-default spreads and the priority and recovery rates of policyholder claims. Embedded derivatives on reinsurance: The carrying value of embedded derivatives is estimated based upon the change in the fair value of the assets supporting the funds withheld payable under reinsurance agreements. The fair value of the embedded derivative is based on market observable inputs and is classified as Level 2. The remaining derivative instruments are classified as Level 3 and are estimated using the income approach. The fair value is calculated by estimating future cash flows for a certain discrete projection period, estimating the terminal value, if appropriate, and discounting these amounts to present value at a rate of return that considers the relative risk of the cash flows and the time value of money. Level 3 Financial Instruments The fair values of certain assets and liabilities are determined using prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (i.e., Level 3 as defined by ASC Topic 820), including but not limited to liquidity spreads for investments within markets deemed not currently active. These valuations, whether derived internally or obtained from a third-party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability. In addition, the Company has determined, for certain financial instruments, an active market is such a significant input to determine fair value that the presence of an inactive market may lead to classification in Level 3. In light of the methodologies employed to obtain the fair values of financial assets and liabilities classified as Level 3, additional information is presented below. The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended September 30, 2023 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — 1 — — — — — (3) 18 — — U.S. corporate private securities 1,732 — (49) 24 — — (46) 63 (256) 1,468 — (49) Foreign corporate private securities (1) 413 (2) (6) 58 — — (20) 53 (21) 475 (2) (6) Residential mortgage-backed securities 57 (3) — 3 — — — 6 — 63 (3) — Other asset-backed securities 45 — — 10 — — (1) — (4) 50 — — Total fixed maturities, including securities pledged 2,268 (5) (54) 95 — — (67) 122 (284) 2,075 (5) (55) Equity securities, at fair value 192 (2) — — — — — — — 190 (2) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (3) (24) — — — — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 344 (5) — 1 — (4) — 6 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — — — — 1 — (3) 18 — — U.S. corporate private securities 1,801 — (46) 104 — (3) (137) 45 (296) 1,468 — (48) Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 1 1 115 — — (197) 130 (7) 475 1 — Residential mortgage-backed securities 28 (6) — 37 — — — 4 — 63 (6) — Other asset-backed securities 64 — (1) 10 — — (1) — (22) 50 — (1) Total fixed maturities, including securities pledged 2,349 (5) (46) 266 — (3) (334) 179 (331) 2,075 (5) (49) Equity securities, at fair value 196 (10) — — — — — 4 — 190 (10) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) (20) — — (1) — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 347 (9) — 8 — (13) — 9 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended September 30, 2022 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 19 $ — $ (1) $ 3 $ — $ — $ (1) $ — $ (5) $ 15 $ — $ — U.S. corporate private securities 1,780 (2) (94) 77 — — (40) 22 — 1,743 (2) (95) Foreign corporate public securities and foreign governments (1) 4 — — — — — — — (4) — — — Foreign corporate private securities (1) 403 (2) (11) 22 — — (4) — (4) 404 (2) (11) Residential mortgage-backed securities 31 (4) — 2 — — — — (3) 26 (4) — Other asset-backed securities 63 — (2) 21 — — (1) — (9) 72 (1) (2) Total fixed maturities, including securities pledged 2,300 (8) (108) 125 — — (46) 22 (25) 2,260 (9) (108) Equity securities, at fair value 203 (8) — — — — — — — 195 (8) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (4) (5) — — — — — — — (9) — — Embedded derivatives on reinsurance (86) (3) — — — — — — — (89) — — Assets held in separate accounts (4) 349 (9) — 32 — (16) — — (17) 339 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (1) $ 7 $ — $ — $ (1) $ — $ (6) $ 15 $ — $ (1) U.S. corporate private securities 1,910 (4) (374) 235 — — (159) 145 (10) 1,743 (4) (373) Foreign corporate private securities (1) 353 (23) (42) 115 — — (33) 148 (114) 404 (6) (42) Residential mortgage-backed securities 43 (19) — 4 — — — — (2) 26 (19) — Other asset-backed securities 44 (1) (6) 52 — (10) (7) — — 72 (1) (6) Total fixed maturities, including securities pledged 2,366 (47) (423) 413 — (10) (200) 293 (132) 2,260 (30) (422) Equity securities, at fair value 203 (35) — 27 — — — — — 195 (35) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (20) 12 — — (1) — — — — (9) — — Embedded derivatives on reinsurance (87) (2) — — — — — — — (89) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — (8) — — — — — Assets held in separate accounts (4) 316 (35) — 164 — (20) — 6 (92) 339 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. For the three and nine months ended September 30, 2023 and 2022, the transfers in and out of Level 3 for fixed maturities were due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes when prices are not available from one of the commercial pricing services are reflected as transfers into Level 3. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate. Significant Unobservable Inputs The Company's Level 3 fair value measurements of its fixed maturities, equity securities and equity and credit derivative contracts are primarily based on broker quotes for which the quantitative detail of the unobservable inputs is neither provided nor reasonably corroborated, thus negating the ability to perform a sensitivity analysis. The Company performs a review of broker quotes by performing a monthly price variance comparison and back tests broker quotes to recent trade prices. Other Financial Instruments The following disclosures are made in accordance with the requirements of ASC Topic 825 which requires disclosure of fair value information about financial instruments, whether or not recognized at fair value on the Condensed Consolidated Balance Sheets. ASC Topic 825 excludes certain financial instruments, including insurance contracts and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: September 30, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 27,620 $ 27,620 $ 30,357 $ 30,357 Equity securities 301 301 336 336 Mortgage loans on real estate 5,373 4,938 5,445 5,149 Policy loans 358 358 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,029 2,029 2,454 2,454 Derivatives 482 482 422 422 Embedded derivatives on reinsurance 101 101 95 95 Other investments 63 63 68 68 Assets held in separate accounts 85,491 85,491 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 32,871 $ 33,433 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,176 1,180 1,285 1,281 Supplementary contracts, immediate annuities and other 455 423 727 636 Stabilizer and MCGs 27 27 6 6 Derivatives 373 373 389 389 Embedded derivative on reinsurance 41 41 46 46 Short-term debt 2 2 141 142 Long-term debt 2,095 1,881 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table presents the classification of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs and Value of Business Acquired	9 Months Ended
	Sep. 30, 2023
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired The following table presents a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses exited Balance as of January 1, 2022 $ 691 $ 1,158 $ 473 Deferrals of commissions and expenses 59 — 5 Amortization expense (59) (115) (39) Balance as of December 31, 2022 $ 691 $ 1,043 $ 439 Deferrals of commissions and expenses 44 — 3 Amortization expense (42) (79) (28) Balance as of September 30, 2023 $ 693 $ 964 $ 414 The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2023 December 31, 2022 DAC: Wealth Solutions Deferred and Individual Annuities $ 693 $ 691 Businesses exited 964 1,043 Other 207 190 VOBA 414 439 Total $ 2,278 $ 2,363

Reserves for Future Policy Bene

Reserves for Future Policy Benefits and Contract Owner Account Balances	9 Months Ended
	Sep. 30, 2023
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Reserves for Future Policy Benefits and Contract Owner Account Balances	Reserves for Future Policy Benefits and Contract Owner Account Balances The balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited are presented in the tables below for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Present Value of Expected Net Premiums: Balance at January 1 $ 77 $ 93 $ 97 $ 105 $ 4,244 $ 5,634 Beginning balance at original discount rate 84 85 100 92 4,128 4,226 Effect of change in cash flow assumptions (6) (7) 6 — (921) (69) Effect of actual variances from expected experience 18 23 6 20 (61) 86 Adjusted balance at January 1 96 101 112 112 3,146 4,243 Interest accrual 2 2 3 4 155 230 Net premiums collected (1) (16) (19) (12) (16) (243) (345) Ending balance at original discount rate 82 84 103 100 3,058 4,128 Effects of changes in discount rate assumptions (8) (7) (7) (3) (47) 116 Balance at end of period $ 74 $ 77 $ 96 $ 97 $ 3,011 $ 4,244 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 881 $ 1,048 $ 285 $ 359 $ 8,639 $ 11,444 Beginning balance at original discount rate 913 952 294 290 8,644 9,079 Effect of change in cash flow assumptions (15) (43) 13 (2) (805) (77) Effect of actual variances from expected experience 1 (27) 6 11 (80) (52) Adjusted balance at January 1 899 882 313 299 7,759 8,950 Issuances 103 139 — — 13 13 Interest accrual 18 25 11 14 317 458 Benefit payments (98) (133) (16) (19) (568) (777) Ending balance at original discount rate 922 913 308 294 7,521 8,644 Effects of changes in discount rate assumptions (57) (32) (29) (9) (330) (5) Balance at end of period $ 865 $ 881 $ 279 $ 285 $ 7,191 $ 8,639 Net liability for future policy benefits $ 791 $ 804 $ 183 $ 188 $ 4,179 $ 4,395 Less: Reinsurance recoverable 301 283 — — 4,127 4,411 Net liability for future policy benefits, after reinsurance recoverable $ 490 $ 521 $ 183 $ 188 $ 52 $ (16) (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: September 30, 2023 December 31, 2022 Health Solutions Group $ 791 $ 804 Health Solutions Voluntary 183 188 Businesses Exited - Future policy benefits 4,179 4,395 Businesses Exited – Additional liability 2,001 2,107 Other 2,217 2,225 Total $ 9,371 $ 9,719 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: September 30, 2023 December 31, 2022 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 1,149 $ 922 $ 1,141 $ 913 Expected future gross premiums 312 247 286 231 Health Solutions Voluntary Expected future benefit payments 671 308 588 294 Expected future gross premiums 343 214 307 205 The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited September 30, 2023 December 31, 2022 Balance at beginning of period $ 2,107 $ 1,715 Effect of change in cash flow assumptions (44) 540 Effect of actual variances from expected experience (20) 15 Adjusted balance at January 1 2,043 2,270 Interest accrual 64 80 Excess Benefits (301) (427) Assessments 195 184 Balance at end of period 2,001 2,107 Less: Reinsurance recoverable 1,949 2,054 Net additional liability, after reinsurance recoverable $ 52 $ 53 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.1 % 5.3 % 5.3 % 4.9 % 5.0 % Current discount rate 5.8 % 5.2 % 6.0 % 5.4 % 5.6 % 5.7 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability. The weighted average interest rates for the additional liability related to businesses exited were 4.2% and 4.3% for the periods ended September 30, 2023 and December 31, 2022, respectively. The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Balance at January 1 $ 33,622 $ 33,044 $ 5,146 $ 5,532 Deposits 1,726 2,962 217 310 Fee income (6) (8) (281) (384) Surrenders and withdrawals (3,891) (4,280) (310) (281) Benefit payments (133) (157) (111) (144) Net transfers from (to) the general account (59) 1,174 (1) — Interest credited 664 874 108 150 Other 8 13 — (37) Ending Balance $ 31,931 $ 33,622 $ 4,768 $ 5,146 Weighted-average crediting rate 2.7 % 2.6 % 2.5 % 2.5 % Net amount at risk (1) $ 148 $ 199 $ 801 $ 900 Cash surrender value $ 31,455 $ 33,125 $ 1,581 $ 1,824 (1) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table shows a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2023 December 31, 2022 Wealth Solutions Deferred group and individual annuity $ 31,931 $ 33,622 Businesses exited 4,768 5,146 Other 3,436 3,687 Total $ 40,135 $ 42,455 The following table summarizes detail on the differences between the interest rate being credited to contract holders as of September 30, 2023, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 141 $ 6,261 $ 2,696 $ 2,010 $ 833 $ 785 $ 12,726 1.01% - 2.00% 553 135 51 4 2 6 751 2.01% - 3.00% 11,617 77 53 110 — 3 11,860 3.01% - 4.00% 9,197 153 — 5 — — 9,355 4.01% and Above 1,584 84 — — — — 1,668 Renewable beyond 12 months (MYGA) (2) 427 — — — 3 — 430 Total discretionary rate setting products $ 23,519 $ 6,710 $ 2,800 $ 2,129 $ 838 $ 794 $ 36,790 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after September 30, 2023 on which we are required to credit interest above the contractual GMIR for at least the next twelve months. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of December 31, 2022 and the respective GMIRs: Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 5,848 $ 2,967 $ 1,907 $ 1,112 $ 1,462 $ 102 $ 13,398 1.01% - 2.00% 707 51 35 2 2 7 804 2.01% - 3.00% 12,677 56 47 109 — 3 12,892 3.01% - 4.00% 9,448 153 — — — — 9,601 4.01% and Above 1,643 87 — — — — 1,730 Renewable beyond 12 months (MYGA) (2) 402 — — — 3 — 405 Total discretionary rate setting products $ 30,725 $ 3,314 $ 1,989 $ 1,223 $ 1,467 $ 112 $ 38,830 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based.

Reinsurance

Reinsurance	9 Months Ended
	Sep. 30, 2023
Insurance [Abstract]
Reinsurance	Reinsurance The Company reinsures its business through a diversified group of reinsurers. However, the Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances are evaluated by monitoring ratings and evaluating the financial strength of its reinsurers. Large reinsurance recoverable balances with offshore or other non-accredited reinsurers are secured through various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit ("LOC"). Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: September 30, 2023 Direct Assumed Ceded Total, Assets Premiums receivable $ 179 $ 10 $ (208) $ (19) Reinsurance recoverable, net of allowance for credit losses — — 11,784 11,784 Total $ 179 $ 10 $ 11,576 $ 11,765 Liabilities Future policy benefits and contract owner account balances $ 48,525 $ 981 $ — $ 49,506 Liability for funds withheld under reinsurance agreements 96 — — 96 Total $ 48,621 $ 981 $ — $ 49,602 December 31, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 11 $ (212) $ (29) Reinsurance recoverable, net of allowance for credit losses — — 12,455 12,455 Total $ 172 $ 11 $ 12,243 $ 12,426 Liabilities Future policy benefits and contract owner account balances $ 51,137 $ 1,037 $ — $ 52,174 Liability for funds withheld under reinsurance agreements 104 — — 104 Total $ 51,241 $ 1,037 $ — $ 52,278 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended September 30, 2023 2022 Premiums: Direct premiums $ 896 $ 815 Reinsurance assumed 5 5 Reinsurance ceded (219) (214) Net premiums $ 682 $ 606 Fee income: Gross fee income $ 585 $ 543 Reinsurance assumed 4 5 Reinsurance ceded (100) (103) Net fee income $ 489 $ 445 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,099 $ 1,351 Reinsurance assumed 21 13 Reinsurance ceded (321) (827) Net interest credited and other benefits to contract owners / policyholders $ 799 $ 537 Nine Months Ended September 30, 2023 2022 Premiums: Direct premiums $ 2,706 $ 2,439 Reinsurance assumed 20 19 Reinsurance ceded (682) (647) Net premiums $ 2,044 $ 1,811 Fee income: Gross fee income $ 1,718 $ 1,588 Reinsurance assumed 13 14 Reinsurance ceded (304) (311) Net fee income $ 1,427 $ 1,291 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 3,221 $ 3,431 Reinsurance assumed 51 35 Reinsurance ceded (1,040) (1,631) Net interest credited and other benefits to contract owners / policyholders $ 2,232 $ 1,835 If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. As of September 30, 2023 and December 31, 2022, the Company had a deposit asset of $1.3 billion and $1.5 billion, respectively, which is reported in Other assets on the Condensed Consolidated Balance Sheets.

Separate Accounts

Separate Accounts	9 Months Ended
	Sep. 30, 2023
Other Liabilities Disclosure [Abstract]
Separate Accounts	Separate Accounts The following tables present a rollforward of Separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Condensed Consolidated Balance Sheets, for the periods indicated: September 30, 2023 December 31, 2022 Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Balance at January 1 $ 7,196 $ 69,152 $ 76,348 $ 8,091 $ 86,927 $ 95,018 Policyholder behavior (1) (288) 244 (44) (68) (1,309) (1,377) Fee income (25) (316) (341) (34) (423) (457) Investment performance 35 5,698 5,733 (794) (16,044) (16,838) Other 1 — 1 1 1 2 Balance at end of period $ 6,919 $ 74,778 $ 81,697 $ 7,196 $ 69,152 $ 76,348 Reconciliation to Condensed Consolidated Balance Sheets: Other 3,794 3,826 Total Separate Account liabilities $ 85,491 $ 80,174 (1) Policyholder behavior includes premiums and deposits, surrenders and withdrawals, benefit payments, and net transfers to and from the separate account. Stabilizer products allow the contract holder to select either the market value of the account or the book value of the account at termination. The book value of the account is equal to deposits plus interest, less any withdrawals. The fair value is estimated using the income approach. Cash surrender value represents the amount of the contract holders' account balances distributable at the balance sheet date, less certain surrender charges. The cash surrender value for Wealth Solutions deferred annuity products was $74,747 and $69,121, as of September 30, 2023 and December 31, 2022, respectively. The aggregate fair value of assets, by major investment asset category, supporting separate accounts was as follows for the periods indicated: September 30, 2023 December 31, 2022 U.S. Treasury securities and obligations of U.S. government corporations and agencies $ 1,026 $ 1,586 Corporate debt securities 1,752 1,647 Foreign debt securities 672 660 Mortgage-backed securities 3,319 3,434 Equity securities (including mutual funds) 78,133 72,309 Cash, cash equivalents and short-term investments 337 311 Receivable for securities and accruals 252 227 Total $ 85,491 $ 80,174

Segments

Segments	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Segments	Segments The Company provides its principal products and services through three segments: Wealth Solutions, Health Solutions and Investment Management. The Company's chief operating decision maker views and manages the business through these three segments. The Wealth Solutions segment provides tax-deferred, employer-sponsored retirement savings plans and administrative services to corporate, education, healthcare, other non-profit and government entities, and stable value products to institutional clients where the Company may or may not be providing defined contribution products and services, as well as individual retirement accounts ("IRAs"), other retail financial products and comprehensive financial services to individual customers. The Health Solutions segment provides stop loss, group life, voluntary employee-paid and disability products to mid-sized and large businesses as well as benefit administration software solutions to employers and health plans. On January 24, 2023, the Company completed its acquisition of Benefitfocus. The financial results of Benefitfocus are reported in the Health Solutions segment for periods after the acquisition. The Investment Management segment provides investment products and retirement solutions across a broad range of geographies, market sectors, investment styles and capitalization spectrums. Products and services are offered to institutional clients, including public, corporate and union retirement plans, endowments and foundations and insurance companies, as well as individual investors and general accounts of the Company's insurance subsidiaries and are distributed through the Company's direct sales force, consultant channel and intermediary partners (such as banks, broker-dealers and independent financial advisers). The Company includes in Corporate the following corporate and business activities: • corporate operations, corporate level assets and financial obligations, financing and interest expenses, dividend payments made to preferred shareholders, and other items not allocated or directly related to the Company's segments, including items such as expenses related to organizational restructurings, certain expenses and liabilities of employee benefit plans, certain adjustments to short-term and long-term incentive accruals and intercompany eliminations; and • investment income on assets backing surplus in excess of amounts held at the segment level. Measurement Effective the first quarter of 2023, the Company excludes from Adjusted operating earnings before income taxes the amortization of acquisition-related intangible assets. In addition, the Company excludes the expected return on plan assets net of interest costs associated with our qualified defined benefit pension plan, which are influenced by economic and market conditions and not indicative of normal operations. Adjusted operating earnings before income taxes in Corporate still includes the service costs related to the Company's qualified defined benefit pension plan and service and interest costs related to non-qualified defined benefit pension plans. Historical periods have been recast to conform with this change. Adjusted operating earnings before income taxes is a meaningful measure used by management to evaluate its business and segment performance. This measure enhances the understanding of the Company’s financial results by focusing on the operating performance and trends of the underlying core business segments by excluding items that tend to be highly variable from period to period based on capital market conditions and/or other factors. The Company uses the same accounting policies and procedures to measure segment Adjusted operating earnings before income taxes as it does for the directly comparable U.S. GAAP measure Income (loss) before income taxes. Adjusted operating earnings before income taxes does not replace Income (loss) before income taxes as the U.S. GAAP measure of the Company’s consolidated results of operations. Therefore, the Company believes that it is useful to evaluate both measures when reviewing the Company’s financial and operating performance. Each segment’s Adjusted operating earnings before income taxes is calculated by adjusting Income (loss) before income taxes for the following items: • Net investment gains (losses), which are significantly influenced by economic and market conditions, including interest rates and credit spreads, and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations, and changes in the fair value of derivative instruments, excluding gains (losses) associated with swap settlements and accrued interest. It also includes changes in the fair value of derivatives related to managed custody guarantees, net of related reserve increases (decreases), less the estimated cost of these benefits, changes in nonperformance spread, and changes in market risk benefits; • Income (loss) related to businesses exited or to be exited through reinsurance or divestment, which includes gains and (losses) associated with transactions to exit blocks of business, amortization of intangible assets and residual run-off activity. Excluding this activity better reveals trends in the Company's core business and more closely aligns Adjusted operating earnings before income taxes with how the Company manages its segments; • Income (loss) attributable to noncontrolling interests to which the Company is not economically entitled, such as Allianz's stake in the results of VIM Holdings LLC (referred to as redeemable noncontrolling interest or Allianz noncontrolling interest) or the attribution of results from consolidated VIEs or VOEs; • Dividend payments made to preferred shareholders are included as reductions to reflect the Adjusted operating earnings before income taxes that are available to common shareholders; • Other adjustments may include the following items: • Income (loss) related to early extinguishment of debt since the outcome of decisions to restructure debt are not indicative of normal operations; • Impairment of goodwill and intangible assets as these represent losses related to infrequent events and do not reflect normal, cash-settled expenses; • Amortization of acquisition-related intangible assets as well as contingent consideration fair value adjustments incurred in connection with certain acquisitions which are not indicative of current Operating expense fundamentals; • Expected return on plan assets net of interest costs associated with the Company's qualified defined benefit pension plan and immediate recognition of net actuarial gains (losses) related to all of the Company's pension and other postretirement benefit obligations and gains (losses) from plan amendments and curtailments. These amounts do not reflect cash-settled expenses, and are not indicative of current Operating expense fundamentals; and • Other items not indicative of normal operations or performance of the Company's segments or related to events such as capital or organizational restructurings, including certain costs related to debt and equity offerings, acquisition / merger integration expenses, severance and other third-party expenses associated with such activities, and expenses attributable to vacant real estate. These items vary widely in timing, scope and frequency between periods as well as between companies to which the Company is compared. Accordingly, the Company adjusts for these items as management believes that these items distort the ability to make a meaningful evaluation of the current and future performance of the Company's segments. The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 179 $ 128 $ 485 $ 553 Health Solutions 53 154 271 226 Investment Management 63 51 168 129 Corporate (52) (66) (175) (193) Total including Allianz noncontrolling interest 242 267 749 715 Less: Earning (loss) attributable to Allianz noncontrolling interest 14 13 35 13 Total $ 229 $ 254 $ 715 $ 703 Adjustments: Net investment gains (losses) 42 (9) (4) (180) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (68) (13) (122) (105) Income (loss) attributable to noncontrolling interests (16) (138) 107 (20) Dividend payments made to preferred shareholders 14 14 32 32 Other adjustments (28) (37) (150) (85) Total adjustments to income (loss) before income taxes (56) (183) (138) (357) Income (loss) before income taxes $ 172 $ 71 $ 576 $ 345 Adjusted operating revenues is a measure of the Company's segment revenues. Each segment's Operating revenues are calculated by adjusting Total revenues to exclude the following items: • Net investment gains (losses); • Revenues related to businesses exited or to be exited through reinsurance or divestment; • Revenues attributable to noncontrolling interests, which represents the attribution of results from consolidated VIEs or VOEs; and • Other adjustments primarily reflect fee income earned by the Company's broker-dealers for sales of non-proprietary products, which are reflected net of commission expense in the Company's segments’ operating revenues, other items where the income is passed on to third parties and the elimination of intercompany investment expenses included in Adjusted operating revenues. The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Adjusted operating revenues by segment: Wealth Solutions $ 702 $ 645 $ 2,090 $ 2,109 Health Solutions 768 645 2,317 1,933 Investment Management 233 192 688 542 Corporate 14 13 39 51 Total $ 1,717 $ 1,495 $ 5,135 $ 4,635 Adjustments: Net investment gains (losses) $ 40 $ (18) $ (21) $ (198) Revenues related to businesses exited or to be exited through reinsurance or divestment 21 (30) 53 (139) Revenues attributable to noncontrolling interests 22 (130) 211 11 Other adjustments 24 30 152 66 Total adjustments to revenues 106 (148) 395 (259) Total revenues $ 1,823 $ 1,345 $ 5,529 $ 4,375 Other Segment Information The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Investment Management intersegment revenues $ 21 $ 23 $ 65 $ 68 The summary below presents Total assets for the Company’s segments as of the dates indicated: September 30, 2023 December 31, 2022 Wealth Solutions $ 114,401 $ 111,701 Health Solutions 3,292 2,668 Investment Management 1,602 1,611 Corporate 25,685 26,712 Total assets, before consolidation (1) 144,980 142,692 Consolidation of investment entities 4,285 3,914 Total assets $ 149,265 $ 146,606 (1) Total assets, before consolidation include the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Share-based Incentive Compensat

Share-based Incentive Compensation Plans	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Incentive Compensation Plans	Share-based Incentive Compensation PlansThe Company offers equity-based compensation awards to its employees and non-employee directors under various employee and non-employee incentive plans (together, the "Omnibus Plans"). As of September 30, 2023, common stock reserved and available for issuance under the Omnibus Plans was 8,709,137 shares. Compensation Cost The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Restricted Stock Unit (RSU) awards $ 14 $ 8 $ 67 $ 38 Performance Stock Unit (PSU) awards 7 6 43 37 Total share-based compensation expense 21 14 110 75 Income tax benefit 4 3 26 21 After-tax share-based compensation expense $ 17 $ 11 $ 84 $ 54 Awards Outstanding The following table summarizes RSU and PSU awards activity under the Omnibus Plans for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2023 1.5 $ 60.91 2.1 $ 55.68 Adjustment for PSU performance factor — — (0.1) 61.50 Granted 1.7 70.51 0.8 66.10 Vested (1.1) 63.51 (0.5) 62.76 Forfeited * 66.21 — * 66.55 Outstanding as of September 30, 2023 2.1 $ 67.12 2.3 $ 61.22 *Less than 0.1 The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2023 1.6 $ 43.05 Granted — — Exercised (0.4) 38.70 Forfeited — — Outstanding as of September 30, 2023 1.2 $ 44.59 Vested, exercisable, as of September 30, 2023 1.2 $ 44.59

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Shareholder's Equity	Shareholders' Equity Common Shares The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 11.7 (11.7) Share-based compensation 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common shares issued 9.6 — 9.6 Common shares acquired - share repurchase — 3.1 (3.1) Share-based compensation 2.1 0.7 1.4 Balance, September 30, 2023 109.5 4.4 105.1 Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Dividends declared per share of Common Stock $ 0.40 $ 0.20 $ 0.80 $ 0.60 Share Repurchase Program From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock. These authorizations permit stock repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including 10b5-1 plans, or tender offers. Share repurchase authorizations typically expire if unused by a prescribed date. As of September 30, 2023, the Company was authorized to repurchase shares up to an aggregate purchase amount of $555. This share repurchase authorization expires on September 30, 2024 (unless extended) and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Company's Board of Directors at any time. During the nine months ended September 30, 2023, the Company repurchased 3.1 million shares of common stock for $216. Subsequent to September 30, 2023, the Company repurchased 773,153 shares pursuant to a 10b5-1 plan for an aggregate purchase price of $51. Warrants On May 7, 2013, the Company issued warrants to purchase up to 26,050,846 shares of the Company's common stock equal in the aggregate to 9.99% of the issued and outstanding shares of common stock on that date. On May 10, 2023, the warrants were net share settled in accordance with their terms, resulting in the issuance of 9.6 million common shares. No warrants remain outstanding as of September 30, 2023. For more information related to the warrants, refer to the Shareholders’ equity Note to the Consolidated Financial Statements included in Part II, Item 8. of the Annual Report on Form 10-K . Preferred Stock As of September 30, 2023 and December 31, 2022, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: September 30, 2023 December 31, 2022 Series Issued Outstanding Issued Outstanding 7.758% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000 On September 15, 2023, the rate on the Non-cumulative Preferred Stock, Series A was reset from 6.125% to 7.758% in accordance with the terms of the preferred stock and applies for the next five years. The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended September 30, Per Share Aggregate Per Share Aggregate 2023 $ 30.625 $ 10 $ 13.375 $ 4 2022 30.625 10 13.375 4 Nine Months Ended September 30, 2023 $ 61.250 $ 20 $ 40.125 $ 12 2022 61.250 20 40.125 12 As of September 30, 2023, there were no preferred stock dividends in arrears.

Earnings per Common Share

Earnings per Common Share	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (in millions, except for per share data) 2023 2022 2023 2022 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 246 $ 42 $ 610 $ 296 Less: Preferred stock dividends 14 14 32 32 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest (16) (138) 107 (20) Net income (loss) available to common shareholders $ 248 $ 166 $ 471 $ 284 Weighted average common shares outstanding Basic 105.8 97.9 102.2 101.9 Dilutive Effects: Warrants (2) — 6.2 4.3 7.2 RSU awards 1.1 0.9 1.1 0.9 PSU awards 1.1 0.9 1.2 0.8 Stock Options 0.4 0.5 0.5 0.6 Diluted 108.4 106.4 109.3 111.4 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (1) : Basic $ 2.35 $ 1.70 $ 4.62 $ 2.79 Diluted $ 2.29 $ 1.57 $ 4.31 $ 2.55 (1) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method. (2) See the Shareholders' Equity

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Shareholders' equity included the following components of AOCI as of the dates indicated: September 30, 2023 2022 Fixed maturities, net of impairment $ (3,881) $ (3,669) Derivatives (1) 100 187 Change in current discount rate (850) (858) Deferred income tax asset (liability) 1,096 1,034 Total (3,535) (3,306) Pension and other postretirement benefits liability, net of tax 2 3 AOCI $ (3,533) $ (3,303) (1) Gains and losses reported in Accumulated Other Comprehensive Income (AOCI) from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of September 30, 2023, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $16. Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (937) $ 197 $ (740) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 18 (4) 14 Change in unrealized gains/losses on available-for-sale securities (919) 193 (726) Derivatives: Derivatives 7 (1) (2) 5 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (4) 1 (3) Change in unrealized gains/losses on derivatives 3 (1) 2 Change in current discount rate (23) 5 (18) Change in Accumulated other comprehensive income (loss) $ (939) $ 197 $ (742) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (619) $ 130 $ (489) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 32 (7) 25 Change in unrealized gains (losses) on available-for-sale securities (587) 123 (464) Derivatives: Derivatives (11) (1) 2 (9) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (14) 3 (11) Change in unrealized gains (losses) on derivatives (25) 5 (20) Change in current discount rate 7 (1) 6 Change in Accumulated other comprehensive income (loss) $ (605) $ 127 $ (478) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended September 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (1,742) $ 367 $ (1,375) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (1) — (1) Change in unrealized gains (losses) on available-for-sale securities (1,743) 367 (1,376) Derivatives: Derivatives 63 (1) (14) 49 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 58 (13) 45 Change in current discount rate 93 (20) 73 Change in Accumulated other comprehensive income (loss) $ (1,592) $ 334 $ (1,258) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (6,953) $ 1,461 $ (5,492) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 89 (19) 70 Change in unrealized gains (losses) on available-for-sale securities (6,864) 1,442 (5,422) Derivatives: Derivatives 122 (1) (26) 96 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (15) 3 (12) Change in unrealized gains (losses) on derivatives 107 (23) 84 Change in current discount rate 289 (61) 228 Change in Accumulated other comprehensive income (loss) $ (6,468) $ 1,358 $ (5,110) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Revenue from Contract with Cust

Revenue from Contract with Customers	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with CustomersRevenue for various financial services and software subscriptions and services is measured based on consideration specified in a contract with a customer and is recognized when the Company has satisfied a performance obligation, unless the transaction price includes variable consideration that is constrained; in such case, we recognize revenue when the uncertainty associated with the constrained amount is subsequently resolved. • Financial Services – For advisory, asset management, and recordkeeping and administration ("R&A") services, the Company recognizes revenue as services are provided, generally over time. The Company provides distribution services at a point in time and recognizes the related revenue as consideration is received. Revenue from shareholder servicing is recognized as services are provided over time. Contract terms are typically less than one year, and consideration is variable. Revenue for financial services is recorded in Fee income and Other revenue in the Condensed Consolidated Statements of Operations. • Software Subscriptions and Services – Software subscriptions and services include access to and usage of cloud-based benefits software for employer and health plan customers, software implementation and support services, and distribution services. Contract terms are typically one For a description of principal activities by segment from which the Company generates revenue, see the Segments Note in these Condensed Consolidated Financial Statements for further information. Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Wealth Solutions Advisory and R&A $ 125 $ 120 $ 369 $ 380 Distribution and shareholder servicing 29 29 88 93 Investment Management Advisory, asset management and R&A 236 264 698 593 Distribution and shareholder servicing 36 34 100 114 Health Solutions R&A 4 4 15 13 Software subscriptions and services 53 — 167 — Corporate R&A 8 13 25 51 Total financial services and software subscriptions and services revenue 491 464 1,462 1,244 Revenue from other sources (1) 79 14 210 164 Total Fee income and Other revenue $ 570 $ 478 $ 1,672 $ 1,408 (1) Primarily consists of revenue from insurance contracts and financial instruments. Net receivables of $361 and $299 are included in Other assets on the Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022, respectively.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred. The Company's effective tax rate for the three months ended September 30, 2023 was (43.0)%. The effective tax rate differed from the statutory rate of 21% primarily due to the Resolution Capital Loss described below, the effect of the dividends received deduction ("DRD") and tax credits. The Company's effective tax rate for the nine months ended September 30, 2023 was (5.9)%. The effective tax rate differed from the statutory rate of 21% primarily due to the Resolution Capital Loss, the effect of the DRD, noncontrolling interest and tax credits. The Company's effective tax rates for the three and nine months ended September 30, 2022 were 40.8% and 14.2%, respectively. The effective tax rates differed from the statutory rate of 21% primarily due to the effect of the DRD, tax credits and noncontrolling interest. On January 4, 2021, the Company completed a series of transactions pursuant to a Master Transaction Agreement ("MTA") with Resolution Life U.S. Holdings Inc. ("Resolution Life US"). As a part of these transactions, Resolution Life US acquired the Company's wholly owned subsidiary, Security Life of Denver Company ("SLD"). SLD generated capital losses in the 2022 tax year, which will be included in a carryback claim for the Company in accordance with the MTA, resulting in a $92 tax benefit and decrease to the effective tax rate (the "Resolution Capital Loss") for the Company. On August 1, 2023, the Company acquired all remaining equity interest in Voya India. The transaction resulted in a GAAP-to-tax outside basis difference of $45. The Company has asserted that its investment in India as of the August 1, 2023 acquisition date is permanently reinvested; therefore, no provision for U.S. federal and state income taxes or foreign withholding taxes has been made in the Company’s current year consolidated financial statements related to the acquisition. In August 2022, President Biden signed into law the Inflation Reduction Act of 2022, which imposes a 15% corporate alternative minimum tax ("CAMT") on the adjusted financial statement income of large corporations. The CAMT is effective in taxable years beginning after December 31, 2022. Recently, the Treasury issued guidance clarifying the treatment of financial statement income related to noncontrolling interests, making it clear that the Company will not be within the scope of CAMT for 2023. For the 2024 tax year, there is uncertainty around whether the Company will be subject to the CAMT, which is driven by limited guidance to date by the US Treasury and IRS. If the CAMT applies in a future year, the Company will be required to pay tax at the 15% CAMT rate despite our U.S. Federal net operating loss carryforwards. Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets ("DTAs") will not be realized. The Company reviews all available positive and negative evidence to determine if a valuation allowance is recorded, including historical and projected pre-tax book income, tax planning strategies and reversals of temporary differences. As of September 30, 2023, the Company had year-to-date losses on securities of $(612) in Other comprehensive income, which increased the related DTA. However, operating income remained positive for the period and was largely consistent with the 2022 year-end valuation allowance analysis. After evaluating the positive and negative evidence, the Company did not change its judgement regarding the realization of DTAs. For more information related to the valuation allowance, refer to the Income Taxes Note to the Consolidated Financial Statements included in Part II, Item 8. of the Annual Report on Form 10-K . Tax Regulatory Matters For the tax years 2021 through 2023, the Company participates in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2023 tax year, the Company is in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year.

Financing Agreements

Financing Agreements	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-term and Long-term Debt The following table summarizes the carrying value of the Company’s debt issued or borrowed and outstanding as of the periods indicated: Issuer Maturity September 30, 2023 December 31, 2022 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 389 $ — 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 444 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (1) Voya Financial, Inc. 01/23/2048 336 336 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 — 388 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 — 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 1.25% Notes, due 2023 Benefitfocus, Inc. 12/15/2023 2 — Subtotal 2,097 2,235 Less: Current portion of long-term debt 2 141 Total $ 2,095 $ 2,094 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below. As of September 30, 2023, the Company was in compliance with its debt covenants. Aetna Notes As of September 30, 2023, the outstanding principal amount of the Aetna Notes was $218, which is guaranteed by ING Group. As of September 30, 2023, the Company provided $224 of collateral benefiting ING Group, comprised of a deposit of $212 to a control account with a third-party collateral agent and $12 of letter of credit. The collateral may be exchanged at any time upon the posting of any other form of acceptable collateral to the account. Credit Facilities The Company uses credit facilities as part of its capital management practices. Total fees associated with credit facilities for the nine months ended September 30, 2023 and 2022 were immaterial. The following table summarizes the Company's credit facilities as of September 30, 2023: ($ in millions) Obligor / Applicant Business Supported Secured / Unsecured Committed / Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Other Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Other Unsecured Committed 04/07/2025 200 12 (1) 188 Total $ 700 $ 12 $ 688 (1) Amount utilized as collateral for outstanding Aetna Notes. Put Option Agreement for Senior Debt Issuance During 2015, the Company entered into an off-balance sheet 10-year put option agreement with a Delaware trust formed by the Company, in connection with the sale by the trust of pre-capitalized trust securities ("P-Caps"), that provides Voya Financial, Inc. the right, at any time over a 10-year period, to issue up to $500 principal amount of its 3.976% Senior Notes due 2025 ("3.976% Senior Notes") to the trust and receive in exchange a corresponding principal amount of U.S. Treasury securities that are held by the trust. The 3.976% Senior Notes will not be issued unless and until the put option is exercised. In return, the Company pays a semi-annual put premium to the trust at a rate of 1.875% per annum applied to the unexercised portion of the put option and reimburses the trust for its expenses. The put premium and expense reimbursements are recorded in Operating expenses in the Condensed Consolidated Statements of Operations. If and when issued, the 3.976% Senior Notes will be guaranteed by Voya Holdings. Upon an event of default, the put option will be exercised automatically in full. The Company has a one-time right to unwind a prior voluntary exercise of the put option by repurchasing all of the 3.976% Senior Notes then held by the trust for U.S. Treasury securities. If the put option has been fully exercised, the 3.976% Senior Notes issued may be redeemed by the Company prior to their maturity at par or, if greater, at a make-whole redemption price, in each case plus accrued and unpaid interest to the date of redemption. The P-Caps are to be redeemed by the trust on February 15, 2025 or upon any early redemption of the 3.976% Senior Notes. On May 1, 2023, pursuant to the put option agreement, the Company exercised the put option to require the trust to purchase $400 aggregate principal amount of 3.976% Senior Notes in exchange for a corresponding amount of U.S. Treasury securities held by the trust. On May 3, 2023, the Company issued $400 aggregate principal amount of 3.976% Senior Notes to the trust and the Company received approximately $400 of U.S. Treasury securities. The proceeds from the sale of the U.S. Treasury securities were used to redeem the 5.650% Fixed-to-Floating Rate Junior Subordinated Notes due 2053 on May 15, 2023 (the "2053 Notes"). See Junior Subordinated Notes below. Junior Subordinated Notes During the nine months ended September 30, 2023, the Company completed the redemption of all of outstanding principal amount of the 2053 Notes at par, resulting in a loss on debt extinguishment of $5, which is included in Interest expense in the Condensed Consolidated Statements of Operations. Senior Unsecured Credit Facility Agreement As of September 30, 2023, the Company had a $500 senior unsecured credit facility with a syndicate of banks which expires May 1, 2028. The facility provides $500 of committed capacity for revolving loan borrowings and letters of credit issuances, including a sublimit for swingline (short-term) loans in an aggregate amount of up to $25. As of September 30, 2023, there were no amounts outstanding as revolving credit borrowings, no amounts of LOCs outstanding, and no amounts of swingline loans outstanding under the senior unsecured credit facility. Under the terms of the facility, the Company is required to maintain a minimum net worth of $4.998 billion, which may increase upon any future equity issuances by the Company.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases During the nine months ended September 30, 2023 and September 30, 2022 the Company recorded an impairment of $14 and $3, respectively, on its right-of-use asset associated with leased office space. There was no impairment on the Company's right-of-use asset associated with leased office space during the three months ended September 30, 2023 and September 30, 2022. The impairments are included in Operating expenses in the Condensed Consolidated Statements of Operations. Commitments Through the normal course of investment operations, the Company commits to either purchase or sell securities, mortgage loans, or money market instruments, at a specified future date and at a specified price or yield. The inability of counterparties to honor these commitments may result in either a higher or lower replacement cost. Also, there is likely to be a change in the value of the securities underlying the commitments. As of September 30, 2023, the Company had off-balance sheet commitments to acquire mortgage loans of $52 and purchase limited partnerships and private placement investments of $951, of which $340 related to consolidated investment entities. Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: September 30, 2023 December 31, 2022 Fixed maturity collateral pledged to FHLB (1) $ 1,708 $ 1,791 FHLB restricted stock (2) 63 67 Other fixed maturities-state deposits 39 38 Cash and cash equivalents 27 27 Securities pledged (3) 1,002 1,162 Total restricted assets $ 2,839 $ 3,085 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $682 and $907 as of September 30, 2023 and December 31, 2022, respectively. In addition, as of September 30, 2023 and December 31, 2022, the Company delivered securities as collateral of $208 and $142 and repurchase agreements of $112 and $113, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets. Federal Home Loan Bank Funding Agreements The Company is a member of the FHLB of Des Moines and the FHLB of Boston and is required to pledge collateral to back funding agreements issued to the FHLB. As of September 30, 2023 and December 31, 2022, the Company had $1,176 and $1,279, respectively, in non-putable funding agreements, which are included in Contract owner account balances on the Condensed Consolidated Balance Sheets. As of September 30, 2023 and December 31, 2022, assets with a market value of approximately $1,708 and $1,791, respectively, collateralized the FHLB funding agreements. Assets pledged to the FHLB are included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. Litigation, Regulatory Matters and Contingencies Litigation, regulatory and other loss contingencies arise in connection with the Company's activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters, arising from the conduct of its business, both in the ordinary course and otherwise. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. The variability in pleading requirements and past experience demonstrate that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. For example, the Company is cooperating with a publicly reported, industry-wide investigation by the SEC regarding compliance with certain record-keeping requirements for business-related electronic communications on unapproved channels. It is the practice of the Company to cooperate fully in these matters. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company's results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of September 30, 2023, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $25. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company's accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. Litigation includes Henkel of America v. ReliaStar Life Insurance Company, et al. (USDC District of Connecticut, No. 1:18-cv-00965)(filed June 8, 2018). Plaintiff alleges that ReliaStar breached the terms of a stop loss policy it issued to Plaintiff by refusing to reimburse Plaintiff for more than $47 in claims incurred by participants in prior years and submitted for coverage under the stop loss policy. Plaintiff alleges a breach of contract claim or, in the alternative, that the stop loss policy be declared to cover the submitted claims, and also asserts that ReliaStar engaged in unfair trade practices and unfair insurance practices in violation of state statutes, and did so willfully and intentionally to warrant an award of punitive damages under state law. On February 7, 2023, the district court issued its ruling on various motions for partial judgment in which the court denied in part and granted in part the various motions except for Express Scripts’ motion, which the court denied in whole. The Company denies the allegations, which it believes are without merit, and intends to defend the case vigorously. Litigation also includes Ravarino, et al. v. Voya Financial, Inc., et al. (USDC District of Connecticut, No. 3:21-cv-01658)(filed December 14, 2021). In this putative class action, the plaintiffs allege that the named defendants breached their fiduciary duties of prudence and loyalty in the administration of the Voya 401(k) Savings Plan. The plaintiffs claim that the named defendants did not exercise proper prudence in their management of allegedly poorly performing investment options, including proprietary funds, and passed excessive investment-management and other administrative fees for proprietary and non-proprietary funds onto plan participants. The plaintiffs also allege that the defendants engaged in self-dealing through the inclusion of the Voya Stable Value Option into the plan offerings and by setting the “crediting rate” for participants’ investment in the Stable Value Fund artificially low in relation to Voya’s general account investment returns in order to maximize the spread and Voya’s profits at the participants’ expense. The complaint seeks disgorgement of unjust profits as well as costs incurred. On June 13, 2023, the Court issued a ruling granting in part and denying in part Voya's motion to dismiss. The court largely dismissed the claims for breach of fiduciary duty. The remaining claims concern allegations of breaches of the ERISA prohibited transactions rule and a claim for failure to monitor the Voya Small Cap Growth fund. The Company continues to deny the allegations, which it believes are without merit, and intends to defend the case vigorously. Finally, litigation includes Advance Trust & Life Escrow Services, LTA v. ReliaStar Life Insurance Company (USDC District of Minnesota, No. 1:18-cv-02863)(filed October 5, 2018). In June 2023, following mediation, the parties agreed in principle to settle the matter, subject to court approval. After preliminary approval by the court and during the class notice period, Voya funded the settlement amount of $39. The deadline for objections occurred on October 5 with no objections received from class members. The court has scheduled a hearing for final approval of the settlement, the terms of which are available on the district court’s public docket, on November 16, 2023. Contingencies related to Performance-based Capital Allocations on Private Equity Funds Certain performance-based capital allocations related to sponsored private equity funds ("carried interest") are not final until the conclusion of an investment term specified in the relevant asset management contract. As a result, such carried interest, if accrued or paid to the Company during such term, is subject to later adjustment based on subsequent fund performance. If the fund’s cumulative investment return falls below specified investment return hurdles, some or all of the previously accrued carried interest is reversed to the extent that the Company is no longer entitled to the performance-based capital allocation. Should the fund’s cumulative investment return subsequently increase above specified investment return hurdles in future periods, previous reversals could be fully or partially recovered. As of September 30, 2023, approximately $129 of previously accrued carried interest would be subject to full or partial reversal in future periods if cumulative fund performance hurdles are not maintained throughout the remaining life of the affected funds.

Consolidated and Nonconsolidate

Consolidated and Nonconsolidated Investment Entities	9 Months Ended
	Sep. 30, 2023
Consolidated Investment Entities [Abstract]
Consolidated and Nonconsolidated Investment Entities	Consolidated and Nonconsolidated Investment Entities The Company holds variable interests in certain investment entities in the form of debt or equity investments, as well as the right to receive management fees, performance fees, and carried interest. The Company consolidates certain entities under the VIE guidance when it is determined that the Company is the primary beneficiary. Alternatively, certain entities are consolidated under the VOE guidance when control is obtained through voting rights. Refer to the Condensed Consolidated Balance Sheets for the assets and liabilities of the Company's consolidated investment entities. The Company has no right to the benefits from, nor does it bear the risks associated with consolidated investment entities beyond the Company’s direct equity and debt investments in and management fees generated from these entities. Such direct investments amounted to approximately $347 and $288 as of September 30, 2023 and December 31, 2022, respectively. If the Company were to liquidate, the assets held by consolidated investment entities would not be available to the general creditors of the Company as a result of the liquidation. Consolidated VIEs and VOEs Collateral Loan Obligations Entities ("CLOs") The Company is involved in the design, creation, and the ongoing management of CLOs. These entities are created for the purpose of acquiring diversified portfolios of senior secured floating rate leveraged loans, and securitizing these assets by issuing multiple tranches of collateralized debt; thereby providing investors with a broad array of risk and return profiles. Also known as collateralized financing entities under Topic 810, CLOs are variable interest entities by definition. In return for providing collateral management services, the Company earns investment management fees and contingent performance fees. In addition to earning fee income, the Company often invests in the subordinated debt of entities formed to be the issuers of CLO offerings during their warehouse periods. The Company’s investments in these CLOs are repaid when the CLOs’ warehouse periods are closed and the CLO offerings are issued. The Company performs ongoing monitoring of the consolidation assessment for CLOs during and after their warehouse periods to determine if Voya remains the primary beneficiary of the CLOs. The fee income earned and investments held are included in the Company's ongoing consolidation assessment for each CLO. The Company was the primary beneficiary of 6 CLOs as of September 30, 2023 and 7 CLOs as of December 31, 2022. Limited Partnerships ("LPs") The Company invests in and manages various limited partnerships, including private equity funds and hedge funds. The LPs generally have a ten-year life and a specified period during which investors can subscribe for limited partnership interests. Once the investors are admitted as limited partners, the investors are required to contribute capital when called by the general partners. The purpose of the LPs is to obtain subscriptions from limited partners and maximize the return to their partners by assembling a diversified portfolio of investments in private equity funds and other securities or assets with similar risk and return characteristics primarily through secondary market purchases. The majority of the investors in the LPs are unrelated parties to the Company. In return for subscriptions, each partner receives an equity interest in the LPs in proportion to its respective investment. These entities have been evaluated by the Company and are determined to be VIEs due to the equity holders, as a group, lacking the characteristics of a controlling financial interest. In return for serving as the general partner of and providing investment management services to these entities, the Company earns management fees and carried interest in the normal course of business. Additionally, the Company often holds an investment in each limited partnership it manages, generally in the form of general partner and limited partner interests. The fee income, carried interest, and investments held are included in the Company’s ongoing consolidation analysis for each limited partnership. The Company consolidated 10 funds, which were structured as partnerships, as of September 30, 2023 and December 31, 2022. The noncontrolling interest related to partnerships increased from $1,482 at December 31, 2022 to $1,659 at September 30, 2023. Changes in market value, contributions, and distributions related to these investments in the funds directly impact the noncontrolling interest component of Shareholders' equity on the Company's Condensed Consolidated Balance Sheets. The change in noncontrolling interest was primarily driven by an increase in net contributions and favorable market appreciation in limited partnership and equity security investments. The Company records the noncontrolling interest using a lag methodology relying on the most recent financial information available. Fair Value Measurement Upon consolidation, the Company elected to apply the FVO for financial assets and financial liabilities held by CLOs and continued to measure these assets (primarily corporate loans) and liabilities (debt obligations issued by CLOs) at fair value in subsequent periods. The Company has elected the FVO to more closely align its accounting with the economics of its transactions and allows the Company to more effectively align changes in the fair value of CLO assets with a commensurate change in the fair value of CLO liabilities. Investments held by consolidated private equity funds are measured and reported at fair value in the Company's Condensed Consolidated Financial Statements. Changes in the fair value of consolidated investment entities are recorded as a separate line item within Income (loss) related to consolidated investment entities in the Company's Condensed Consolidated Statements of Operations. The methodology for measuring the fair value of financial assets and liabilities of consolidated investment entities, and the classification of these measurements in the fair value hierarchy is consistent with the methodology and classification applied by the Company to its investment portfolio, as discussed within the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements. As discussed in more detail below, the Company utilizes valuations obtained from third-party commercial pricing services, brokers and investment sponsors or third-party administrators that supply NAV (or its equivalent) per share used as a practical expedient. The valuations obtained from brokers and third-party commercial pricing services are non-binding. These valuations are reviewed on a monthly or quarterly basis depending on the entity and its underlying investments. Procedures include, but are not limited to, a review of underlying fund investor reports, review of top and worst performing funds requiring further scrutiny, review of variance from prior periods and review of variance from benchmarks, where applicable. In addition, the Company considers both macro and fund specific events that may impact the latest NAV supplied and determines if further adjustments of value should be made. Such changes, if any, are subject to senior management review. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Broker quotes and prices obtained from pricing services are reviewed and validated through an internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. Cash and Cash Equivalents The carrying amounts for cash reflect the assets’ fair values. The fair value for cash equivalents is determined based on quoted market prices. These assets are classified as Level 1. CLOs Corporate loans : Corporate loan investments, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans maturing at various dates between 2024 and 2031, paying interest at LIBOR, SOFR, EURIBOR or PRIME plus a spread of up to 8.5%. As of September 30, 2023 and December 31, 2022, the unpaid principal balance exceeded the fair value of the corporate loans by approximately $43 and $85, respectively. Less than 1.0% of the collateral loans were in default as of September 30, 2023 and December 31, 2022. The fair values for corporate loans are determined using independent commercial pricing services. Fair value measurement based on pricing services may be classified in Level 2 or Level 3 depending on the type, complexity, observability and liquidity of the asset being measured. The inputs used by independent commercial pricing services, such as benchmark yields and credit risk adjustments, are those that are derived principally from or corroborated by observable market data. Hence, the fair value measurement of corporate loans priced by independent pricing service providers is classified within Level 2 of the fair value hierarchy. In addition, there are assets held with CLO portfolios that represent senior level debt of other third party CLOs. These CLO investments are classified within Level 3 of the fair value hierarchy. See description of fair value process for CLO notes below. CLO notes : The CLO notes are backed by diversified loan portfolios consisting primarily of senior secured floating rate leveraged loans. Repayment risk is segmented into tranches with credit ratings of these tranches reflecting both the credit quality of underlying collateral as well as how much protection a given tranche is afforded by tranches that are subordinate to it. The most subordinated tranche bears the first loss and receives the residual payments, if any. The interest rates are generally variable rates based on LIBOR, SOFR or EURIBOR plus a pre-defined spread, which varies from 1.0% for the more senior tranches to 9.6% for the more subordinated tranches. CLO notes mature in 2034 and 2037, and have a weighted average maturity of 12 years as of September 30, 2023. The investors in this debt are not affiliated with the Company and have no recourse to the general credit of the Company for this debt. The fair values of the CLO notes are measured based on the fair value of the CLO's corporate loans, as the Company uses the measurement alternative available under ASU 2014-13 and determined that the inputs for measuring financial assets are more observable. The CLO notes are classified within Level 2 of the fair value hierarchy, consistent with the classification of the majority of the CLO financial assets. The Company reviews the detailed prices including comparisons to prior periods for reasonableness. The Company utilizes a formal pricing challenge process to request a review of any price during which time the vendor examines its assumptions and relevant market inputs to determine if a price change is warranted. The following narrative indicates the sensitivity of inputs: • Default Rate: An increase (decrease) in the expected default rate would likely increase (decrease) the discount margin (increase risk premium) used to value the CLO investments and CLO notes and, as a result, would potentially decrease the value of the CLO investments and CLO notes. • Recovery Rate: A decrease (increase) in the expected recovery of defaulted assets would potentially decrease (increase) the valuation of CLO investments and CLO notes. • Prepayment Rate: A decrease (increase) in the expected rate of collateral prepayments would potentially decrease (increase) the valuation of CLO investments and CLO notes as the expected weighted average life ("WAL") would increase (decrease). • Discount Margin (spread over LIBOR/SOFR): An increase (decrease) in the discount margin used to value the CLO investments and CLO notes would decrease (increase) the value of the CLO investments and CLO notes. Private Equity Funds As prescribed in ASC Topic 820, the unit of account for these investments is the interest in the investee fund. The Company owns an undivided interest in the fund portfolio and does not have the ability to dispose of individual assets and liabilities in the fund portfolio. Rather, the Company would be required to redeem or dispose of its entire interest in the investee fund. There is no current active market for interests in underlying private equity funds. Valuation is generally based on the valuations provided by the fund's general partner or investment manager. The valuations typically reflect the fair value of the Company's capital account balance of each fund investment, including unrealized capital gains (losses), as reported in the financial statements of the respective investee fund as of the respective year end or the latest available date. In circumstances where fair values are not provided, the Company seeks to determine the fair value of fund investments based upon other information provided by the fund's general partner or investment manager or from other sources. The fair value of securities received in-kind from fund investments is determined based on the restrictions around the securities. • Unrestricted, publicly traded securities are valued at the closing public market price on the reporting date; • Restricted, publicly traded securities may be valued at a discount from the closing public market price on the reporting date, depending on the circumstances; and • Privately held securities are valued by the directors/general partner of the investee fund, based on a variety of factors, including the price of recent transactions in the company's securities and the company's earnings, revenue and book value. In the case of direct investments or co-investments in private equity companies, the Company initially recognizes investments at cost and subsequently adjusts investments to fair value. On a quarterly basis, the Company reviews the general partner or lead investor's valuation of the investee company, taking into account other available information, such as indications of a market value through subsequent issues of capital or transactions between third parties, performance of the investee company during the period and public, comparable companies' analysis, where appropriate. Investments in these funds typically may not be fully redeemed at net asset value ("NAV") within 90 days because of inherent restriction on near term redemptions. As of September 30, 2023 and December 31, 2022, certain private equity funds maintained term loans and revolving lines of credit of $1,352 and $1,366, respectively. The term loans mature in twelve The following table summarizes the fair value hierarchy levels of consolidated investment entities as of September 30, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,396 — — 1,396 Limited partnerships/corporations — — — 3,079 3,079 VOE Corporate loans — 32 — — 32 Total assets $ 88 $ 1,428 $ — $ 3,079 $ 4,595 Liabilities VIEs CLO notes $ — $ 1,329 $ — $ — $ 1,329 Total liabilities $ — $ 1,329 $ — $ — $ 1,329 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234 Transfers of investments out of Level 3 and into Level 2 or Level 1, if any, are recorded as of the beginning of the period in which the transfer occurred. For the three and nine months ended September 30, 2023 and 2022, there were no transfers in or out of Level 3 or transfers between Level 1 and Level 2. Deconsolidation of Certain Investment Entities Certain investment entities that have historically been consolidated in the financial statements may require deconsolidation as of the reporting period because: (a) such funds have been liquidated or dissolved; or (b) the Company is no longer deemed to be the primary beneficiary of the VIEs/VOEs as it no longer has a controlling financial interest. The change in CLO’s consolidation status due to the close of the warehouse and the launch of the CLO do not meet the criteria described above as this transaction represents normal business operations of the entity. Refer to the CLO life cycle described above. The Company had one deconsolidation during the three and nine months ended September 30, 2023 as a result of CLO notes redemption. The Company had no deconsolidation during the three and nine months ended September 30, 2022. For deconsolidated investment entities, the Company continues to serve as the general partner and/or investment manager until such entities are fully liquidated. Nonconsolidated VIEs The Company also holds variable interest in certain CLOs and LPs that are not consolidated as it has been determined that the Company is not the primary beneficiary. CLOs As of September 30, 2023 and December 31, 2022, the Company held $366 and $364 ownership interests, respectively, in unconsolidated CLOs, which also represents the Company's maximum exposure to loss. LPs As of September 30, 2023 and December 31, 2022, the Company held $1,792 and $1,781 ownership interests, respectively, in unconsolidated limited partnerships, which also represents the Company's maximum exposure to loss. Securitizations The Company invests in various tranches of securitization entities, including RMBS, CMBS and ABS. Through its investments, the Company is not obligated to provide any financial or other support to these entities. Each of the RMBS, CMBS and ABS entities are thinly capitalized by design and considered VIEs. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer or investment manager, which are generally viewed to have the power to direct the activities that most significantly impact the securitization entities' economic performance, in any of these entities, nor does the Company function in any of these roles. The Company, through its investments or other arrangements, does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. Therefore, the Company is not the primary beneficiary and does not consolidate any of the RMBS, CMBS and ABS entities in which it holds investments. These investments are accounted for as investments available-for-sale as described in the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements and unrealized capital gains (losses) on these securities are recorded directly in AOCI, except for certain RMBS which are accounted for under the FVO whose change in fair value is reflected in Net gains (losses) in the Condensed Consolidated Statements of Operations. The Company’s maximum exposure to loss on these structured investments is limited to the amount of its investment. Refer to the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements for details regarding the carrying amounts and classifications of these assets.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Corporate Consolidated Balance as of January 1, 2022 $ 17 $ 24 $ 31 $ — $ 72 Additions from business combinations — — 255 — 255 Balance as of December 31, 2022 $ 17 $ 24 $ 286 $ — $ 327 Additions from business combinations (1) — 319 — 102 421 Balance as of September 30, 2023 $ 17 $ 343 $ 286 $ 102 $ 748 (1) See the Business, Basis of Presentation and Significant Accounting Policies Note for information on recent business combinations. Other Intangible Assets The following table presents other intangible assets as of the dates indicated: Weighted September 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 17 years $ 190 $ 13 $ 177 $ 741 $ 554 $ 187 Customer relationship lists 8 years 325 124 201 135 111 24 Trademarks 8 years 15 1 14 — — — Computer software 4 years 489 332 158 502 432 70 Total intangible assets $ 1,369 $ 470 $ 900 $ 1,728 $ 1,097 $ 631 Amortization expense related to intangible assets were $63 and $36 for the nine months ended September 30, 2023 and 2022, respectively. Fully amortized management contract rights of $550 were written off during the second quarter of 2023.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 262	$ 180	$ 503	$ 316

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Adoption of New Pronouncements	The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.
Derivatives	The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of September 30, 2023 and December 31, 2022.
Income Tax	The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred.

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Adoption of New Accounting Pronouncements and Future Adoption of Accounting Pronouncements	The following tables provide additional information related to the transition adjustments: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses Exited (1) Balance, December 31, 2020 $ 119 $ 1,186 $ 70 Adjustment for removal of related balances in AOCI 571 104 635 Balance, January 1, 2021 $ 690 $ 1,290 $ 705 Liability for Future Policy Benefits Health Solutions Group (2) Health Solutions Voluntary (3) Businesses Exited (1) Balance, December 31, 2020 $ 822 $ 188 $ 5,448 Adjustment for reversal of related balances in AOCI — — (386) Adjustment for loss contracts under the modified retrospective approach 7 3 3 Effect of remeasurement of liability at current discount rate 118 83 1,362 Balance, January 1, 2021 $ 947 $ 274 $ 6,427 (1) Includes long duration retail individual life and annuity business exited via reinsurance (2) Includes long duration employee-sponsored group life and health products (3) Includes long duration employee-paid whole life products The following table presents information on transition adjustments, net of tax, related to the adoption of ASU 2018-12 for retained earnings and AOCI to arrive at the opening balances as of January 1, 2021: Total Shareholders' equity December 31, 2020 $ 11,178 AOCI Reversal of AOCI adjustments 1,328 Effect of remeasurement of liability at current discount rate (1,065) Total AOCI adjustments $ 263 Retained Earnings Establishment of MRBs $ (132) Other adjustments 27 Total Retained earnings $ (105) Total adjustment for the adoption of ASU 2018-12 $ 158 Total Shareholders' equity January 1, 2021 $ 11,336 The following table provides a description of the Company’s adoption of other new ASUs issued by the FASB and the impact of adoption on the Company’s financial statements: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. January 1, 2023 on a prospective basis. Adoption of the ASU did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements . ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments were effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2024. The Company has elected to apply the optional expedient provided in ASU 2020-04 for qualifying contract modifications. To date, adoption of the guidance has not had a material impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as the project nears completion. Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.

Investments (excluding Consol_2

Investments (excluding Consolidated Investment Entities) (Tables)	9 Months Ended
	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of September 30, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 458 $ — $ 40 $ — $ — $ 418 U.S. Government agencies and authorities 54 1 2 — — 53 State, municipalities and political subdivisions 881 — 155 — — 726 U.S. corporate public securities 8,554 57 1,436 — — 7,175 U.S. corporate private securities 5,114 10 521 — — 4,603 Foreign corporate public securities and foreign governments (1) 2,974 10 431 — 6 2,547 Foreign corporate private securities (1) 3,111 10 241 — 1 2,879 Residential mortgage-backed securities 3,710 28 340 (1) — 3,397 Commercial mortgage-backed securities 4,226 2 739 — 10 3,479 Other asset-backed securities 2,439 11 105 — 2 2,343 Total fixed maturities, including securities pledged 31,521 129 4,010 (1) 19 27,620 Less: Securities pledged 1,157 — 155 — — 1,002 Total fixed maturities $ 30,364 $ 129 $ 3,855 $ (1) $ 19 $ 26,618 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 590 $ 12 $ 21 $ — $ — $ 581 U.S. Government agencies and authorities 58 3 2 — — 59 State, municipalities and political subdivisions 978 1 134 — — 845 U.S. corporate public securities 9,343 97 1,239 — — 8,201 U.S. corporate private securities 5,087 14 409 — — 4,692 Foreign corporate public securities and foreign governments (1) 3,343 18 403 — 9 2,949 Foreign corporate private securities (1) 3,254 7 225 — 2 3,034 Residential mortgage-backed securities 4,230 34 290 3 — 3,977 Commercial mortgage-backed securities 4,466 2 585 — — 3,883 Other asset-backed securities 2,307 3 173 — 1 2,136 Total fixed maturities, including securities pledged 33,656 191 3,481 3 12 30,357 Less: Securities pledged 1,303 3 144 — — 1,162 Total fixed maturities $ 32,353 $ 188 $ 3,337 $ 3 $ 12 $ 29,195 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations.
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturities, including securities pledged, as of September 30, 2023, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Cost Fair Value Due to mature: One year or less $ 831 $ 812 After one year through five years 3,890 3,663 After five years through ten years 4,091 3,738 After ten years 12,334 10,188 Mortgage-backed securities 7,936 6,876 Other asset-backed securities 2,439 2,343 Fixed maturities, including securities pledged $ 31,521 $ 27,620
Schedule of Securities Pledged	The following table presents Securities pledged as of the dates indicated: September 30, 2023 December 31, 2022 Securities pledged/obligations under repurchase agreements (1) $ 112 $ 113 Securities loaned to lending agent (2) 682 907 Securities pledged as collateral (2)(3) 208 142 Total $ 1,002 $ 1,162 (1) Comprised of other asset-backed securities and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. (2) Included in Securities pledged on the Condensed Consolidated Balance Sheets. (3) See Collateral within the Derivatives Note to these Condensed Consolidated Financial Statements for more information.
Schedule of Securities Borrowed Under Securities Lending Transactions	The following table presents collateral held by asset class that the Company pledged under securities lending as of the dates indicated: September 30, 2023 December 31, 2022 U.S. Treasuries $ 19 $ 53 U.S. corporate public securities 494 604 Short-term investments 1 — Foreign corporate public securities and foreign governments 193 285 Total (1) $ 707 $ 942 (1) As of September 30, 2023 and December 31, 2022, liabilities to return cash collateral were $560 and $807, respectively, and included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets.
Financing Receivable, Allowance for Credit Loss	The following tables presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Nine Months Ended September 30, 2023 U.S. corporate public securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded — 10 — — 1 11 Reductions for securities sold during the period — — (2) — — (2) Increase (decrease) on securities with allowance recorded in previous period — — (1) (1) — (2) Balance as of September 30 $ — $ 10 $ 6 $ 1 $ 2 $ 19 Year Ended December 31, 2022 Residential mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 1 $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded — 9 — — 9 Reductions for securities sold during the period — — (57) — (57) Increase (decrease) on securities with allowance recorded in previous period (1) — 3 — 2 Balance as of December 31 $ — $ 9 $ 2 $ 1 $ 12 For additional information about the Company’s methodology and significant inputs used in determining whether a credit loss exists, see the Business, Basis of Presentation and Significant Accounting Policies Note to the Consolidated Financial Statements in Part II, Item 8. of the Annual Report on Form 10-K .
Schedule of Unrealized Loss on Investments	The following tables present available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by investment category and duration as of the dates indicated: As of September 30, 2023 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 276 $ 11 $ 99 $ 29 $ 375 $ 40 U.S. Government agencies and authorities 13 1 3 1 16 2 State, municipalities and political subdivisions 28 1 682 154 710 155 U.S. corporate public securities 1,375 97 4,761 1,339 6,136 1,436 U.S. corporate private securities 967 39 3,249 482 4,216 521 Foreign corporate public securities and foreign governments 565 25 1,670 406 2,235 431 Foreign corporate private securities 437 18 2,101 223 2,538 241 Residential mortgage-backed 349 17 1,307 323 1,656 340 Commercial mortgage-backed 84 4 3,234 735 3,318 739 Other asset-backed 110 5 1,618 100 1,728 105 Total $ 4,204 $ 218 $ 18,724 $ 3,792 $ 22,928 $ 4,010 As of December 31, 2022 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 197 $ 19 $ 9 $ 2 $ 206 $ 21 U.S. Government agencies and authorities 21 2 — — 21 2 State, municipalities and political subdivisions 751 121 30 13 781 134 U.S. corporate public securities 5,479 792 1,137 447 6,616 1,239 U.S. corporate private securities 3,569 322 458 87 4,027 409 Foreign corporate public securities and foreign governments 2,050 260 391 143 2,441 403 Foreign corporate private securities 2,728 211 65 14 2,793 225 Residential mortgage-backed 1,538 128 562 162 2,100 290 Commercial mortgage-backed 2,628 390 1,133 195 3,761 585 Other asset-backed 1,430 104 578 69 2,008 173 Total $ 20,391 $ 2,349 $ 4,363 $ 1,132 $ 24,754 $ 3,481
Mortgage Loans by Loan to Value Ratio	The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 89 $ 255 $ — $ — $ — $ 344 2022 243 342 65 — — 650 2021 247 224 230 — — 701 2020 161 145 — 10 16 332 2019 234 74 29 — — 337 Prior 2,603 359 6 — 41 3,009 Total $ 3,577 $ 1,399 $ 330 $ 10 $ 57 $ 5,373 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 Prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445
Mortgage Loans by Debt Service Coverage Ratio	The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 168 $ 109 $ 67 $ — $ 344 2022 229 56 203 162 650 2021 262 14 77 348 701 2020 225 25 5 77 332 2019 204 26 86 21 337 Prior 2,243 315 261 190 3,009 Total $ 3,331 $ 545 $ 699 $ 798 $ 5,373 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 Prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans
Mortgage Loans by Geographic Location of Collateral	The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 70 $ 55 $ 7 $ 99 $ 39 $ 42 $ 3 $ 26 $ 3 $ 344 2022 140 131 48 99 113 93 5 1 20 650 2021 99 63 126 148 111 94 10 49 1 701 2020 73 156 17 10 12 40 — 7 17 332 2019 53 101 10 75 46 4 14 13 21 337 Prior 778 620 777 202 217 202 47 146 20 3,009 Total $ 1,213 $ 1,126 $ 985 $ 633 $ 538 $ 475 $ 79 $ 242 $ 82 $ 5,373 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 Prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445
Mortgage Loans by Property Type of Collateral	The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of September 30, 2023 and December 31, 2022, respectively. As of September 30, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 110 $ 157 $ 26 $ 19 $ 32 $ — $ — $ 344 2022 79 264 253 34 10 10 — 650 2021 36 151 363 124 — 18 9 701 2020 57 59 73 143 — — — 332 2019 46 83 161 36 11 — — 337 Prior 800 768 668 491 67 165 50 3,009 Total $ 1,128 $ 1,482 $ 1,544 $ 847 $ 120 $ 193 $ 59 $ 5,373 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 Prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445
Allowance for Credit Losses on Financing Receivables	The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: September 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded 2 3 Increase (decrease) on mortgage loans with an allowance recorded in a previous period 9 — Provision for expected credit losses 29 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 29 $ 18
Financing Receivable, Past Due	The following table presents past due commercial mortgage loans as of the dates indicated: September 30, 2023 December 31, 2022 Delinquency: Current $ 5,335 $ 5,445 30-59 days past due 38 — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,373 $ 5,445
Net Investment Income	The following table summarizes Net investment income by investment type for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Fixed maturities $ 438 $ 483 $ 1,336 $ 1,457 Equity securities 3 (3) 17 6 Mortgage loans on real estate 64 58 187 177 Policy loans 5 5 16 16 Short-term investments and cash equivalents 10 3 28 6 Limited partnerships and other 44 (10) 106 115 Gross investment income 564 536 1,690 1,777 Less: Investment expenses 17 14 53 44 Net investment income $ 547 $ 522 $ 1,637 $ 1,733
Realized Gain (Loss) on Investments	Net gains (losses) were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ (24) $ 8 $ (41) $ (71) Fixed maturities, at fair value option (135) (294) (243) (844) Equity securities, at fair value (3) (7) (6) (39) Derivatives 134 174 199 300 Embedded derivatives - fixed maturities (3) (2) (4) (8) Other derivatives — 2 — — Standalone derivatives 1 (3) 1 (2) Managed custody guarantees (15) (6) (12) (8) Stabilizer (9) — (9) 19 Mortgage loans (1) (1) (11) 4 Other investments 48 4 47 10 Net gains (losses) $ (7) $ (125) $ (79) $ (639)
Gain (Loss) on Investments	Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Proceeds on sales $ 862 $ 1,138 $ 4,499 $ 3,358 Gross gains 11 30 54 60 Gross losses 14 19 69 63

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts and fair values of derivatives were as follows as of the dates indicated: September 30, 2023 December 31, 2022 Notional Asset Fair Value Liability Notional Asset Fair Value Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 105 $ 6 $ — $ 81 $ — $ 6 Cash flow hedges: Interest rate contracts 22 — — 22 — — Foreign exchange contracts 736 60 2 718 71 2 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 17,996 408 353 18,304 341 376 Foreign exchange contracts 219 6 7 160 9 2 Equity contracts 241 2 8 248 1 1 Credit contracts 157 — 3 174 — 2 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A — 1 N/A 3 — Within reinsurance agreements (4) N/A 101 41 N/A 95 46 Managed custody guarantees (3) N/A — 18 N/A — 6 Stabilizers (3) N/A — 9 N/A — — Total $ 583 $ 442 $ 520 $ 441 (1) Open derivative contracts are reported as Derivatives assets or liabilities at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, Other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable
Offsetting Assets and Liabilities
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Three Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ 7 $ — $ 64 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 3 — 4 Nine Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (11) $ (2) $ 126 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 8 — 9 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Three Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 547 $ (7) $ 522 $ (125) Fair value hedges: Foreign exchange contracts: Hedged items — (3) — (6) Derivatives designated as hedging instruments (1) — 4 — 6 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 3 — 4 — Nine Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 1,637 $ (79) $ 1,733 $ (639) Fair value hedges: Foreign exchange contracts: Hedged items — (1) — (13) Derivatives designated as hedging instruments (1) — 3 — 14 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 8 — 9 — (1) For the three months and nine months ended September 30, 2023, $1 and $2 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning, respectively. For the three months ended September 30, 2022, an immaterial amount of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the nine months ended September 30, 2022, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) on Derivative Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ 138 $ 176 $ 196 $ 328 Foreign exchange contracts Net gains (losses) (2) — (1) (2) Equity contracts Net gains (losses) (7) (8) 1 (36) Credit contracts Net gains (losses) 1 — — (4) Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) (3) (2) (4) (8) Within reinsurance agreements (1) Policyholder benefits 29 57 11 233 Managed custody guarantees Net gains (losses) (15) (6) (12) (8) Stabilizers Net gains (losses) (9) — (9) 19 Total $ 132 $ 217 $ 182 $ 522 (1) For the three months and nine months ended September 30, 2023, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Net gains (losses). For the three months an d nine months ended September 30, 2022, the amount excluded gains (losses) of $(3) and $(2), respectively, from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (excl_2

Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of September 30, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 366 $ 52 $ — $ 418 U.S. Government agencies and authorities — 52 1 53 State, municipalities and political subdivisions — 726 — 726 U.S. corporate public securities — 7,157 18 7,175 U.S. corporate private securities — 3,135 1,468 4,603 Foreign corporate public securities and foreign governments (1) — 2,547 — 2,547 Foreign corporate private securities (1) — 2,404 475 2,879 Residential mortgage-backed securities — 3,334 63 3,397 Commercial mortgage-backed securities — 3,479 — 3,479 Other asset-backed securities — 2,293 50 2,343 Total fixed maturities, including securities pledged 366 25,179 2,075 27,620 Equity securities 111 — 190 301 Derivatives: Interest rate contracts 1 407 — 408 Foreign exchange contracts — 72 — 72 Equity contracts — 2 — 2 Embedded derivative on reinsurance — 101 — 101 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,016 13 — 2,029 Assets held in separate accounts 79,775 5,375 341 85,491 Total assets $ 82,269 $ 31,149 $ 2,606 $ 116,024 Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 27 27 Derivatives: Interest rate contracts 11 342 — 353 Foreign exchange contracts — 9 — 9 Equity contracts — 8 — 8 Credit contracts — 3 — 3 Embedded derivative on reinsurance — (16) (2) 57 (3) 41 Total liabilities $ 11 $ 346 $ 196 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 433 $ 148 $ — $ 581 U.S. Government agencies and authorities — 58 1 59 State, municipalities and political subdivisions — 845 — 845 U.S. corporate public securities — 8,181 20 8,201 U.S. corporate private securities — 2,891 1,801 4,692 Foreign corporate public securities and foreign governments (1) — 2,946 3 2,949 Foreign corporate private securities (1) — 2,602 432 3,034 Residential mortgage-backed securities — 3,949 28 3,977 Commercial mortgage-backed securities — 3,883 — 3,883 Other asset-backed securities — 2,072 64 2,136 Total fixed maturities, including securities pledged 433 27,575 2,349 30,357 Equity securities 140 — 196 336 Derivatives: Interest rate contracts 2 339 — 341 Foreign exchange contracts — 80 — 80 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 95 — 95 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,430 24 — 2,454 Assets held in separate accounts 74,600 5,227 347 80,174 Total assets $ 77,605 $ 33,341 $ 2,892 $ 113,838 Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 6 6 Derivatives: Interest rate contracts 3 373 — 376 Foreign exchange contracts — 10 — 10 Equity contracts — 1 — 1 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 58 (3) 46 Total liabilities $ 3 $ 374 $ 176 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. (3) Represents the standalone derivative.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended September 30, 2023 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — 1 — — — — — (3) 18 — — U.S. corporate private securities 1,732 — (49) 24 — — (46) 63 (256) 1,468 — (49) Foreign corporate private securities (1) 413 (2) (6) 58 — — (20) 53 (21) 475 (2) (6) Residential mortgage-backed securities 57 (3) — 3 — — — 6 — 63 (3) — Other asset-backed securities 45 — — 10 — — (1) — (4) 50 — — Total fixed maturities, including securities pledged 2,268 (5) (54) 95 — — (67) 122 (284) 2,075 (5) (55) Equity securities, at fair value 192 (2) — — — — — — — 190 (2) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (3) (24) — — — — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 344 (5) — 1 — (4) — 6 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — — — — 1 — (3) 18 — — U.S. corporate private securities 1,801 — (46) 104 — (3) (137) 45 (296) 1,468 — (48) Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 1 1 115 — — (197) 130 (7) 475 1 — Residential mortgage-backed securities 28 (6) — 37 — — — 4 — 63 (6) — Other asset-backed securities 64 — (1) 10 — — (1) — (22) 50 — (1) Total fixed maturities, including securities pledged 2,349 (5) (46) 266 — (3) (334) 179 (331) 2,075 (5) (49) Equity securities, at fair value 196 (10) — — — — — 4 — 190 (10) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) (20) — — (1) — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 347 (9) — 8 — (13) — 9 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended September 30, 2022 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 19 $ — $ (1) $ 3 $ — $ — $ (1) $ — $ (5) $ 15 $ — $ — U.S. corporate private securities 1,780 (2) (94) 77 — — (40) 22 — 1,743 (2) (95) Foreign corporate public securities and foreign governments (1) 4 — — — — — — — (4) — — — Foreign corporate private securities (1) 403 (2) (11) 22 — — (4) — (4) 404 (2) (11) Residential mortgage-backed securities 31 (4) — 2 — — — — (3) 26 (4) — Other asset-backed securities 63 — (2) 21 — — (1) — (9) 72 (1) (2) Total fixed maturities, including securities pledged 2,300 (8) (108) 125 — — (46) 22 (25) 2,260 (9) (108) Equity securities, at fair value 203 (8) — — — — — — — 195 (8) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (4) (5) — — — — — — — (9) — — Embedded derivatives on reinsurance (86) (3) — — — — — — — (89) — — Assets held in separate accounts (4) 349 (9) — 32 — (16) — — (17) 339 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (1) $ 7 $ — $ — $ (1) $ — $ (6) $ 15 $ — $ (1) U.S. corporate private securities 1,910 (4) (374) 235 — — (159) 145 (10) 1,743 (4) (373) Foreign corporate private securities (1) 353 (23) (42) 115 — — (33) 148 (114) 404 (6) (42) Residential mortgage-backed securities 43 (19) — 4 — — — — (2) 26 (19) — Other asset-backed securities 44 (1) (6) 52 — (10) (7) — — 72 (1) (6) Total fixed maturities, including securities pledged 2,366 (47) (423) 413 — (10) (200) 293 (132) 2,260 (30) (422) Equity securities, at fair value 203 (35) — 27 — — — — — 195 (35) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (20) 12 — — (1) — — — — (9) — — Embedded derivatives on reinsurance (87) (2) — — — — — — — (89) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — (8) — — — — — Assets held in separate accounts (4) 316 (35) — 164 — (20) — 6 (92) 339 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company.
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: September 30, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 27,620 $ 27,620 $ 30,357 $ 30,357 Equity securities 301 301 336 336 Mortgage loans on real estate 5,373 4,938 5,445 5,149 Policy loans 358 358 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,029 2,029 2,454 2,454 Derivatives 482 482 422 422 Embedded derivatives on reinsurance 101 101 95 95 Other investments 63 63 68 68 Assets held in separate accounts 85,491 85,491 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 32,871 $ 33,433 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,176 1,180 1,285 1,281 Supplementary contracts, immediate annuities and other 455 423 727 636 Stabilizer and MCGs 27 27 6 6 Derivatives 373 373 389 389 Embedded derivative on reinsurance 41 41 46 46 Short-term debt 2 2 141 142 Long-term debt 2,095 1,881 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of September 30, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,396 — — 1,396 Limited partnerships/corporations — — — 3,079 3,079 VOE Corporate loans — 32 — — 32 Total assets $ 88 $ 1,428 $ — $ 3,079 $ 4,595 Liabilities VIEs CLO notes $ — $ 1,329 $ — $ — $ 1,329 Total liabilities $ — $ 1,329 $ — $ — $ 1,329 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234
Financial Instruments Not Carried at Fair Value	The following table presents the classification of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs and Value of Business Acquired (Tables)	9 Months Ended
	Sep. 30, 2023
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	The following table presents a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses exited Balance as of January 1, 2022 $ 691 $ 1,158 $ 473 Deferrals of commissions and expenses 59 — 5 Amortization expense (59) (115) (39) Balance as of December 31, 2022 $ 691 $ 1,043 $ 439 Deferrals of commissions and expenses 44 — 3 Amortization expense (42) (79) (28) Balance as of September 30, 2023 $ 693 $ 964 $ 414 The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2023 December 31, 2022 DAC: Wealth Solutions Deferred and Individual Annuities $ 693 $ 691 Businesses exited 964 1,043 Other 207 190 VOBA 414 439 Total $ 2,278 $ 2,363

Reserves for Future Policy Be_2

Reserves for Future Policy Benefits and Contract Owner Account Balances (Tables)	9 Months Ended
	Sep. 30, 2023
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Liability for Future Policy Benefit, Activity	The balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited are presented in the tables below for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Present Value of Expected Net Premiums: Balance at January 1 $ 77 $ 93 $ 97 $ 105 $ 4,244 $ 5,634 Beginning balance at original discount rate 84 85 100 92 4,128 4,226 Effect of change in cash flow assumptions (6) (7) 6 — (921) (69) Effect of actual variances from expected experience 18 23 6 20 (61) 86 Adjusted balance at January 1 96 101 112 112 3,146 4,243 Interest accrual 2 2 3 4 155 230 Net premiums collected (1) (16) (19) (12) (16) (243) (345) Ending balance at original discount rate 82 84 103 100 3,058 4,128 Effects of changes in discount rate assumptions (8) (7) (7) (3) (47) 116 Balance at end of period $ 74 $ 77 $ 96 $ 97 $ 3,011 $ 4,244 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 881 $ 1,048 $ 285 $ 359 $ 8,639 $ 11,444 Beginning balance at original discount rate 913 952 294 290 8,644 9,079 Effect of change in cash flow assumptions (15) (43) 13 (2) (805) (77) Effect of actual variances from expected experience 1 (27) 6 11 (80) (52) Adjusted balance at January 1 899 882 313 299 7,759 8,950 Issuances 103 139 — — 13 13 Interest accrual 18 25 11 14 317 458 Benefit payments (98) (133) (16) (19) (568) (777) Ending balance at original discount rate 922 913 308 294 7,521 8,644 Effects of changes in discount rate assumptions (57) (32) (29) (9) (330) (5) Balance at end of period $ 865 $ 881 $ 279 $ 285 $ 7,191 $ 8,639 Net liability for future policy benefits $ 791 $ 804 $ 183 $ 188 $ 4,179 $ 4,395 Less: Reinsurance recoverable 301 283 — — 4,127 4,411 Net liability for future policy benefits, after reinsurance recoverable $ 490 $ 521 $ 183 $ 188 $ 52 $ (16) (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: September 30, 2023 December 31, 2022 Health Solutions Group $ 791 $ 804 Health Solutions Voluntary 183 188 Businesses Exited - Future policy benefits 4,179 4,395 Businesses Exited – Additional liability 2,001 2,107 Other 2,217 2,225 Total $ 9,371 $ 9,719 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: September 30, 2023 December 31, 2022 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 1,149 $ 922 $ 1,141 $ 913 Expected future gross premiums 312 247 286 231 Health Solutions Voluntary Expected future benefit payments 671 308 588 294 Expected future gross premiums 343 214 307 205 The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited September 30, 2023 December 31, 2022 Balance at beginning of period $ 2,107 $ 1,715 Effect of change in cash flow assumptions (44) 540 Effect of actual variances from expected experience (20) 15 Adjusted balance at January 1 2,043 2,270 Interest accrual 64 80 Excess Benefits (301) (427) Assessments 195 184 Balance at end of period 2,001 2,107 Less: Reinsurance recoverable 1,949 2,054 Net additional liability, after reinsurance recoverable $ 52 $ 53 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.1 % 5.3 % 5.3 % 4.9 % 5.0 % Current discount rate 5.8 % 5.2 % 6.0 % 5.4 % 5.6 % 5.7 %
Policyholder Account Balance	The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Balance at January 1 $ 33,622 $ 33,044 $ 5,146 $ 5,532 Deposits 1,726 2,962 217 310 Fee income (6) (8) (281) (384) Surrenders and withdrawals (3,891) (4,280) (310) (281) Benefit payments (133) (157) (111) (144) Net transfers from (to) the general account (59) 1,174 (1) — Interest credited 664 874 108 150 Other 8 13 — (37) Ending Balance $ 31,931 $ 33,622 $ 4,768 $ 5,146 Weighted-average crediting rate 2.7 % 2.6 % 2.5 % 2.5 % Net amount at risk (1) $ 148 $ 199 $ 801 $ 900 Cash surrender value $ 31,455 $ 33,125 $ 1,581 $ 1,824 (1) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table shows a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2023 December 31, 2022 Wealth Solutions Deferred group and individual annuity $ 31,931 $ 33,622 Businesses exited 4,768 5,146 Other 3,436 3,687 Total $ 40,135 $ 42,455 The following table summarizes detail on the differences between the interest rate being credited to contract holders as of September 30, 2023, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 141 $ 6,261 $ 2,696 $ 2,010 $ 833 $ 785 $ 12,726 1.01% - 2.00% 553 135 51 4 2 6 751 2.01% - 3.00% 11,617 77 53 110 — 3 11,860 3.01% - 4.00% 9,197 153 — 5 — — 9,355 4.01% and Above 1,584 84 — — — — 1,668 Renewable beyond 12 months (MYGA) (2) 427 — — — 3 — 430 Total discretionary rate setting products $ 23,519 $ 6,710 $ 2,800 $ 2,129 $ 838 $ 794 $ 36,790 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after September 30, 2023 on which we are required to credit interest above the contractual GMIR for at least the next twelve months. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of December 31, 2022 and the respective GMIRs: Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 5,848 $ 2,967 $ 1,907 $ 1,112 $ 1,462 $ 102 $ 13,398 1.01% - 2.00% 707 51 35 2 2 7 804 2.01% - 3.00% 12,677 56 47 109 — 3 12,892 3.01% - 4.00% 9,448 153 — — — — 9,601 4.01% and Above 1,643 87 — — — — 1,730 Renewable beyond 12 months (MYGA) (2) 402 — — — 3 — 405 Total discretionary rate setting products $ 30,725 $ 3,314 $ 1,989 $ 1,223 $ 1,467 $ 112 $ 38,830 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based.

Reinsurance (Tables)

Reinsurance (Tables)	9 Months Ended
	Sep. 30, 2023
Insurance [Abstract]
Effects of Reinsurance	Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: September 30, 2023 Direct Assumed Ceded Total, Assets Premiums receivable $ 179 $ 10 $ (208) $ (19) Reinsurance recoverable, net of allowance for credit losses — — 11,784 11,784 Total $ 179 $ 10 $ 11,576 $ 11,765 Liabilities Future policy benefits and contract owner account balances $ 48,525 $ 981 $ — $ 49,506 Liability for funds withheld under reinsurance agreements 96 — — 96 Total $ 48,621 $ 981 $ — $ 49,602 December 31, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 11 $ (212) $ (29) Reinsurance recoverable, net of allowance for credit losses — — 12,455 12,455 Total $ 172 $ 11 $ 12,243 $ 12,426 Liabilities Future policy benefits and contract owner account balances $ 51,137 $ 1,037 $ — $ 52,174 Liability for funds withheld under reinsurance agreements 104 — — 104 Total $ 51,241 $ 1,037 $ — $ 52,278 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended September 30, 2023 2022 Premiums: Direct premiums $ 896 $ 815 Reinsurance assumed 5 5 Reinsurance ceded (219) (214) Net premiums $ 682 $ 606 Fee income: Gross fee income $ 585 $ 543 Reinsurance assumed 4 5 Reinsurance ceded (100) (103) Net fee income $ 489 $ 445 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,099 $ 1,351 Reinsurance assumed 21 13 Reinsurance ceded (321) (827) Net interest credited and other benefits to contract owners / policyholders $ 799 $ 537 Nine Months Ended September 30, 2023 2022 Premiums: Direct premiums $ 2,706 $ 2,439 Reinsurance assumed 20 19 Reinsurance ceded (682) (647) Net premiums $ 2,044 $ 1,811 Fee income: Gross fee income $ 1,718 $ 1,588 Reinsurance assumed 13 14 Reinsurance ceded (304) (311) Net fee income $ 1,427 $ 1,291 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 3,221 $ 3,431 Reinsurance assumed 51 35 Reinsurance ceded (1,040) (1,631) Net interest credited and other benefits to contract owners / policyholders $ 2,232 $ 1,835

Separate Accounts (Tables)

Separate Accounts (Tables)	9 Months Ended
	Sep. 30, 2023
Other Liabilities Disclosure [Abstract]
Separate Account, Liability	The following tables present a rollforward of Separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Condensed Consolidated Balance Sheets, for the periods indicated: September 30, 2023 December 31, 2022 Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Wealth Solutions Stabilizer Wealth Solutions Deferred Annuity Total Balance at January 1 $ 7,196 $ 69,152 $ 76,348 $ 8,091 $ 86,927 $ 95,018 Policyholder behavior (1) (288) 244 (44) (68) (1,309) (1,377) Fee income (25) (316) (341) (34) (423) (457) Investment performance 35 5,698 5,733 (794) (16,044) (16,838) Other 1 — 1 1 1 2 Balance at end of period $ 6,919 $ 74,778 $ 81,697 $ 7,196 $ 69,152 $ 76,348 Reconciliation to Condensed Consolidated Balance Sheets: Other 3,794 3,826 Total Separate Account liabilities $ 85,491 $ 80,174 (1) Policyholder behavior includes premiums and deposits, surrenders and withdrawals, benefit payments, and net transfers to and from the separate account.
Fair Value, Separate Account Investment	The aggregate fair value of assets, by major investment asset category, supporting separate accounts was as follows for the periods indicated: September 30, 2023 December 31, 2022 U.S. Treasury securities and obligations of U.S. government corporations and agencies $ 1,026 $ 1,586 Corporate debt securities 1,752 1,647 Foreign debt securities 672 660 Mortgage-backed securities 3,319 3,434 Equity securities (including mutual funds) 78,133 72,309 Cash, cash equivalents and short-term investments 337 311 Receivable for securities and accruals 252 227 Total $ 85,491 $ 80,174

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2023
Segment Reporting [Abstract]
Reconciliation of Operating Earnings Before Income Taxes from Segments to Consolidated	The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 179 $ 128 $ 485 $ 553 Health Solutions 53 154 271 226 Investment Management 63 51 168 129 Corporate (52) (66) (175) (193) Total including Allianz noncontrolling interest 242 267 749 715 Less: Earning (loss) attributable to Allianz noncontrolling interest 14 13 35 13 Total $ 229 $ 254 $ 715 $ 703 Adjustments: Net investment gains (losses) 42 (9) (4) (180) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (68) (13) (122) (105) Income (loss) attributable to noncontrolling interests (16) (138) 107 (20) Dividend payments made to preferred shareholders 14 14 32 32 Other adjustments (28) (37) (150) (85) Total adjustments to income (loss) before income taxes (56) (183) (138) (357) Income (loss) before income taxes $ 172 $ 71 $ 576 $ 345
Reconciliation of Revenue from Segments to Total Revenues	The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Adjusted operating revenues by segment: Wealth Solutions $ 702 $ 645 $ 2,090 $ 2,109 Health Solutions 768 645 2,317 1,933 Investment Management 233 192 688 542 Corporate 14 13 39 51 Total $ 1,717 $ 1,495 $ 5,135 $ 4,635 Adjustments: Net investment gains (losses) $ 40 $ (18) $ (21) $ (198) Revenues related to businesses exited or to be exited through reinsurance or divestment 21 (30) 53 (139) Revenues attributable to noncontrolling interests 22 (130) 211 11 Other adjustments 24 30 152 66 Total adjustments to revenues 106 (148) 395 (259) Total revenues $ 1,823 $ 1,345 $ 5,529 $ 4,375
Schedule of Intersegment Revenues Included in Investment Management Segment	The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Investment Management intersegment revenues $ 21 $ 23 $ 65 $ 68
Summary of Financial Information for Segments	The summary below presents Total assets for the Company’s segments as of the dates indicated: September 30, 2023 December 31, 2022 Wealth Solutions $ 114,401 $ 111,701 Health Solutions 3,292 2,668 Investment Management 1,602 1,611 Corporate 25,685 26,712 Total assets, before consolidation (1) 144,980 142,692 Consolidation of investment entities 4,285 3,914 Total assets $ 149,265 $ 146,606 (1) Total assets, before consolidation include the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Share-based Incentive Compens_2

Share-based Incentive Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan	The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Restricted Stock Unit (RSU) awards $ 14 $ 8 $ 67 $ 38 Performance Stock Unit (PSU) awards 7 6 43 37 Total share-based compensation expense 21 14 110 75 Income tax benefit 4 3 26 21 After-tax share-based compensation expense $ 17 $ 11 $ 84 $ 54
Schedule of Share-based Compensation, Activity	The following table summarizes RSU and PSU awards activity under the Omnibus Plans for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2023 1.5 $ 60.91 2.1 $ 55.68 Adjustment for PSU performance factor — — (0.1) 61.50 Granted 1.7 70.51 0.8 66.10 Vested (1.1) 63.51 (0.5) 62.76 Forfeited * 66.21 — * 66.55 Outstanding as of September 30, 2023 2.1 $ 67.12 2.3 $ 61.22 *Less than 0.1
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2023 1.6 $ 43.05 Granted — — Exercised (0.4) 38.70 Forfeited — — Outstanding as of September 30, 2023 1.2 $ 44.59 Vested, exercisable, as of September 30, 2023 1.2 $ 44.59

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward	The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 11.7 (11.7) Share-based compensation 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common shares issued 9.6 — 9.6 Common shares acquired - share repurchase — 3.1 (3.1) Share-based compensation 2.1 0.7 1.4 Balance, September 30, 2023 109.5 4.4 105.1
Schedule of Dividends Declared	Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Dividends declared per share of Common Stock $ 0.40 $ 0.20 $ 0.80 $ 0.60 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended September 30, Per Share Aggregate Per Share Aggregate 2023 $ 30.625 $ 10 $ 13.375 $ 4 2022 30.625 10 13.375 4 Nine Months Ended September 30, 2023 $ 61.250 $ 20 $ 40.125 $ 12 2022 61.250 20 40.125 12
Schedule of Preferred Stock Issued and Outstanding	Preferred stock issued and outstanding are as follows: September 30, 2023 December 31, 2022 Series Issued Outstanding Issued Outstanding 7.758% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	9 Months Ended
	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (in millions, except for per share data) 2023 2022 2023 2022 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 246 $ 42 $ 610 $ 296 Less: Preferred stock dividends 14 14 32 32 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest (16) (138) 107 (20) Net income (loss) available to common shareholders $ 248 $ 166 $ 471 $ 284 Weighted average common shares outstanding Basic 105.8 97.9 102.2 101.9 Dilutive Effects: Warrants (2) — 6.2 4.3 7.2 RSU awards 1.1 0.9 1.1 0.9 PSU awards 1.1 0.9 1.2 0.8 Stock Options 0.4 0.5 0.5 0.6 Diluted 108.4 106.4 109.3 111.4 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (1) : Basic $ 2.35 $ 1.70 $ 4.62 $ 2.79 Diluted $ 2.29 $ 1.57 $ 4.31 $ 2.55 (1) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method. (2) See the Shareholders' Equity

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	Shareholders' equity included the following components of AOCI as of the dates indicated: September 30, 2023 2022 Fixed maturities, net of impairment $ (3,881) $ (3,669) Derivatives (1) 100 187 Change in current discount rate (850) (858) Deferred income tax asset (liability) 1,096 1,034 Total (3,535) (3,306) Pension and other postretirement benefits liability, net of tax 2 3 AOCI $ (3,533) $ (3,303)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (937) $ 197 $ (740) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 18 (4) 14 Change in unrealized gains/losses on available-for-sale securities (919) 193 (726) Derivatives: Derivatives 7 (1) (2) 5 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (4) 1 (3) Change in unrealized gains/losses on derivatives 3 (1) 2 Change in current discount rate (23) 5 (18) Change in Accumulated other comprehensive income (loss) $ (939) $ 197 $ (742) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (619) $ 130 $ (489) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 32 (7) 25 Change in unrealized gains (losses) on available-for-sale securities (587) 123 (464) Derivatives: Derivatives (11) (1) 2 (9) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (14) 3 (11) Change in unrealized gains (losses) on derivatives (25) 5 (20) Change in current discount rate 7 (1) 6 Change in Accumulated other comprehensive income (loss) $ (605) $ 127 $ (478) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended September 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (1,742) $ 367 $ (1,375) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (1) — (1) Change in unrealized gains (losses) on available-for-sale securities (1,743) 367 (1,376) Derivatives: Derivatives 63 (1) (14) 49 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives 58 (13) 45 Change in current discount rate 93 (20) 73 Change in Accumulated other comprehensive income (loss) $ (1,592) $ 334 $ (1,258) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (6,953) $ 1,461 $ (5,492) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 89 (19) 70 Change in unrealized gains (losses) on available-for-sale securities (6,864) 1,442 (5,422) Derivatives: Derivatives 122 (1) (26) 96 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (15) 3 (12) Change in unrealized gains (losses) on derivatives 107 (23) 84 Change in current discount rate 289 (61) 228 Change in Accumulated other comprehensive income (loss) $ (6,468) $ 1,358 $ (5,110) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Revenue from Contracts with Cus

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Wealth Solutions Advisory and R&A $ 125 $ 120 $ 369 $ 380 Distribution and shareholder servicing 29 29 88 93 Investment Management Advisory, asset management and R&A 236 264 698 593 Distribution and shareholder servicing 36 34 100 114 Health Solutions R&A 4 4 15 13 Software subscriptions and services 53 — 167 — Corporate R&A 8 13 25 51 Total financial services and software subscriptions and services revenue 491 464 1,462 1,244 Revenue from other sources (1) 79 14 210 164 Total Fee income and Other revenue $ 570 $ 478 $ 1,672 $ 1,408 (1) Primarily consists of revenue from insurance contracts and financial instruments.

Financing Agreements (Tables)

Financing Agreements (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the carrying value of the Company’s debt issued or borrowed and outstanding as of the periods indicated: Issuer Maturity September 30, 2023 December 31, 2022 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 389 $ — 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 444 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (1) Voya Financial, Inc. 01/23/2048 336 336 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 — 388 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 — 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 1.25% Notes, due 2023 Benefitfocus, Inc. 12/15/2023 2 — Subtotal 2,097 2,235 Less: Current portion of long-term debt 2 141 Total $ 2,095 $ 2,094 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below.
Schedule of Line of Credit Facilities	The following table summarizes the Company's credit facilities as of September 30, 2023: ($ in millions) Obligor / Applicant Business Supported Secured / Unsecured Committed / Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Other Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Other Unsecured Committed 04/07/2025 200 12 (1) 188 Total $ 700 $ 12 $ 688 (1) Amount utilized as collateral for outstanding Aetna Notes.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Restricted Assets	Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: September 30, 2023 December 31, 2022 Fixed maturity collateral pledged to FHLB (1) $ 1,708 $ 1,791 FHLB restricted stock (2) 63 67 Other fixed maturities-state deposits 39 38 Cash and cash equivalents 27 27 Securities pledged (3) 1,002 1,162 Total restricted assets $ 2,839 $ 3,085 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $682 and $907 as of September 30, 2023 and December 31, 2022, respectively. In addition, as of September 30, 2023 and December 31, 2022, the Company delivered securities as collateral of $208 and $142 and repurchase agreements of $112 and $113, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets.

Consolidated and Nonconsolida_2

Consolidated and Nonconsolidated Investment Entities (Tables)	9 Months Ended
	Sep. 30, 2023
Consolidated Investment Entities [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: September 30, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 27,620 $ 27,620 $ 30,357 $ 30,357 Equity securities 301 301 336 336 Mortgage loans on real estate 5,373 4,938 5,445 5,149 Policy loans 358 358 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,029 2,029 2,454 2,454 Derivatives 482 482 422 422 Embedded derivatives on reinsurance 101 101 95 95 Other investments 63 63 68 68 Assets held in separate accounts 85,491 85,491 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 32,871 $ 33,433 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,176 1,180 1,285 1,281 Supplementary contracts, immediate annuities and other 455 423 727 636 Stabilizer and MCGs 27 27 6 6 Derivatives 373 373 389 389 Embedded derivative on reinsurance 41 41 46 46 Short-term debt 2 2 141 142 Long-term debt 2,095 1,881 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of September 30, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,396 — — 1,396 Limited partnerships/corporations — — — 3,079 3,079 VOE Corporate loans — 32 — — 32 Total assets $ 88 $ 1,428 $ — $ 3,079 $ 4,595 Liabilities VIEs CLO notes $ — $ 1,329 $ — $ — $ 1,329 Total liabilities $ — $ 1,329 $ — $ — $ 1,329 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234

Intangible Assets, Goodwill and

Intangible Assets, Goodwill and Other (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Corporate Consolidated Balance as of January 1, 2022 $ 17 $ 24 $ 31 $ — $ 72 Additions from business combinations — — 255 — 255 Balance as of December 31, 2022 $ 17 $ 24 $ 286 $ — $ 327 Additions from business combinations (1) — 319 — 102 421 Balance as of September 30, 2023 $ 17 $ 343 $ 286 $ 102 $ 748 (1) See the Business, Basis of Presentation and Significant Accounting Policies Note for information on recent business combinations.
Schedule of Indefinite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted September 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 17 years $ 190 $ 13 $ 177 $ 741 $ 554 $ 187 Customer relationship lists 8 years 325 124 201 135 111 24 Trademarks 8 years 15 1 14 — — — Computer software 4 years 489 332 158 502 432 70 Total intangible assets $ 1,369 $ 470 $ 900 $ 1,728 $ 1,097 $ 631
Schedule of Finite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted September 30, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 17 years $ 190 $ 13 $ 177 $ 741 $ 554 $ 187 Customer relationship lists 8 years 325 124 201 135 111 24 Trademarks 8 years 15 1 14 — — — Computer software 4 years 489 332 158 502 432 70 Total intangible assets $ 1,369 $ 470 $ 900 $ 1,728 $ 1,097 $ 631

Business, Basis of Presentati_4

Business, Basis of Presentation and Significant Accounting Policies - Narrative (Details) $ in Millions		3 Months Ended		9 Months Ended
	Jan. 24, 2023 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) segment	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Number of operating segments | segment				3
Payments for business acquisitions, net of cash acquired				$ 584	$ 2
Goodwill acquired		$ 748		748		$ 327	$ 72
Estimated amortization expense for year two		29		29
Estimated amortization expense for year three		29		29
Estimated amortization expense for year four		29		29
Estimated amortization expense for year five		29		29
Net gains (losses)		(7)	$ (125)	(79)	$ (639)
Benefitfocus
Total purchase consideration	$ 595
Cash purchase consideration	583
Payments for business acquisitions, net of cash acquired	558
Cash acquired from acquisition	25
Cash acquired	49
Goodwill acquired	319
Lease liabilities assumed	91
Intangible assets acquired	275
Deferred tax assets acquired	45
Estimated amortization expense for the next year		29		29
Customer Relationships | Benefitfocus
Finite-lived intangible assets acquired	$ 190
Acquired finite-lived intangible assets, useful life	15 years
Software | Benefitfocus
Finite-lived intangible assets acquired	$ 70
Acquired finite-lived intangible assets, useful life	5 years
VFI SLK
Cash purchase consideration				53
Voya India
Goodwill acquired		102		102
Net gains (losses)		$ 45		$ 45
Voya India
Noncontrolling interest, ownership percentage by parent		4,900%		4,900%
SLK
Noncontrolling interest, ownership percentage by noncontrolling owners		5,100%		5,100%

Business, Basis of Presentati_5

Business, Basis of Presentation and Significant Accounting Policies - Adoption of New Pronouncements (Details) - USD ($) $ in Millions	Dec. 31, 2020	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Jan. 01, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC		$ 2,278		$ 2,363
VOBA		414		439			$ 473
Total Shareholders' equity		4,786	$ 5,357	4,831	$ 4,506	$ 5,298	9,668
Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity		(3,533)	(2,791)	(3,055)	(3,303)	(2,045)	1,807
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity		302	$ 40	(201)	$ (854)	$ (1,034)	(1,170)
Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC		693		691			691
business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC		964		1,043			1,158
Liability for Future Policy Benefits		7,191		8,639			11,444
Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits		865		881			1,048
Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits		$ 279		$ 285			$ 359
Previously Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
VOBA	$ 70
Total Shareholders' equity	11,178
Previously Reported | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	119
Previously Reported | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	1,186
Liability for Future Policy Benefits	5,448
Previously Reported | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	822
Previously Reported | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	188
Revision of Prior Period, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
VOBA								$ 705
Total Shareholders' equity								11,336
Revision of Prior Period, Adjustment | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
VOBA, Adjustment for removal of related balances in AOCI	635
Effect of remeasurement of liability at current discount rate	(1,065)
Total Shareholders' equity	1,328
Revision of Prior Period, Adjustment | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Establishment of MRBs	(132)
Other Adjustments	27
Revision of Prior Period, Adjustment | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC								690
Revision of Prior Period, Adjustment | Wealth Solutions | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	571
Revision of Prior Period, Adjustment | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC								1,290
Liability for Future Policy Benefits								6,427
Effect of remeasurement of liability at current discount rate	1,362
Revision of Prior Period, Adjustment | business exited | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
DAC	104
Liability for Future Policy Benefits	(386)
Revision of Prior Period, Adjustment | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits								947
Effect of remeasurement of liability at current discount rate	118
Revision of Prior Period, Adjustment | Employee Benefits, Group | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	0
Revision of Prior Period, Adjustment | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits								274
Effect of remeasurement of liability at current discount rate	83
Revision of Prior Period, Adjustment | Employee Benefits, Voluntary | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	0
Effect of Modified Retrospective Application Accounting Standards Update 2018-12
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity								$ 158
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity	263
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total Shareholders' equity	(105)
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	3
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	7
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits	$ 3

Investments (excluding Consol_3

Investments (excluding Consolidated Investment Entities) - Fixed Maturities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 28,409		$ 28,409		$ 30,202
Fixed maturities, allowance for credit losses	19		19		12
Securities pledged, amortized costs	1,157		1,157		1,303
Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings	$ 18	$ 12	$ 25	$ 21
Minimum
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed Maturities Average Duration	6 years		6 years
Maximum
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed Maturities Average Duration	6 years 6 months		6 years 6 months
Collateral Pledged
Schedule of Available for Sale, including Securities Pledged [Line Items]
Securities pledged	$ 1,002		$ 1,002		1,162
U.S. Treasuries
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	458		458		590
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	0		0		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	418		418		581
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0		0		12
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	40		40		21
U.S. Government agencies and authorities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	54		54		58
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	0		0		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	53		53		59
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	1		1		3
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	2		2		2
State, municipalities and political subdivisions
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	881		881		978
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	0		0		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	726		726		845
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	0		0		1
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	155		155		134
U.S. corporate public securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	8,554		8,554		9,343
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	0		0		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	7,175		7,175		8,201
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	57		57		97
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	1,436		1,436		1,239
U.S. corporate private securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	5,114		5,114		5,087
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	0		0		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	4,603		4,603		4,692
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	10		10		14
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	521		521		409
Foreign corporate public securities and foreign governments
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	2,974		2,974		3,343
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	6		6		9
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	2,547		2,547		2,949
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	10		10		18
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	431		431		403
Foreign corporate private securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,111		3,111		3,254
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	1		1		2
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	2,879		2,879		3,034
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	10		10		7
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	241		241		225
Residential mortgage-backed
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,710		3,710		4,230
Embedded Derivatives	1		1		(3)
Fixed maturities, allowance for credit losses	0		0		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	3,397		3,397		3,977
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	28		28		34
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	340		340		290
Commercial mortgage-backed securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,226		4,226		4,466
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	10		10		0
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	3,479		3,479		3,883
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	2		2		2
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	739		739		585
Other asset-backed securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	2,439		2,439		2,307
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	2		2		1
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	2,343		2,343		2,136
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	11		11		3
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	105		105		173
Fixed maturities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	31,521		31,521		33,656
Embedded Derivatives	1		1		(3)
Fixed maturities, allowance for credit losses	19		19		12
Fixed maturities, available-for-sale, at fair value (amortized cost of $28,409 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $19 as of 2023 and $12 as of 2022)	27,620		27,620		30,357
Total fixed maturities, less securities pledged, Amortized Cost	30,364		30,364		32,353
Total fixed maturities, less securities pledged, Gross Unrealized Capital Gains	129		129		188
Total fixed maturities, less securities pledged, Gross Unrealized Capital Losses	3,855		3,855		3,337
Total fixed maturities, less securities pledged, Fair Value	26,618		26,618		29,195
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	129		129		191
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	4,010		4,010		3,481
Fixed maturities | Collateral Pledged
Schedule of Available for Sale, including Securities Pledged [Line Items]
Embedded Derivatives	0		0		0
Fixed maturities, allowance for credit losses	0		0		0
Securities pledged, amortized costs	1,157		1,157		1,303
Securities pledged, Gross Unrealized Capital Gains	0		0		3
Securities pledged, Gross Unrealized Capital Losses	155		155		144
Securities pledged	$ 1,002		$ 1,002		$ 1,162

Investments (excluding Consol_4

Investments (excluding Consolidated Investment Entities) - Debt Maturities (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 28,409	$ 30,202
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
One year or less, Amortized Cost	831
One year or less, Fair Value	812
After one year through five years, Amortized Cost	3,890
After one year through five years, Fair Value	3,663
After five years through ten years, Amortized Cost	4,091
After five years through ten years, Fair Value	3,738
After ten years, Amortized Cost	12,334
After ten years, Fair Value	10,188
Fixed maturities, amortized cost	31,521	33,656
Fixed maturities, available-for-sale, at fair value	27,620	30,357
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	7,936
Without single maturity date, Fair Value	6,876
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	2,439
Without single maturity date, Fair Value	2,343
Fixed maturities, amortized cost	2,439	2,307
Fixed maturities, available-for-sale, at fair value	$ 2,343	$ 2,136

Investments (excluding Consol_5

Investments (excluding Consolidated Investment Entities) - Repurchase Agreements and Securities Pledged (Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Available-for-sale Securities, Including Securities Pledged [Line Items]
Single issuer in excess of total equity	no
Initial collateral required, percent of market value of loaned securities	102%
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities sold under agreements to repurchase, asset	$ 0

Investments (excluding Consol_6

Investments (excluding Consolidated Investment Entities) - Securities Pledged (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Securities Financing Transaction [Line Items]
Initial collateral required, percent of market value of loaned securities	102%
Collateral Pledged
Securities Financing Transaction [Line Items]
Securities pledged	$ 1,002	$ 1,162
Securities sold under agreements to repurchase, asset	0
Collateral Pledged | Fixed maturities
Securities Financing Transaction [Line Items]
Securities pledged	1,002	1,162
Securities pledged
Securities Financing Transaction [Line Items]
Securities pledged/obligations under repurchase agreements	112	113
Securities loaned to lending agent	682	907
Securities pledged as collateral	$ 208	$ 142

Investments (excluding Consol_7

Investments (excluding Consolidated Investment Entities) - Borrowings under securities lending transactions (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 1,190	$ 1,302
Single issuer in excess of total equity	no
Short-term Investments
Summary of Investment Holdings [Line Items]
Securities received as collateral	$ 560	807
Collateral Pledged
Summary of Investment Holdings [Line Items]
Securities pledged	1,002	1,162
U.S. Treasuries
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	19	53
U.S. corporate public securities
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	494	604
Short-term Investments
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	1	0
Foreign corporate public securities and foreign governments
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	193	285
Total
Summary of Investment Holdings [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	707	942
Fixed maturities | Collateral Pledged
Summary of Investment Holdings [Line Items]
Securities pledged	$ 1,002	$ 1,162

Investments (excluding Consol_8

Investments (excluding Consolidated Investment Entities) - Allowance for Credit Losses on Available-for-sale Fixed Maturity Securities (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 12	$ 12	$ 58
Credit losses on securities for which credit losses were not previously recorded		11
Credit losses on securities for which credit losses were not previously recorded	9
Reductions for securities sold during the period	(57)	(2)
Increase (decrease) on securities with allowance recorded in previous period	2	(2)
Ending Balance		19	12
U.S. corporate public securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	0
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period		0
Increase (decrease) on securities with allowance recorded in previous period		0
Ending Balance		0	0
Residential mortgage-backed
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	0	1
Credit losses on securities for which credit losses were not previously recorded	0
Reductions for securities sold during the period	0
Increase (decrease) on securities with allowance recorded in previous period	(1)
Ending Balance			0
Commercial mortgage-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	0
Credit losses on securities for which credit losses were not previously recorded		10
Reductions for securities sold during the period		0
Increase (decrease) on securities with allowance recorded in previous period		0
Ending Balance		10	0
Foreign corporate public securities and foreign governments
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	9	9	0
Credit losses on securities for which credit losses were not previously recorded		0
Credit losses on securities for which credit losses were not previously recorded	9
Reductions for securities sold during the period	0	(2)
Increase (decrease) on securities with allowance recorded in previous period	0	(1)
Ending Balance		6	9
Foreign corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	2	2	56
Credit losses on securities for which credit losses were not previously recorded		0
Credit losses on securities for which credit losses were not previously recorded	0
Reductions for securities sold during the period	(57)	0
Increase (decrease) on securities with allowance recorded in previous period	3	(1)
Ending Balance		1	2
Other asset-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1	1	1
Credit losses on securities for which credit losses were not previously recorded		1
Credit losses on securities for which credit losses were not previously recorded	0
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	$ 0	0
Ending Balance		$ 2	$ 1

Investments (excluding Consol_9

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 4,204	$ 20,391
Twelve months or less below amortized cost, Unrealized Capital Loss	218	2,349
More than twelve months below amortized cost, Fair Value	18,724	4,363
More than twelve months below amortized cost, Unrealized Capital Loss	3,792	1,132
Total, Fair Value	22,928	24,754
Total Unrealized Capital Losses	4,010	3,481
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	276	197
Twelve months or less below amortized cost, Unrealized Capital Loss	11	19
More than twelve months below amortized cost, Fair Value	99	9
More than twelve months below amortized cost, Unrealized Capital Loss	29	2
Total, Fair Value	375	206
Total Unrealized Capital Losses	40	21
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	13	21
Twelve months or less below amortized cost, Unrealized Capital Loss	1	2
More than twelve months below amortized cost, Fair Value	3	0
More than twelve months below amortized cost, Unrealized Capital Loss	1	0
Total, Fair Value	16	21
Total Unrealized Capital Losses	2	2
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	28	751
Twelve months or less below amortized cost, Unrealized Capital Loss	1	121
More than twelve months below amortized cost, Fair Value	682	30
More than twelve months below amortized cost, Unrealized Capital Loss	154	13
Total, Fair Value	710	781
Total Unrealized Capital Losses	155	134
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	1,375	5,479
Twelve months or less below amortized cost, Unrealized Capital Loss	97	792
More than twelve months below amortized cost, Fair Value	4,761	1,137
More than twelve months below amortized cost, Unrealized Capital Loss	1,339	447
Total, Fair Value	6,136	6,616
Total Unrealized Capital Losses	1,436	1,239
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	967	3,569
Twelve months or less below amortized cost, Unrealized Capital Loss	39	322
More than twelve months below amortized cost, Fair Value	3,249	458
More than twelve months below amortized cost, Unrealized Capital Loss	482	87
Total, Fair Value	4,216	4,027
Total Unrealized Capital Losses	521	409
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	565	2,050
Twelve months or less below amortized cost, Unrealized Capital Loss	25	260
More than twelve months below amortized cost, Fair Value	1,670	391
More than twelve months below amortized cost, Unrealized Capital Loss	406	143
Total, Fair Value	2,235	2,441
Total Unrealized Capital Losses	431	403
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	437	2,728
Twelve months or less below amortized cost, Unrealized Capital Loss	18	211
More than twelve months below amortized cost, Fair Value	2,101	65
More than twelve months below amortized cost, Unrealized Capital Loss	223	14
Total, Fair Value	2,538	2,793
Total Unrealized Capital Losses	241	225
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	349	1,538
Twelve months or less below amortized cost, Unrealized Capital Loss	17	128
More than twelve months below amortized cost, Fair Value	1,307	562
More than twelve months below amortized cost, Unrealized Capital Loss	323	162
Total, Fair Value	1,656	2,100
Total Unrealized Capital Losses	340	290
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	84	2,628
Twelve months or less below amortized cost, Unrealized Capital Loss	4	390
More than twelve months below amortized cost, Fair Value	3,234	1,133
More than twelve months below amortized cost, Unrealized Capital Loss	735	195
Total, Fair Value	3,318	3,761
Total Unrealized Capital Losses	739	585
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	110	1,430
Twelve months or less below amortized cost, Unrealized Capital Loss	5	104
More than twelve months below amortized cost, Fair Value	1,618	578
More than twelve months below amortized cost, Unrealized Capital Loss	100	69
Total, Fair Value	1,728	2,008
Total Unrealized Capital Losses	$ 105	$ 173

Investments (excluding Conso_10

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses 1 (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($) loan	Dec. 31, 2022 USD ($)
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total Unrealized Capital Losses	$ 4,010	$ 3,481
More than twelve months below amortized cost, Unrealized Capital Loss	$ 3,792	1,132
Commercial mortgage loans
Available-for-sale Securities, Including Securities Pledged [Line Items]
Troubled debt restructuring, number of contracts | loan	0
Minimum
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed Maturities Average Duration	6 years
Maximum
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed Maturities Average Duration	6 years 6 months
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total Unrealized Capital Losses	$ 739	585
More than twelve months below amortized cost, Unrealized Capital Loss	$ 735	$ 195

Investments (excluding Conso_11

Investments (excluding Consolidated Investment Entities) - Loans by Loan to Value (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Targeted maximum amount of mortgage loans lended, percent of estimated fair value of underlying real estate	75%
Commercial mortgage loans	$ 5,373	$ 5,445
0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	0%
Loan to value ratio, maximum	50%
Commercial mortgage loans	$ 3,577	3,605
50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	50%
Loan to value ratio, maximum	60%
Commercial mortgage loans	$ 1,399	1,418
60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	60%
Loan to value ratio, maximum	70%
Commercial mortgage loans	$ 330	402
70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	70%
Loan to value ratio, maximum	80%
Commercial mortgage loans	$ 10	20
80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	80%
Commercial mortgage loans	$ 57	0
Year of Origination 2023
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	344
Year of Origination 2023 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	89
Year of Origination 2023 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	255
Year of Origination 2023 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2022 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	243	250
Year of Origination 2022 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	342	320
Year of Origination 2022 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	65	65
Year of Origination 2022 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2021 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	247	240
Year of Origination 2021 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	224	272
Year of Origination 2021 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	230	255
Year of Origination 2021 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	10
Year of Origination 2021 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2020 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	161	119
Year of Origination 2020 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	145	209
Year of Origination 2020 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	25
Year of Origination 2020 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2020 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	16	0
Year of Origination 2019
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2019 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	234	227
Year of Origination 2019 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	74	94
Year of Origination 2019 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	29	29
Year of Origination 2019 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2018 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	2,603	163
Year of Origination 2018 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	359	41
Year of Origination 2018 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	6	2
Year of Origination 2018 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	$ 41	0
Year of Origination 2017 and prior
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		3,114
Year of Origination 2017 and prior | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		2,606
Year of Origination 2017 and prior | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		482
Year of Origination 2017 and prior | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		26
Year of Origination 2017 and prior | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0
Year of Origination 2017 and prior | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		$ 0

Investments (excluding Conso_12

Investments (excluding Consolidated Investment Entities) - Loans by Debt Service Coverage Ratio (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,373	$ 5,445
>1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	150%
>1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	125%
Debt Service Coverage Ratio, maximum	150%
>1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	100%
Debt Service Coverage Ratio, maximum	125%
Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, maximum	100%
Year of Origination 2023
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 344
Year of Origination 2023 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	168
Year of Origination 2023 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	109
Year of Origination 2023 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	67
Year of Origination 2023 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	344
Year of Origination 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2022 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	229	331
Year of Origination 2022 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	56	100
Year of Origination 2022 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	203	181
Year of Origination 2022 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	162	23
Year of Origination 2022 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2021
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2021 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	262	273
Year of Origination 2021 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	14	33
Year of Origination 2021 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	77	269
Year of Origination 2021 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	348	202
Year of Origination 2021 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2020
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2020 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	225	259
Year of Origination 2020 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	25	11
Year of Origination 2020 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	5	11
Year of Origination 2020 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	77	82
Year of Origination 2020 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2019
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2019 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	204	222
Year of Origination 2019 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	26	54
Year of Origination 2019 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	86	67
Year of Origination 2019 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	21	7
Year of Origination 2019 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2018
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2018 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,243	128
Year of Origination 2018 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	315	27
Year of Origination 2018 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	261	51
Year of Origination 2018 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	190	0
Year of Origination 2018 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2017 and prior
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		3,114
Year of Origination 2017 and prior | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		2,172
Year of Origination 2017 and prior | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		454
Year of Origination 2017 and prior | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		226
Year of Origination 2017 and prior | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		262
Year of Origination 2017 and prior | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		3,114
Total | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,331	3,385
Total | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	545	679
Total | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	699	805
Total | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	798	576
Total | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,373	$ 5,445

Investments (excluding Conso_13

Investments (excluding Consolidated Investment Entities) - Loans by U.S. Region (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,373	$ 5,445
Year of Origination 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	344
Year of Origination 2023 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	70
Year of Origination 2023 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	55
Year of Origination 2023 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	7
Year of Origination 2023 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	99
Year of Origination 2023 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	39
Year of Origination 2023 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	42
Year of Origination 2023 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3
Year of Origination 2023 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	26
Year of Origination 2023 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3
Year of Origination 2023 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	344
Year of Origination 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2022 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	140	140
Year of Origination 2022 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	131	129
Year of Origination 2022 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	48	48
Year of Origination 2022 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	99	98
Year of Origination 2022 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	113	114
Year of Origination 2022 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	93	82
Year of Origination 2022 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	5	4
Year of Origination 2022 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1	1
Year of Origination 2022 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20	19
Year of Origination 2022 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2021 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	99	99
Year of Origination 2021 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	63	72
Year of Origination 2021 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	126	134
Year of Origination 2021 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	148	143
Year of Origination 2021 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	111	112
Year of Origination 2021 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	94	138
Year of Origination 2021 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	9
Year of Origination 2021 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	49	48
Year of Origination 2021 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1	22
Year of Origination 2021 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2020
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2020 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	73	74
Year of Origination 2020 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	156	170
Year of Origination 2020 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	18
Year of Origination 2020 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	16
Year of Origination 2020 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2020 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	40	39
Year of Origination 2020 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2020 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	27
Year of Origination 2020 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2019 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	53	58
Year of Origination 2019 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	101	106
Year of Origination 2019 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2019 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	75	77
Year of Origination 2019 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	46	46
Year of Origination 2019 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	4	5
Year of Origination 2019 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2019 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	13	13
Year of Origination 2019 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	21	21
Year of Origination 2019 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2018
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2018 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	778	50
Year of Origination 2018 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	620	62
Year of Origination 2018 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	777	55
Year of Origination 2018 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	202	10
Year of Origination 2018 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	217	14
Year of Origination 2018 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	202	10
Year of Origination 2018 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	47	0
Year of Origination 2018 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	146	5
Year of Origination 2018 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20	0
Year of Origination 2018 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2017 and prior
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		3,114
Year of Origination 2017 and prior | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		777
Year of Origination 2017 and prior | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		623
Year of Origination 2017 and prior | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		759
Year of Origination 2017 and prior | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		248
Year of Origination 2017 and prior | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		227
Year of Origination 2017 and prior | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		257
Year of Origination 2017 and prior | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		49
Year of Origination 2017 and prior | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		149
Year of Origination 2017 and prior | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		25
Year of Origination 2017 and prior | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		3,114
Total | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,213	1,198
Total | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,126	1,162
Total | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	985	1,024
Total | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	633	592
Total | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	538	525
Total | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	475	531
Total | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	79	76
Total | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	242	223
Total | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	82	114
Total | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,373	$ 5,445

Investments (excluding Conso_14

Investments (excluding Consolidated Investment Entities) - Loans by Property Type (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,373	$ 5,445
Year of Origination 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	344
Year of Origination 2023 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	110
Year of Origination 2023 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	157
Year of Origination 2023 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	26
Year of Origination 2023 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	19
Year of Origination 2023 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	32
Year of Origination 2023 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	344
Year of Origination 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2022 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	79	79
Year of Origination 2022 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	264	255
Year of Origination 2022 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	253	247
Year of Origination 2022 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	34	34
Year of Origination 2022 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	650	635
Year of Origination 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2021 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	36	37
Year of Origination 2021 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	151	168
Year of Origination 2021 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	363	420
Year of Origination 2021 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	124	125
Year of Origination 2021 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2021 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	701	777
Year of Origination 2020
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2020 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	57	58
Year of Origination 2020 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	59	61
Year of Origination 2020 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	73	93
Year of Origination 2020 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	143	151
Year of Origination 2020 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	332	363
Year of Origination 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2019 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	46	46
Year of Origination 2019 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	83	85
Year of Origination 2019 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	161	165
Year of Origination 2019 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	36	40
Year of Origination 2019 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	11	14
Year of Origination 2019 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	337	350
Year of Origination 2018
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2018 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	800	37
Year of Origination 2018 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	768	84
Year of Origination 2018 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	668	56
Year of Origination 2018 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	491	12
Year of Origination 2018 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	67	0
Year of Origination 2018 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	165	17
Year of Origination 2018 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	50	0
Year of Origination 2018 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3,009	206
Year of Origination 2017 and prior
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		3,114
Year of Origination 2017 and prior | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		888
Year of Origination 2017 and prior | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		757
Year of Origination 2017 and prior | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		679
Year of Origination 2017 and prior | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		513
Year of Origination 2017 and prior | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		69
Year of Origination 2017 and prior | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		156
Year of Origination 2017 and prior | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		52
Year of Origination 2017 and prior | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		3,114
Total | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,128	1,145
Total | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,482	1,410
Total | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,544	1,660
Total | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	847	875
Total | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	120	93
Total | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	193	201
Total | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	59	61
Total | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 5,373	$ 5,445

Investments (excluding Conso_15

Investments (excluding Consolidated Investment Entities) - Allowance for Losses for Commercial Mortgage Loans (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 12	$ 12	$ 58
Credit losses on securities for which credit losses were not previously recorded	9
Increase (decrease) on securities with allowance recorded in previous period	2	(2)
Ending Balance		19	12
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 18	18	15
Credit losses on securities for which credit losses were not previously recorded		2	3
Increase (decrease) on securities with allowance recorded in previous period		9	0
Provision for expected credit losses		29	18
Write-offs		0	0
Recoveries of amounts previously written-off		0	0
Ending Balance		$ 29	$ 18

Investments (excluding Conso_16

Investments (excluding Consolidated Investment Entities) - Past due commercial mortgage loans (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Financing Receivable, Past Due [Line Items]
Financing Receivable, 90 Days or More Past Due, Still Accruing	$ 38,000,000	$ 0
Financing Receivable, Nonaccrual, Interest Income	0	0
Current
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	5,335,000,000	5,445,000,000
30-59 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	38,000,000	0
60-89 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Greater than 90 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Total
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	$ 5,373,000,000	$ 5,445,000,000

Investments (excluding Conso_17

Investments (excluding Consolidated Investment Entities) - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Net Investment Income [Line Items]
Gross investment income	$ 564	$ 536	$ 1,690	$ 1,777
Less: Investment expenses	17	14	53	44
Net investment income	547	522	1,637	1,733
Net gains (losses)	(7)	(125)	(79)	(639)
Voya India
Net Investment Income [Line Items]
Net gains (losses)	45		45
Fixed maturities
Net Investment Income [Line Items]
Gross investment income	438	483	1,336	1,457
Investments in fixed maturities that did not produce net investment income	18		18		$ 11
Equity securities
Net Investment Income [Line Items]
Gross investment income	3	(3)	17	6
Mortgage loans on real estate
Net Investment Income [Line Items]
Gross investment income	64	58	187	177
Net gains (losses)	(1)	(1)	(11)	4
Policy loans
Net Investment Income [Line Items]
Gross investment income	5	5	16	16
Short-term investments and cash equivalents
Net Investment Income [Line Items]
Gross investment income	10	3	28	6
Limited partnerships and other
Net Investment Income [Line Items]
Gross investment income	44	(10)	106	115
Net gains (losses)	$ 48	$ 4	$ 47	$ 10

Investments (excluding Conso_18

Investments (excluding Consolidated Investment Entities) - Net Realized Capital Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Realized Gain/(Losses) [Line Items]
Net gains (losses)	$ (7)	$ (125)	$ (79)	$ (639)
Voya India
Realized Gain/(Losses) [Line Items]
Net gains (losses)	45		45
Fixed maturities
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(3)	(2)	(4)	(8)
Other derivatives, net
Realized Gain/(Losses) [Line Items]
Net gains (losses)	0	2	0	0
Standalone derivatives
Realized Gain/(Losses) [Line Items]
Net gains (losses)	1	(3)	1	(2)
Managed custody guarantees
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(9)	0	(9)	19
Managed Custody Guarantees
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(15)	(6)	(12)	(8)
Derivatives
Realized Gain/(Losses) [Line Items]
Net gains (losses)	134	174	199	300
Mortgage loans on real estate
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(1)	(1)	(11)	4
Other investments
Realized Gain/(Losses) [Line Items]
Net gains (losses)	48	4	47	10
Fixed maturities, available-for-sale, including securities pledged
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(24)	8	(41)	(71)
Fixed maturities, at fair value option
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(135)	(294)	(243)	(844)
Equity securities, at fair value
Realized Gain/(Losses) [Line Items]
Net gains (losses)	$ (3)	$ (7)	$ (6)	$ (39)

Investments (excluding Conso_19

Investments (excluding Consolidated Investment Entities) - Gross Gains/(Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Proceeds on sales	$ 862	$ 1,138	$ 4,499	$ 3,358
Gross gains	11	30	54	60
Gross losses	14	19	69	63
Less: Investment expenses	17	14	53	44
Gross Gains/(Losses) [Line Items]
Proceeds on sales	862	1,138	4,499	3,358
Gross gains	11	30	54	60
Gross losses	$ 14	$ 19	$ 69	$ 63

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional and Fair Values (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 583,000,000	$ 520,000,000
Derivative Liability, Fair Value, Gross Liability	442,000,000	441,000,000
Excluded asset exchange traded contract	0	2
Excluded Liability Exchange Traded Contracts		0
Not Designated as Hedging Instrument | Credit contracts
Derivative [Line Items]
Notional Amount	157,000,000	174,000,000
Not Designated as Hedging Instrument | Derivatives | Credit contracts
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	3,000,000	2,000,000
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	219,000,000	160,000,000
Foreign exchange contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	6,000,000	9,000,000
Derivative Liability, Fair Value, Gross Liability	7,000,000	2,000,000
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	105,000,000	81,000,000
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	6,000,000	0
Derivative Liability, Fair Value, Gross Liability	0	6,000,000
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	736,000,000	718,000,000
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	60,000,000	71,000,000
Derivative Liability, Fair Value, Gross Liability	2,000,000	2,000,000
Interest rate contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	17,996,000,000	18,304,000,000
Interest rate contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	408,000,000	341,000,000
Derivative Liability, Fair Value, Gross Liability	353,000,000	376,000,000
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	22,000,000	22,000,000
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Equity contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	241,000,000	248,000,000
Equity contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	2,000,000	1,000,000
Derivative Liability, Fair Value, Gross Liability	8,000,000	1,000,000
Fixed maturities | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	3,000,000
Derivative Liability, Fair Value, Gross Liability	1,000,000	0
Embedded derivative on reinsurance | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	101,000,000	95,000,000
Derivative Liability, Fair Value, Gross Liability		46,000,000
Derivative Liability, Not Subject to Master Netting Arrangement	41,000,000
Managed custody guarantees | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	9,000,000	0
Managed Custody Guarantees | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	$ 18,000,000	$ 6,000,000

Derivative Financial Instrume_4

Derivative Financial Instruments - Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Offsetting Assets and Liabilities [Line Items]
Asset Fair Value	$ 482	$ 420
Liability Fair Value	373	389
Counterparty netting, Assets	(328)	(295)
Counterparty netting, Liabilities	(328)	(295)
Cash collateral netting, Assets	(145)	(64)
Cash collateral netting, Liabilities	(26)	(88)
Securities collateral netting, Assets	(6)	(6)
Securities collateral netting, Liabilities	(9)	(1)
Net receivables/payables, Assets	3	55
Net receivables/payables, Liabilities	$ 10	$ 5

Derivative Financial Instrume_5

Derivative Financial Instruments - Collateral and Credit Default Swaps (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Securities pledged as collateral
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 6	$ 7
Securities pledged as collateral	208	142
Over the counter | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	133	56
Cleared derivative contract | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 11	$ 79

Derivative Financial Instrume_6

Derivative Financial Instruments - Effect of Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Net investment income	$ 547	$ 522	$ 1,637	$ 1,733
Net gains (losses)	(7)	(125)	(79)	(639)
Gain (loss) on derivative, net	132	217	182	522
Not Designated as Hedging Instrument | Credit contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	1	0	0	(4)
Interest rate contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	138	176	196	328
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0	0	(2)
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Investment Income [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0	0	0
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(2)	0	(1)	(2)
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	7	64	(11)	126
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Investment Income [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	3	4	8	9
Gain (loss) on derivative, net	3	4	8	9
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Gain (Loss) on Investments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Investment Income [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Gain (Loss) on Investments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(3)	(6)	(1)	(13)
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Investment Income [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Gain (Loss) on Investments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	4	6	3	14
Embedded derivative on reinsurance
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	29	57	11	233
Embedded derivative on reinsurance | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings	1	0	2	1
Total Realized/Unrealized Gains (Losses) Included in Net income	1	(3)	1	(2)
Equity contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(7)	(8)	1	(36)
Fixed maturities
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	(3)	(2)	(4)	(8)
Gain (loss) on derivative, net	(3)	(2)	(4)	(8)
Managed Custody Guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	(15)	(6)	(12)	(8)
Gain (loss) on derivative, net	(15)	(6)	(12)	(8)
Managed custody guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	(9)	0	(9)	19
Gain (loss) on derivative, net	(9)	0	(9)	19
Managed custody guarantees | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Total Realized/Unrealized Gains (Losses) Included in Net income	$ (24)	$ (5)	$ (20)	$ 12

Fair Value Measurements (excl_3

Fair Value Measurements (excluding Consolidated Investment Entities) - Fair Value Measurement (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 85,491	$ 80,174
Total assets	149,265	146,606
Derivatives	373	389
Total liabilities	144,306	141,609
Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	27,620	30,357
U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	418	581
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	53	59
State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	726	845
U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	7,175	8,201
U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,603	4,692
Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,547	2,949
Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,879	3,034
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,397	3,977
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,479	3,883
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,343	2,136
Measured at fair value on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	27,620	30,357
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,029	2,454
Assets held in separate accounts	85,491	80,174
Total assets	116,024	113,838
Contingent consideration	112	112
Total liabilities	553	553
Measured at fair value on a recurring basis | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	27	6
Measured at fair value on a recurring basis | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	408	341
Derivatives	353	376
Measured at fair value on a recurring basis | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	72	80
Derivatives	9	10
Measured at fair value on a recurring basis | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	1
Derivatives	8	1
Measured at fair value on a recurring basis | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	101	95
Embedded derivative on reinsurance	41	46
Measured at fair value on a recurring basis | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	2
Measured at fair value on a recurring basis | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	418	581
Measured at fair value on a recurring basis | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	53	59
Measured at fair value on a recurring basis | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	726	845
Measured at fair value on a recurring basis | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	7,175	8,201
Measured at fair value on a recurring basis | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,603	4,692
Measured at fair value on a recurring basis | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,547	2,949
Measured at fair value on a recurring basis | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,879	3,034
Measured at fair value on a recurring basis | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,397	3,977
Measured at fair value on a recurring basis | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,479	3,883
Measured at fair value on a recurring basis | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,343	2,136
Measured at fair value on a recurring basis | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	301	336
Measured at fair value on a recurring basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	366	433
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,016	2,430
Assets held in separate accounts	79,775	74,600
Total assets	82,269	77,605
Contingent consideration	0	0
Total liabilities	11	3
Measured at fair value on a recurring basis | Level 1 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	1	2
Derivatives	11	3
Measured at fair value on a recurring basis | Level 1 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	0	0
Measured at fair value on a recurring basis | Level 1 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	366	433
Measured at fair value on a recurring basis | Level 1 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	111	140
Measured at fair value on a recurring basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	25,179	27,575
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	13	24
Assets held in separate accounts	5,375	5,227
Total assets	31,149	33,341
Contingent consideration	0	0
Total liabilities	346	374
Measured at fair value on a recurring basis | Level 2 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 2 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	407	339
Derivatives	342	373
Measured at fair value on a recurring basis | Level 2 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	72	80
Derivatives	9	10
Measured at fair value on a recurring basis | Level 2 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	1
Derivatives	8	1
Measured at fair value on a recurring basis | Level 2 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	101	95
Embedded derivative on reinsurance	(16)	(12)
Measured at fair value on a recurring basis | Level 2 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	2
Measured at fair value on a recurring basis | Level 2 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	52	148
Measured at fair value on a recurring basis | Level 2 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	52	58
Measured at fair value on a recurring basis | Level 2 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	726	845
Measured at fair value on a recurring basis | Level 2 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	7,157	8,181
Measured at fair value on a recurring basis | Level 2 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,135	2,891
Measured at fair value on a recurring basis | Level 2 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,547	2,946
Measured at fair value on a recurring basis | Level 2 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,404	2,602
Measured at fair value on a recurring basis | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,334	3,949
Measured at fair value on a recurring basis | Level 2 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,479	3,883
Measured at fair value on a recurring basis | Level 2 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,293	2,072
Measured at fair value on a recurring basis | Level 2 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0	0
Measured at fair value on a recurring basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,075	2,349
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	0	0
Assets held in separate accounts	341	347
Total assets	2,606	2,892
Contingent consideration	112	112
Total liabilities	196	176
Measured at fair value on a recurring basis | Level 3 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	27	6
Measured at fair value on a recurring basis | Level 3 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	57	58
Measured at fair value on a recurring basis | Level 3 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1	1
Measured at fair value on a recurring basis | Level 3 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	18	20
Measured at fair value on a recurring basis | Level 3 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1,468	1,801
Measured at fair value on a recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	3
Measured at fair value on a recurring basis | Level 3 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	475	432
Measured at fair value on a recurring basis | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	63	28
Measured at fair value on a recurring basis | Level 3 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	50	64
Measured at fair value on a recurring basis | Level 3 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 190	$ 196

Fair Value Measurements (excl_4

Fair Value Measurements (excluding Consolidated Investment Entities) - Level 3 Financial Instruments (Details) - Measured at fair value on a recurring basis - Level 3 - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Embedded derivative on reinsurance
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	$ (58)	$ (86)	$ (58)	$ (87)
Total Realized/Unrealized Gains (Losses) Included in Net income	1	(3)	1	(2)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(57)	(89)	(57)	(89)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
Managed custody guarantees
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	(3)	(4)	(6)	(20)
Total Realized/Unrealized Gains (Losses) Included in Net income	(24)	(5)	(20)	12
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	(1)	(1)
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(27)	(9)	(27)	(9)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
Short-term investments and cash equivalents
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance				0
Total Realized/Unrealized Gains (Losses) Included in Net income				0
Total Realized/Unrealized Gains (Losses) Included in OCI				0
Purchases				8
Issuances				0
Sales				0
Settlements				(8)
Transfers out of Level 3				0
Fair Value, Derivatives, ending balance		0		0
Change In Unrealized Gains (Losses) Included in Earnings				0
Change In Unrealized Gains (Losses) Included in OCI				0
Transfers in to Level 3				0
U.S. corporate public securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		19		16
Total Realized/Unrealized Gains (Losses) Included in Net income		0		0
Total Realized/Unrealized Gains (Losses) Included in OCI		(1)		(1)
Purchases		3		7
Issuances		0		0
Sales		0		0
Settlements		(1)		(1)
Transfers out of Level 3		(5)		(6)
Fair Value, Assets, ending balance		15		15
Change In Unrealized Gains (Losses) Included in Earnings		0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0		(1)
Transfers in to Level 3		0		0
U.S. corporate public securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	20		20
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	1		0
Purchases	0		0
Issuances	0		0
Sales	0		0
Settlements	0		1
Transfers out of Level 3	(3)		(3)
Fair Value, Assets, ending balance	18		18
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	0		0
U.S. corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		1,780		1,910
Total Realized/Unrealized Gains (Losses) Included in Net income		(2)		(4)
Total Realized/Unrealized Gains (Losses) Included in OCI		(94)		(374)
Purchases		77		235
Issuances		0		0
Sales		0		0
Settlements		(40)		(159)
Transfers out of Level 3		0		(10)
Fair Value, Assets, ending balance		1,743		1,743
Change In Unrealized Gains (Losses) Included in Earnings		(2)		(4)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(95)		(373)
Transfers in to Level 3		22		145
U.S. corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1,732		1,801
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	(49)		(46)
Purchases	24		104
Issuances	0		0
Sales	0		(3)
Settlements	(46)		(137)
Transfers out of Level 3	(256)		(296)
Fair Value, Assets, ending balance	1,468		1,468
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(49)		(48)
Transfers in to Level 3	63		45
Foreign corporate public securities and foreign governments | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		4	3
Total Realized/Unrealized Gains (Losses) Included in Net income		0	0
Total Realized/Unrealized Gains (Losses) Included in OCI		0	0
Purchases		0	0
Issuances		0	0
Sales		0	0
Settlements		0	0
Transfers out of Level 3		(4)	(3)
Fair Value, Assets, ending balance	0	0	0	0
Change In Unrealized Gains (Losses) Included in Earnings		0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0	0
Transfers in to Level 3		0	0
Foreign corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		403		353
Total Realized/Unrealized Gains (Losses) Included in Net income		(2)		(23)
Total Realized/Unrealized Gains (Losses) Included in OCI		(11)		(42)
Purchases		22		115
Issuances		0		0
Sales		0		0
Settlements		(4)		(33)
Transfers out of Level 3		(4)		(114)
Fair Value, Assets, ending balance		404		404
Change In Unrealized Gains (Losses) Included in Earnings		(2)		(6)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(11)		(42)
Transfers in to Level 3		0		148
Foreign corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	413		432
Total Realized/Unrealized Gains (Losses) Included in Net income	(2)		1
Total Realized/Unrealized Gains (Losses) Included in OCI	(6)		1
Purchases	58		115
Issuances	0		0
Sales	0		0
Settlements	(20)		(197)
Transfers out of Level 3	(21)		(7)
Fair Value, Assets, ending balance	475		475
Change In Unrealized Gains (Losses) Included in Earnings	(2)		1
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(6)		0
Transfers in to Level 3	53		130
Residential mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		31		43
Total Realized/Unrealized Gains (Losses) Included in Net income		(4)		(19)
Total Realized/Unrealized Gains (Losses) Included in OCI		0		0
Purchases		2		4
Issuances		0		0
Sales		0		0
Settlements		0		0
Transfers out of Level 3		(3)		(2)
Fair Value, Assets, ending balance		26		26
Change In Unrealized Gains (Losses) Included in Earnings		(4)		(19)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0		0
Transfers in to Level 3		0		0
Residential mortgage-backed securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	57		28
Total Realized/Unrealized Gains (Losses) Included in Net income	(3)		(6)
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	3		37
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	63		63
Change In Unrealized Gains (Losses) Included in Earnings	(3)		(6)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	6		4
Commercial mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		63		44
Total Realized/Unrealized Gains (Losses) Included in Net income		0		(1)
Total Realized/Unrealized Gains (Losses) Included in OCI		(2)		(6)
Purchases		21		52
Issuances		0		0
Sales		0		(10)
Settlements		(1)		(7)
Transfers out of Level 3		(9)		0
Fair Value, Assets, ending balance		72		72
Change In Unrealized Gains (Losses) Included in Earnings		(1)		(1)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(2)		(6)
Transfers in to Level 3		0		0
Asset-backed Securities [Member]
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		2,300		2,366
Total Realized/Unrealized Gains (Losses) Included in Net income		(8)		(47)
Total Realized/Unrealized Gains (Losses) Included in OCI		(108)		(423)
Purchases		125		413
Issuances		0		0
Sales		0		(10)
Settlements		(46)		(200)
Transfers out of Level 3		(25)		(132)
Fair Value, Assets, ending balance		2,260		2,260
Change In Unrealized Gains (Losses) Included in Earnings		(9)		(30)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(108)		(422)
Transfers in to Level 3		22		293
Asset-backed Securities [Member] | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	45		64
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	0		(1)
Purchases	10		10
Issuances	0		0
Sales	0		0
Settlements	(1)		(1)
Transfers out of Level 3	(4)		(22)
Fair Value, Assets, ending balance	50		50
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		(1)
Transfers in to Level 3	0		0
Fixed maturities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	2,268		2,349
Total Realized/Unrealized Gains (Losses) Included in Net income	(5)		(5)
Total Realized/Unrealized Gains (Losses) Included in OCI	(54)		(46)
Purchases	95		266
Issuances	0		0
Sales	0		(3)
Settlements	(67)		(334)
Transfers out of Level 3	(284)		(331)
Fair Value, Assets, ending balance	2,075		2,075
Change In Unrealized Gains (Losses) Included in Earnings	(5)		(5)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(55)		(49)
Transfers in to Level 3	122		179
Equity securities, at fair value
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	192	203	196	203
Total Realized/Unrealized Gains (Losses) Included in Net income	(2)	(8)	(10)	(35)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	27
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Assets, ending balance	190	195	190	195
Change In Unrealized Gains (Losses) Included in Earnings	(2)	(8)	(10)	(35)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	4	0
US Government Agencies Debt Securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1		1
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0
Total Realized/Unrealized Gains (Losses) Included in OCI	0		0
Purchases	0		0
Issuances	0		0
Sales	0		0
Settlements	0		0
Transfers out of Level 3	0		0
Fair Value, Assets, ending balance	1		1
Change In Unrealized Gains (Losses) Included in Earnings	0		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0
Transfers in to Level 3	0		0
Contingent Consideration
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	(112)	(11)	(112)	(11)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Assets, ending balance	(112)	(11)	(112)	(11)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	0	0	0	0
Assets held in separate accounts
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	344	349	347	316
Total Realized/Unrealized Gains (Losses) Included in Net income	(5)	(9)	(9)	(35)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	1	32	8	164
Issuances	0	0	0	0
Sales	(4)	(16)	(13)	(20)
Settlements	0	0	0	0
Transfers out of Level 3	(1)	(17)	(1)	(92)
Fair Value, Assets, ending balance	341	339	341	339
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Transfers in to Level 3	$ 6	$ 0	$ 9	$ 6

Fair Value Measurements (excl_5

Fair Value Measurements (excluding Consolidated Investment Entities) - Other Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 85,491	$ 80,174
Derivatives	373	389
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	27,620	30,357
Equity securities	301	336
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,029	2,454
Derivatives	482	422
Other investments	63	68
Assets held in separate accounts	85,491	80,174
Short-term debt	2	141
Long-term debt	2,095	2,094
Carrying Value | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	373	389
Carrying Value | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	101	95
Derivatives	41	46
Carrying Value | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	27	6
Carrying Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	32,871	35,707
Carrying Value | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,176	1,285
Carrying Value | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	455	727
Carrying Value | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	5,373	5,445
Carrying Value | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	358	363
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	27,620	30,357
Equity securities	301	336
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,029	2,454
Derivatives	482	422
Other investments	63	68
Assets held in separate accounts	85,491	80,174
Short-term debt	2	142
Long-term debt	1,881	1,935
Estimate of Fair Value Measurement | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	373	389
Estimate of Fair Value Measurement | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	101	95
Derivatives	41	46
Estimate of Fair Value Measurement | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	27	6
Estimate of Fair Value Measurement | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	33,433	36,385
Estimate of Fair Value Measurement | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,180	1,281
Estimate of Fair Value Measurement | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	423	636
Estimate of Fair Value Measurement | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	4,938	5,149
Estimate of Fair Value Measurement | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	$ 358	$ 363

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs and Value of Business Acquired - DAC and VOBA Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Sep. 30, 2022
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		$ 2,363	$ 2,363
Ending balance	$ 2,278		2,278
Movement Analysis Of Value of Business Acquired VOBA [Roll Forward]
Beginning balance		439	439	$ 473
Deferrals of commissions and expenses		5	3
Net amortization included in Condensed Consolidated Statements of Operations	(28)	(39)
Ending balance	414		414
Present Value of Future Insurance Profits, Impairment Loss			0	0
Wealth Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		691	691	691
Deferrals of commissions and expenses	44	59
Net amortization included in the Consolidated Statements of Operations	(42)	(59)
Ending balance	693		693
business exited
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		1,043	1,043	$ 1,158
Deferrals of commissions and expenses		0	0
Net amortization included in the Consolidated Statements of Operations	(79)	(115)
Ending balance	964		964
Other Segments
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		$ 190	190
Ending balance	$ 207		$ 207

Reserves for Future Policy Be_3

Reserves for Future Policy Benefits and Contract Owner Account Balances (Details) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($) yr	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) yr	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) yr	Dec. 31, 2021 USD ($)
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits	$ 9,371		$ 9,371		$ 9,719
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			42,455
Interest credited	328	$ 240	813	$ 716
Policyholder Account Balance, Ending Balance	40,135		40,135		42,455
Policyholder Account Balance	40,135		40,135		42,455
Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			13,398
Policyholder Account Balance, Ending Balance	12,726		12,726		13,398
Policyholder Account Balance	12,726		12,726		13,398
1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			804
Policyholder Account Balance, Ending Balance	751		751		804
Policyholder Account Balance	751		751		804
2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			12,892
Policyholder Account Balance, Ending Balance	11,860		11,860		12,892
Policyholder Account Balance	11,860		11,860		12,892
3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			9,601
Policyholder Account Balance, Ending Balance	9,355		9,355		9,601
Policyholder Account Balance	9,355		9,355		9,601
4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,730
Policyholder Account Balance, Ending Balance	1,668		1,668		1,730
Policyholder Account Balance	1,668		1,668		1,730
Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			405
Policyholder Account Balance, Ending Balance	430		430		405
Policyholder Account Balance	430		430		405
Total discretionary rate setting products
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			38,830
Policyholder Account Balance, Ending Balance	36,790		36,790		38,830
Policyholder Account Balance	36,790		36,790		38,830
At GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			30,725
Policyholder Account Balance, Ending Balance	23,519		23,519		30,725
Policyholder Account Balance	23,519		23,519		30,725
At GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			5,848
Policyholder Account Balance, Ending Balance	141		141		5,848
Policyholder Account Balance	141		141		5,848
At GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			707
Policyholder Account Balance, Ending Balance	553		553		707
Policyholder Account Balance	553		553		707
At GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			12,677
Policyholder Account Balance, Ending Balance	11,617		11,617		12,677
Policyholder Account Balance	11,617		11,617		12,677
At GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			9,448
Policyholder Account Balance, Ending Balance	9,197		9,197		9,448
Policyholder Account Balance	9,197		9,197		9,448
At GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,643
Policyholder Account Balance, Ending Balance	1,584		1,584		1,643
Policyholder Account Balance	1,584		1,584		1,643
At GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			402
Policyholder Account Balance, Ending Balance	427		427		402
Policyholder Account Balance	427		427		402
Up to .50% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3,314
Policyholder Account Balance, Ending Balance	6,710		6,710		3,314
Policyholder Account Balance	6,710		6,710		3,314
Up to .50% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			2,967
Policyholder Account Balance, Ending Balance	6,261		6,261		2,967
Policyholder Account Balance	6,261		6,261		2,967
Up to .50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			51
Policyholder Account Balance, Ending Balance	135		135		51
Policyholder Account Balance	135		135		51
Up to .50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			56
Policyholder Account Balance, Ending Balance	77		77		56
Policyholder Account Balance	77		77		56
Up to .50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			153
Policyholder Account Balance, Ending Balance	153		153		153
Policyholder Account Balance	153		153		153
Up to .50% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			87
Policyholder Account Balance, Ending Balance	84		84		87
Policyholder Account Balance	84		84		87
Up to .50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
0.51% - 1.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,989
Policyholder Account Balance, Ending Balance	2,800		2,800		1,989
Policyholder Account Balance	2,800		2,800		1,989
0.51% - 1.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,907
Policyholder Account Balance, Ending Balance	2,696		2,696		1,907
Policyholder Account Balance	2,696		2,696		1,907
0.51% - 1.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			35
Policyholder Account Balance, Ending Balance	51		51		35
Policyholder Account Balance	51		51		35
0.51% - 1.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			47
Policyholder Account Balance, Ending Balance	53		53		47
Policyholder Account Balance	53		53		47
0.51% - 1.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
0.51% - 1.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
0.51% - 1.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.01% - 1.50% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,223
Policyholder Account Balance, Ending Balance	2,129		2,129		1,223
Policyholder Account Balance	2,129		2,129		1,223
1.01% - 1.50% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,112
Policyholder Account Balance, Ending Balance	2,010		2,010		1,112
Policyholder Account Balance	2,010		2,010		1,112
1.01% - 1.50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			2
Policyholder Account Balance, Ending Balance	4		4		2
Policyholder Account Balance	4		4		2
1.01% - 1.50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			109
Policyholder Account Balance, Ending Balance	110		110		109
Policyholder Account Balance	110		110		109
1.01% - 1.50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	5		5		0
Policyholder Account Balance	5		5		0
1.01% - 1.50% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.01% - 1.50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,467
Policyholder Account Balance, Ending Balance	838		838		1,467
Policyholder Account Balance	838		838		1,467
1.51% - 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			1,462
Policyholder Account Balance, Ending Balance	833		833		1,462
Policyholder Account Balance	833		833		1,462
1.51% - 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			2
Policyholder Account Balance, Ending Balance	2		2		2
Policyholder Account Balance	2		2		2
1.51% - 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
1.51% - 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3
Policyholder Account Balance, Ending Balance	3		3		3
Policyholder Account Balance	3		3		3
More than 2.00% Above GMIR
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			112
Policyholder Account Balance, Ending Balance	794		794		112
Policyholder Account Balance	794		794		112
More than 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			102
Policyholder Account Balance, Ending Balance	785		785		102
Policyholder Account Balance	785		785		102
More than 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			7
Policyholder Account Balance, Ending Balance	6		6		7
Policyholder Account Balance	6		6		7
More than 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3
Policyholder Account Balance, Ending Balance	3		3		3
Policyholder Account Balance	3		3		3
More than 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
More than 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
More than 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			0
Policyholder Account Balance, Ending Balance	0		0		0
Policyholder Account Balance	0		0		0
Employee Benefits, Group
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning Balance			77	93	93
Beginning balance at original discount rate			84	85	85
Effect of change in cash flow assumptions					(6)	$ (7)
Effect of actual variances from expected experience					18	23
Adjusted balance at January 1					96	101
Interest accrual			2		2
Net premiums collected			(16)		(19)
Ending balance at original discount rate	82		82		84
Effects of changes in discount rate assumptions	(8)		(8)		(7)
Ending Balance	74		74		77
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			881	1,048	1,048
Beginning balance at original discount rate			913	952	952
Effect of change in cash flow assumptions					(15)	(43)
Effect of actual variances from expected experience					1	(27)
Adjusted balance at January 1					899	882
Issuances			103		139
Interest accrual			18		25
Benefit payments			(98)		(133)
Ending balance at original discount rate	922		922		913
Effects of changes in discount rate assumptions	(57)		(57)		(32)
Ending Balance	865		865		881
Net liability for future policy benefits	791		791		804
Less: Reinsurance recoverable	301		301		283
Net additional liability, after reinsurance recoverable	$ 490		$ 490		$ 521
Weighted average duration (in years) | yr	7		7		7
Interest accretion rate	4%		4%		4.10%
Current discount rate	5.80%		5.80%		5.20%
undiscounted expected gross premiums and future benefit payments [Line Items]
Expected future benefit payments, Undiscounted	$ 1,149		$ 1,149		$ 1,141
Expected future gross premiums, Undiscounted	312		312		286
Expected future benefit payments, Discounted	922		922		913	952
Expected future gross premiums, Discounted	247		247		231
Employee Benefits, Voluntary
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning Balance			97	105	105
Beginning balance at original discount rate			100	92	92
Effect of change in cash flow assumptions					6	0
Effect of actual variances from expected experience					6	20
Adjusted balance at January 1					112	112
Interest accrual			3		4
Net premiums collected			(12)		(16)
Ending balance at original discount rate	103		103		100
Effects of changes in discount rate assumptions	(7)		(7)		(3)
Ending Balance	96		96		97
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			285	359	359
Beginning balance at original discount rate			294	290	290
Effect of change in cash flow assumptions					13	(2)
Effect of actual variances from expected experience					6	11
Adjusted balance at January 1					313	299
Issuances			0		0
Interest accrual			11		14
Benefit payments			(16)		(19)
Ending balance at original discount rate	308		308		294
Effects of changes in discount rate assumptions	(29)		(29)		(9)
Ending Balance	279		279		285
Net liability for future policy benefits	183		183		188
Less: Reinsurance recoverable	0		0		0
Net additional liability, after reinsurance recoverable	$ 183		$ 183		$ 188
Weighted average duration (in years) | yr	14,000,000		14,000,000		14,000,000
Interest accretion rate	5.30%		5.30%		5.30%
Current discount rate	6%		6%		5.40%
undiscounted expected gross premiums and future benefit payments [Line Items]
Expected future benefit payments, Undiscounted	$ 671		$ 671		$ 588
Expected future gross premiums, Undiscounted	343		343		307
Expected future benefit payments, Discounted	308		308		294	290
Expected future gross premiums, Discounted	214		214		205
business exited
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Beginning Balance			4,244	5,634	5,634
Beginning balance at original discount rate			4,128	4,226	4,226
Effect of change in cash flow assumptions					(921)	(69)
Effect of actual variances from expected experience					(61)	86
Adjusted balance at January 1					3,146	4,243
Interest accrual			155		230
Net premiums collected			(243)		(345)
Ending balance at original discount rate	3,058		3,058		4,128
Effects of changes in discount rate assumptions	(47)		(47)		116
Ending Balance	3,011		3,011		4,244
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			8,639	11,444	11,444
Beginning balance at original discount rate			8,644	9,079	9,079
Effect of change in cash flow assumptions					(805)	(77)
Effect of actual variances from expected experience					(80)	(52)
Adjusted balance at January 1					7,759	8,950
Issuances			13		13
Interest accrual			317		458
Benefit payments			(568)		(777)
Ending balance at original discount rate	7,521		7,521		8,644
Effects of changes in discount rate assumptions	(330)		(330)		(5)
Ending Balance	7,191		7,191		8,639
Net liability for future policy benefits	4,179		4,179		4,395
Less: Reinsurance recoverable	4,127		4,127		4,411
Net additional liability, after reinsurance recoverable	$ 52		$ 52		$ (16)
Weighted average duration (in years) | yr	8,000,000		8,000,000		8,000,000
Interest accretion rate	4.90%		4.90%		5%
Current discount rate	5.60%		5.60%		5.70%
undiscounted expected gross premiums and future benefit payments [Line Items]
Expected future benefit payments, Discounted	$ 7,521		$ 7,521		$ 8,644	9,079
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			5,146	5,532	5,532
Deposits			217		310
Fee income			(281)		(384)
Surrenders and withdrawals			(310)		(281)
Benefit payments			(111)		(144)
Net transfers from (to) separate accounts			(1)		0
Interest credited			108		150
Other			0		(37)
Policyholder Account Balance, Ending Balance	$ 4,768		$ 4,768		$ 5,146
Weighted-average crediting rate	2.50%		2.50%		2.50%
Net amount at risk	$ 801		$ 801		$ 900
Cash surrender value	1,581		1,581		1,824
Policyholder Account Balance	4,768		4,768		5,146	5,532
business exited, additional liability
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Beginning Balance			2,107	1,715	1,715
Effect of change in cash flow assumptions					(44)	540
Effect of actual variances from expected experience					(20)	15
Adjusted balance at January 1					2,043	2,270
Interest accrual			64		80
Benefit payments			(301)		(427)
Assessments			195		184
Ending Balance					2,107
Net liability for future policy benefits	2,001		2,001		2,107
Less: Reinsurance recoverable	1,949		1,949		2,054
Net additional liability, after reinsurance recoverable	$ 52		$ 52		$ 53
Current discount rate	4.20%		4.20%		4.30%
Other Segments
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits	$ 2,217		$ 2,217		$ 2,225
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			3,687
Policyholder Account Balance, Ending Balance	3,436		3,436		3,687
Policyholder Account Balance	3,436		3,436		3,687
Wealth Solutions
Policyholder Account Balance [Roll Forward]
Policyholder Account Balance, Beginning Balance			33,622	$ 33,044	33,044
Deposits			1,726		2,962
Fee income			(6)		(8)
Surrenders and withdrawals			(3,891)		(4,280)
Benefit payments			(133)		(157)
Net transfers from (to) separate accounts			(59)		1,174
Interest credited			664		874
Other			8		13
Policyholder Account Balance, Ending Balance	$ 31,931		$ 31,931		$ 33,622
Weighted-average crediting rate	2.70%		2.70%		2.60%
Net amount at risk	$ 148		$ 148		$ 199
Cash surrender value	31,455		31,455		33,125
Policyholder Account Balance	$ 31,931		$ 31,931		$ 33,622	$ 33,044

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Assets
Premiums receivable, direct	$ 179		$ 179		$ 172
Premiums Receivable, assumed	10		10		11
Premiums receivable, ceded	(208)		(208)		(212)
Premiums Receivable, net	(19)		(19)		(29)
Reinsurance recoverable, net of allowance for credit losses, ceded	11,784		11,784		12,455
Reinsurance recoverable, net of allowance for credit losses, net	11,784		11,784		12,455
Total assets, direct	179		179		172
Total assets, assumed	10		10		11
Total assets, ceded	11,576		11,576		12,243
Total assets, net	11,765		11,765		12,426
Liabilities
Future policy benefits and contract owner account balances, direct	48,525		48,525		51,137
Future policy benefits and contract owner account balances, assumed	981		981		1,037
Future policy benefits and contract owner account balances, net	49,506		49,506		52,174
Liability for funds withheld under reinsurance agreements, direct	96		96		104
Liability for funds withheld under reinsurance agreements, net	96		96		104
Total liabilities, direct	48,621		48,621		51,241
Total liabilities, assumed	981		981		1,037
Total liabilities, net	49,602		49,602		$ 52,278
Fee income	$ 489	$ 445	$ 1,427	$ 1,291

Reinsurance - Effect of Reinusa

Reinsurance - Effect of Reinusance (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Premiums Earned, Net [Abstract]
Direct Premiums Earned	$ 896	$ 815	$ 2,706	$ 2,439
Assumed Premiums Earned	5	5	20	19
Ceded Premiums Earned	219	214	682	647
Premiums	682	606	2,044	1,811
Policyholder Benefits and Claims Incurred, Net [Abstract]
Revenue from Contract with Customer, Including Assessed Tax	585	543	1,718	1,588
Assumed Insurance Commissions and Fees	4	5	13	14
Ceded Insurance Commissions And Fees	100	103	304	311
Fee income	489	445	1,427	1,291
Policyholder Benefits and Claims Incurred, Assumed and Ceded [Abstract]
Policyholder Benefits and Claims Incurred, Direct	1,099	1,351	3,221	3,431
Policyholder Benefits and Claims Incurred, Assumed	21	13	51	35
Policyholder Benefits and Claims Incurred, Ceded	321	827	1,040	1,631
Policyholder Interest and Other Benefits, Net	799	$ 537	2,232	$ 1,835
Deposit asset	$ 1,300		$ 1,300		$ 1,500

Separate Accounts (Details)

Separate Accounts (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	$ 85,491	$ 85,491	$ 80,174
Liabilities related to separate accounts	85,491	85,491	80,174
Wealth Solutions Stabilizer
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Separate Account, Liability, Policyholder Behavior		(288)
Wealth Solutions
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	81,697	81,697	76,348	$ 95,018
Separate Account, Liability, Policyholder Behavior		(44)	(1,377)
Separate Account, Liability, Policy Charge		(341)	(457)
Separate Account, Liability, Increase (Decrease) from Invested Performance		5,733	(16,838)
Separate Account, Liability, Increase (Decrease) from Other Change		1	2
Separate Account, Liability, Cash Surrender Value, Amount	74,747	74,747	69,121
Wealth Solutions | Wealth Solutions Stabilizer
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	6,919	6,919	7,196	8,091
Separate Account, Liability, Policyholder Behavior			(68)
Separate Account, Liability, Policy Charge		(25)	(34)
Separate Account, Liability, Increase (Decrease) from Invested Performance		35	(794)
Separate Account, Liability, Increase (Decrease) from Other Change	1		1
Wealth Solutions | Deferred Variable Annuity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	74,778	74,778	69,152	$ 86,927
Separate Account, Liability, Policyholder Behavior		244	(1,309)
Separate Account, Liability, Policy Charge		(316)	(423)
Separate Account, Liability, Increase (Decrease) from Invested Performance		5,698	(16,044)
Separate Account, Liability, Increase (Decrease) from Other Change	0		1
Other Segments
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	3,794	3,794	3,826
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	1,026	1,026	1,586
Corporate Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	1,752	1,752	1,647
Separate Account, Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	337	337	311
Separate Account, Debt Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	672	672	660
Separate Account, Mortgage-Backed Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	3,319	3,319
Separate Account, Mortgage-Backed Security | Mortgage-Backed Securities, Issued by Private Enterprises
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts			3,434
Separate Account, Equity Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	78,133	78,133	72,309
Asset-Backed Securities, Securitized Loans and Receivables
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	$ 252	$ 252	$ 227

Segments - Narrative (Details)

Segments - Narrative (Details)	9 Months Ended
	Sep. 30, 2023 segment
Segment Reporting [Abstract]
Number of operating segments	3

Segments - Operating Earnings B

Segments - Operating Earnings Before Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Income (loss) attributable to noncontrolling interests	$ (16)	$ (138)	$ 107	$ (20)
Less: Preferred stock dividends	14	14	32	32
Total adjustments to income (loss) before income taxes	172	71	576	345
Adjustments
Segment Reporting Information [Line Items]
Net investment gains (losses) and related charges and adjustments	42	(9)	(4)	(180)
Income (loss) related to businesses exited or to be exited through reinsurance or divestment	(68)	(13)	(122)	(105)
Other adjustments	(28)	(37)	(150)	(85)
Total adjustments to income (loss) before income taxes	(56)	(183)	(138)	(357)
Operating Segments
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	229	254	715	703
Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax	242	267	749	715
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	14	13	35	13
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	179	128	485	553
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	63	51	168	129
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	53	154	271	226
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	$ (52)	$ (66)	$ (175)	$ (193)

Segments - Operating Revenues (

Segments - Operating Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 1,823	$ 1,345	$ 5,529	$ 4,375
Adjustments
Segment Reporting Information [Line Items]
Total revenues	106	(148)	395	(259)
Net investment gains (losses) and related charges and adjustments	40	(18)	(21)	(198)
Revenues related to businesses exited or to be exited through reinsurance or divestment	21	(30)	53	(139)
Revenues attributable to noncontrolling interests	22	(130)	211	11
Other adjustments	24	30	152	66
Operating Segments
Segment Reporting Information [Line Items]
Total revenues	1,717	1,495	5,135	4,635
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total revenues	702	645	2,090	2,109
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total revenues	233	192	688	542
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total revenues	768	645	2,317	1,933
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Total revenues	14	13	39	51
Intersegment | Investment Management
Segment Reporting Information [Line Items]
Total revenues	$ 21	$ 23	$ 65	$ 68

Segments - Total Assets (Detail

Segments - Total Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total assets	$ 149,265	$ 146,606
Noncontrolling Interest
Segment Reporting Information [Line Items]
Total assets	4,285	3,914
Total | Parent
Segment Reporting Information [Line Items]
Total assets	144,980	142,692
Corporate
Segment Reporting Information [Line Items]
Total assets	25,685	26,712
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total assets	114,401	111,701
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total assets	1,602	1,611
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total assets	$ 3,292	$ 2,668

Share-based Incentive Compens_3

Share-based Incentive Compensation Plans - Narrative (Details)	Sep. 30, 2023 shares
2019 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)	8,709,137

Share-based Incentive Compens_4

Share-based Incentive Compensation Plans - Compensation Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 21	$ 14	$ 110	$ 75
Income tax benefit	4	3	26	21
After-tax share-based compensation expense	17	11	84	54
Restricted Stock Unit (RSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	14	8	67	38
Performance Stock Unit (PSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 7	$ 6	$ 43	$ 37

Share-based Incentive Compens_5

Share-based Incentive Compensation Plans - Awards Outstanding (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
RSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,500,000
Adjustment for PSU performance factor (in shares) | shares	0
Granted (in shares) | shares	1,700,000
Vested (in shares) | shares	(1,100,000)
Forfeited (in shares) | shares
Outstanding, ending balance (in shares) | shares	2,100,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 60.91
Adjustment for PSU performance factor (usd per share) | $ / shares	0
Granted (usd per share) | $ / shares	70.51
Vested (usd per share) | $ / shares	63.51
Forfeited (usd per share) | $ / shares	66.21
Outstanding, ending balance (usd per share) | $ / shares	$ 67.12
PSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	2,100,000
Adjustment for PSU performance factor (in shares) | shares	(100,000)
Granted (in shares) | shares	800,000
Vested (in shares) | shares	(500,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,300,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 55.68
Adjustment for PSU performance factor (usd per share) | $ / shares	61.50
Granted (usd per share) | $ / shares	66.10
Vested (usd per share) | $ / shares	62.76
Forfeited (usd per share) | $ / shares	66.55
Outstanding, ending balance (usd per share) | $ / shares	$ 61.22
Stock options
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,600,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(400,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,200,000
Vested, exercisable (in shares) | shares	1,200,000
Weighted Average Exercise Price
Outstanding, beginning balance (usd per share) | $ / shares	$ 43.05
Granted (usd per share) | $ / shares	0
Exercised (usd per share) | $ / shares	38.70
Forfeited (usd per share) | $ / shares	0
Outstanding, ending balance (usd per share) | $ / shares	44.59
Vested, exercisable, weighted average exercise price (usd per share) | $ / shares	$ 44.59

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Rollforward (Details) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)	97,789,852
Common shares, held in treasury, beginning balance (in shares)	602,882
Common shares, beginning balance (in shares)	97,186,970
Common stock acquired - share repurchase (in shares)	3,100,000	11,700,000
Share-based compensation programs (in shares)	1,400,000	1,000,000
Treasury Stock retirement (in shares)		0
Common stock, shares issued, ending balance (in shares)	109,500,599	97,789,852
Common shares, held in treasury, ending balance (in shares)	4,426,578	602,882
Common shares, ending balance (in shares)	105,074,021	97,186,970
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)	97,800,000	109,000,000
Common shares, beginning balance (in shares)	97,200,000	107,800,000
Common shares issued (in shares)	9,600,000	100,000
Common stock acquired - share repurchase (in shares)	0	0
Share-based compensation programs (in shares)	2,100,000	1,700,000
Treasury Stock retirement (in shares)		(13,000,000)
Common stock, shares issued, ending balance (in shares)	109,500,000	97,800,000
Common shares, ending balance (in shares)		97,200,000
Treasury Stock
Increase (Decrease) in Stockholders' Equity
Common shares, held in treasury, beginning balance (in shares)	(600,000)	(1,200,000)
Common shares issued (in shares)	0	0
Common stock acquired - share repurchase (in shares)	3,100,000	11,700,000
Share-based compensation programs (in shares)	700,000	700,000
Treasury Stock retirement (in shares)		(13,000,000)
Common shares, held in treasury, ending balance (in shares)	4,400,000	(600,000)

Shareholders' Equity - Common_2

Shareholders' Equity - Common stock Dividends Declared (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Equity [Abstract]
Dividends declared per share of Common Stock (usd per share)	$ 0.40	$ 0.20	$ 0.80	$ 0.60

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 01, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	May 10, 2023	May 07, 2013
Class of Stock [Line Items]
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 555		$ 555
Common stock acquired - share repurchase (in shares)				3,100,000		11,700,000
Payment for share repurchases		$ 54	$ 0	$ 216	$ 750
Number of warrants issued and outstanding (in shares)		0		0				26,050,846
Warrants issued allowing purchase of shares, percentage of common stock issued and outstanding								9.99%
Number of securities called by warrants or rights (in shares)							9,600,000
Preferred Stock, shares authorized (in shares)		100,000,000		100,000,000		100,000,000
Preferred Stock, amount of preferred dividends in arrears				$ 0
Subsequent Event
Class of Stock [Line Items]
Common stock acquired - share repurchase (in shares)	773,153
Payment for share repurchases	$ 51

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Share Repurchases (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Equity [Abstract]
Payment for share repurchases	$ 54	$ 0	$ 216	$ 750
Common stock acquired - share repurchase (in shares)			3.1		11.7

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 15, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Aggregate (in shares)	$ 14	$ 14	$ 32	$ 32
Preferred Stock, Dividend Rate, Period					5 years
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares)	625,000		625,000			625,000
Preferred Stock, shares outstanding (in shares)	625,000		625,000			625,000
Series A Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			0.07758%	6.125%
Preferred Stock, shares issued (in shares)	325,000		325,000			325,000
Preferred Stock, shares outstanding (in shares)	325,000		325,000			325,000
Per Share (usd per share)	$ 30.625	$ 30.625	$ 61.250	$ 61.250
Aggregate (in shares)	$ 10	$ 10	$ 20	$ 20
Series B Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			0.0535%
Preferred Stock, shares issued (in shares)	300,000		300,000			300,000
Preferred Stock, shares outstanding (in shares)	300,000		300,000			300,000
Per Share (usd per share)	$ 13.375	$ 13.375	$ 40.125	$ 40.125
Aggregate (in shares)	$ 4	$ 4	$ 12	$ 12

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Net income (loss) available to common shareholders:
Income (loss) from continuing operations	$ 246	$ 42	$ 610	$ 296
Less: Preferred stock dividends	14	14	32	32
Less: Net income (loss) attributable to noncontrolling interest	(16)	(138)	107	(20)
Net income (loss) available to common shareholders	$ 248	$ 166	$ 471	$ 284
Weighted average common shares outstanding
Basic (in shares)	105.8	97.9	102.2	101.9
Dilutive Effects:
Diluted (in shares)	108.4	106.4	109.3	111.4
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 2.35	$ 1.70	$ 4.62	$ 2.79
Diluted (usd per share)	$ 2.29	$ 1.57	$ 4.31	$ 2.55
Warrant
Dilutive Effects:
Dilutive Effects (in shares)	0	6.2	4.3	7.2
RSU awards
Dilutive Effects:
Dilutive Effects (in shares)	1.1	0.9	1.1	0.9
PSU awards
Dilutive Effects:
Dilutive Effects (in shares)	1.1	0.9	1.2	0.8
Stock options
Dilutive Effects:
Dilutive Effects (in shares)	0.4	0.5	0.5	0.6

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Components of AOCI (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fixed maturities, net of impairment	$ (3,881)		$ (3,669)
DAC/VOBA adjustment on available-for-sale securities	100		187
AOCI, Liability for Future Policy Benefit, before Tax	(850)		(858)
Deferred income tax asset (liability)	1,096		1,034
Total	(3,535)		(3,306)
Pension and other postretirement benefits liability, net of tax	2		3
AOCI	(3,533)	$ (3,055)	$ (3,303)
Other Contract
Accumulated Other Comprehensive Income (Loss) [Line Items]
Portion of AOCI expected to be reclassified into earnings within next 12 months	$ 16

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Changes in AOCI, including Reclassification Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Available-for-sale securities, Before-Tax Amount:
Fixed maturities	$ (937)	$ (1,742)	$ (619)	$ (6,953)
Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations	18	(1)	32	89
Change in unrealized gains/losses on available-for-sale securities	(919)	(1,743)	(587)	(6,864)
Available-for-sale securities, Income Tax:
Fixed maturities	197	367	130	1,461
Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations	(4)	0	(7)	(19)
Change in unrealized gains/losses on available-for-sale securities	193	367	123	1,442
Available-for-sale securities, After-Tax Amount:
Fixed maturities	(740)	(1,375)	(489)	(5,492)
Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations	14	(1)	25	70
Change in unrealized gains/losses on available-for-sale securities	(726)	(1,376)	(464)	(5,422)
Derivatives, Before-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	7	63	(11)	122
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(4)	(5)	(14)	(15)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Total	3	58	(25)	107
Derivatives, Income Tax:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	(2)	(14)	2	(26)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	1	1	3	3
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Total	1	13	(5)	23
Derivatives, After-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	5	49	(9)	96
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	(3)	(4)	(11)	(12)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Total	2	45	(20)	84
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	(23)	93	7	289
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	5	(20)	(1)	(61)
OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax	(18)	73	6	228
Other Comprehensive Income (Loss), before Tax, Total	(939)	(1,592)	(605)	(6,468)
Other comprehensive income (loss), tax	197	334	127	1,358
Other Comprehensive Income (Loss), Net of Tax, Total	$ (742)	$ (1,258)	$ (478)	$ (5,110)

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	$ 491,000,000	$ 464,000,000	$ 1,462,000,000	$ 1,244,000,000
Revenue from other sources	79,000,000	14,000,000	210,000,000	164,000,000
Total fee income and other revenue	570,000,000	478,000,000	$ 1,672,000,000	1,408,000,000
Financial Service
Disaggregation of Revenue [Line Items]
Contract term			1 year
Software Subscription and Service | Minimum
Disaggregation of Revenue [Line Items]
Contract term			1 year
Software Subscription and Service | Maximum
Disaggregation of Revenue [Line Items]
Contract term			3 years
Wealth Solutions
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	125,000,000	120,000,000	$ 369,000,000	380,000,000
Wealth Solutions | DistributionFeesMember [Member]
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	29,000,000	29,000,000	88,000,000	93,000,000
Investment Management
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	236,000,000	264,000,000	698,000,000	593,000,000
Investment Management | DistributionFeesMember [Member]
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	36,000,000	34,000,000	100,000,000	114,000,000
Health Solutions
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	4,000,000	4,000,000	15,000,000	13,000,000
Benefitfocus
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	53,000,000	0	167,000,000	0
Corporate
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	$ 8,000,000	$ 13,000,000	$ 25,000,000	$ 51,000,000
Accounting Standards Update 2014-09 [Member]
Disaggregation of Revenue [Line Items]
Net receivables					$ 361,000,000	$ 299

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Net Investment Income [Line Items]
Effective tax rate	(43.00%)	40.80%	(5.90%)	14.20%
Income tax expense (benefit)	$ (74)	$ 29	$ (34)	$ 49
Net gains (losses)	(7)	(125)	(79)	(639)
Unrealized gains (losses) on securities	(916)	$ (1,685)	(612)	$ (6,757)
SLD
Net Investment Income [Line Items]
Income tax expense (benefit)			(92)
Voya India
Net Investment Income [Line Items]
Net gains (losses)	$ 45		$ 45

Financing Agreements - Schedule

Financing Agreements - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Mar. 17, 2015	May 16, 2013
Debt Instrument [Line Items]
Long-term debt	$ 2,097	$ 2,235
Less: Current portion of long-term debt	2	141
Total long-term debt, excluding current portion	$ 2,095	2,094
7.25% Voya Holdings Inc. debentures, due 2023 | Debentures
Debt Instrument [Line Items]
Annual interest rate on debt	7.25%
One Point Two Five Percent Convertible Senior Notes, due 2023 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.25%
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt			1.875%
Senior Notes | 3.976% Senior Notes, Due 2025
Debt Instrument [Line Items]
Long-term debt	$ 389	0
Annual interest rate on debt	3.976%
Senior Notes | 3.65% Senior Notes, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 444	445
Annual interest rate on debt	3.65%
Senior Notes | 5.7% Senior Notes, due 2043
Debt Instrument [Line Items]
Long-term debt	$ 396	396
Annual interest rate on debt	5.70%
Senior Notes | 4.8% Senior Notes, due 2046
Debt Instrument [Line Items]
Long-term debt	$ 297	297
Annual interest rate on debt	4.80%
Senior Notes | One Point Two Five Percent Convertible Senior Notes, due 2023
Debt Instrument [Line Items]
Long-term debt	$ 2	0
Junior Subordinated Notes | 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048(1)
Debt Instrument [Line Items]
Long-term debt	$ 336	336
Annual interest rate on debt	4.70%
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Long-term debt	$ 0	388
Annual interest rate on debt	5.65%			5.65%
Debentures | 7.25% Voya Holdings Inc. debentures, due 2023
Debt Instrument [Line Items]
Long-term debt	$ 0	140
Debentures | 7.63% Voya Holdings Inc. debentures, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 139	139
Annual interest rate on debt	7.63%
Debentures | 6.97% Voya Holdings Inc. debentures, due 2036
Debt Instrument [Line Items]
Long-term debt	$ 79	79
Annual interest rate on debt	6.97%
Notes payable, other | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027
Debt Instrument [Line Items]
Long-term debt	$ 13	13
Annual interest rate on debt	8.42%
Loans payable | 1.00% Windsor Property Loan
Debt Instrument [Line Items]
Long-term debt	$ 2	$ 2
Annual interest rate on debt	1%
Debt Securities | Interest Expense
Debt Instrument [Line Items]
Income (loss) related to early extinguishment of debt	$ (5)

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details) - USD ($) $ in Millions		9 Months Ended
	Mar. 17, 2015	Sep. 30, 2023	Sep. 30, 2022	May 03, 2023	May 01, 2023	Dec. 31, 2022	May 16, 2013
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 2,097				$ 2,235
Maximum borrowing capacity		700
Line of Credit		12
Business Agreement, Processing and Operation Services Period	10 years
Put Option Agreement, Face Amount	$ 500
Line of Credit Facility, Remaining Borrowing Capacity		688
Payments of Financing Costs		0	$ 0
Aetna Notes
Debt Instrument [Line Items]
Amount of letters of credit outstanding		12
Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		500
Minimum net worth required for compliance					$ 4,998
Unsecured and Committed [Member] | Voya Financial, Inc.
Debt Instrument [Line Items]
Maximum borrowing capacity		500
Line of Credit		0
Line of Credit Facility, Remaining Borrowing Capacity		500
Unsecured and Committed [Member] | Voya Financial, Inc. Three
Debt Instrument [Line Items]
Maximum borrowing capacity		200
Line of Credit		12
Line of Credit Facility, Remaining Borrowing Capacity		188
Voya Holdings Debentures | Aetna Notes
Debt Instrument [Line Items]
Amount of collateral for credit facility		224
Amount of collateral deposited to a control account		212
Short-term Debt | Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity					25
Revolving Credit agreement
Debt Instrument [Line Items]
Line of Credit		0
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		218
Revolving Credit agreement
Debt Instrument [Line Items]
Amount of letters of credit outstanding		0
Line of Credit		0
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.875%
Senior Notes | Pre-Capitalized Trust
Debt Instrument [Line Items]
Annual interest rate on debt	3.976%
Debt Instrument, Face Amount				$ 400	$ 400
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 0				$ 388
Annual interest rate on debt		5.65%					5.65%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Loss Contingencies [Line Items]
Possible losses in excess of amounts accrued	$ 25		$ 25
Potential future loss	129		129
Pledged Collateral	1,708		1,708		$ 1,791
Impairment of right-of-use asset	0	$ 0	14	$ 3
Liability for unpaid claims	47		47
Payments for legal settlements			39
Securities Loaned
Loss Contingencies [Line Items]
Securities pledged as collateral	208		208		142
Federal Home Loan Bank | Line of Credit
Loss Contingencies [Line Items]
Non-putable funding agreements issued to FHLB	1,176		1,176		1,279
Pledged Collateral	$ 1,708		1,708		$ 1,791
Acquisition of mortgage loans
Loss Contingencies [Line Items]
Amount of purchase commitments			52
Purchase of limited partnership and private placement investments
Loss Contingencies [Line Items]
Amount of purchase commitments			951
Purchase of limited partnership and private placement investments | VOEs
Loss Contingencies [Line Items]
Amount of purchase commitments			$ 340

Commitments and Contingencies_2

Commitments and Contingencies - Restricted Assets (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Loss Contingencies [Line Items]
Fixed maturity collateral pledged to FHLB	$ 1,708	$ 1,791
FHLB restricted stock	63	67
Other fixed maturities-state deposits	39	38
Cash and cash equivalents	27	27
Total restricted assets	2,839	3,085
Collateral Pledged
Loss Contingencies [Line Items]
Securities pledged	1,002	1,162
Securities pledged as collateral
Loss Contingencies [Line Items]
Fair value of loaned securities	682	907
Securities pledged under repurchase agreements, carrying value	$ 112	$ 113

Consolidated and Nonconsolida_3

Consolidated and Nonconsolidated Investment Entities - General and Consolidated VIEs and VOEs and Nonconsolidated VIEs (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($) fund CLO	Dec. 31, 2022 USD ($) CLO
Variable Interest Entity [Line Items]
Consolidated collateral loan obligations | CLO	6	7
Limited Partnerships life	10 years
Consolidated funds | fund	10
Noncontrolling interest	$ 1,659	$ 1,482
Consolidated Investment Entities
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 347	$ 288

Consolidated and Nonconsolida_4

Consolidated and Nonconsolidated Investment Entities - Components of the Consolidated Investment Entities (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Assets of Consolidated Investment Entities
Assets	$ 149,265	$ 146,606
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	144,306	141,609
Noncontrolling interest	1,659	1,482
Total liabilities, mezzanine equity and shareholders' equity	$ 149,265	$ 146,606

Consolidated and Nonconsolida_5

Consolidated and Nonconsolidated Investment Entities - Fair Value Measurement (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 700
Outstanding borrowings	12
VOEs | Private Equity Funds
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 1,352	$ 1,366
Renewal period for term loan	3 years
Outstanding borrowings	$ 1,256	1,143
VOEs | Minimum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	1.55%
Term of debt	18 months
VOEs | Maximum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	2%
Term of debt	12 months
VOEs | LIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
VOEs | EURIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs
Variable Interest Entity [Line Items]
Unpaid principal exceeds fair value, amount	$ 43	$ 85
Default of collateral assets, percentage	1%
Weighted average maturity	12 years
Senior secured corporate loans | VIEs | Maximum
Variable Interest Entity [Line Items]
Basis spread on loans	8.50%
Senior secured corporate loans | VIEs | LIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
Senior secured corporate loans | VIEs | LIBOR | Minimum
Variable Interest Entity [Line Items]
Basis spread on notes	1%
Senior secured corporate loans | VIEs | LIBOR | Maximum
Variable Interest Entity [Line Items]
Basis spread on notes	9.60%
Senior secured corporate loans | VIEs | EURIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs | PRIME
Variable Interest Entity [Line Items]
Description of variable rate basis	PRIME
Senior secured corporate loans | VIEs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Variable Interest Entity [Line Items]
Description of variable rate basis	SOFR

Consolidated and Nonconsolida_6

Consolidated and Nonconsolidated Investment Entities - Fair Value Hierarchy (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	$ 0
Measured at fair value on a recurring basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	3,079	$ 2,802
Assets, Including NAV	4,595	4,183
Liabilities	1,329	1,234
Measured at fair value on a recurring basis | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Measured at fair value on a recurring basis | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	88	88
Assets, Net Asset Value (NAV)	0	0
Measured at fair value on a recurring basis | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,396	1,293
Assets, Net Asset Value (NAV)	0	0
Measured at fair value on a recurring basis | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	32
Assets, Net Asset Value (NAV)	0
Measured at fair value on a recurring basis | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	3,079	2,802
Assets, Including NAV	3,079	2,802
Measured at fair value on a recurring basis | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Liabilities	1,329	1,234
Measured at fair value on a recurring basis | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	88	88
Liabilities	0	0
Measured at fair value on a recurring basis | Level 1 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	88	88
Measured at fair value on a recurring basis | Level 1 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 1 | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0
Measured at fair value on a recurring basis | Level 1 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 1 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Measured at fair value on a recurring basis | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,428	1,293
Liabilities	1,329	1,234
Measured at fair value on a recurring basis | Level 2 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 2 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,396	1,293
Measured at fair value on a recurring basis | Level 2 | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	32
Measured at fair value on a recurring basis | Level 2 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 2 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	1,329	1,234
Measured at fair value on a recurring basis | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Measured at fair value on a recurring basis | Level 3 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 3 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 3 | Corporate loans | Consolidated Entity, Excluding Consolidated VIE
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0
Measured at fair value on a recurring basis | Level 3 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Measured at fair value on a recurring basis | Level 3 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 0	$ 0

Consolidated and Nonconsolida_7

Consolidated and Nonconsolidated Investment Entities - Deconsolidation and Nonconsolidated VIEs (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($) loan	Sep. 30, 2022 loan	Dec. 31, 2022 USD ($)
Variable Interest Entity [Line Items]
Number of deconsolidated investment entities | loan	1	0
Total assets	$ 149,265		$ 146,606
VIEs, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Amount of ownership interest in unconsolidated CLOs	$ 366		$ 364

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 327	$ 72
Additions from business combinations	421	255
Goodwill, Ending Balance	748
Wealth
Goodwill [Roll Forward]
Goodwill, Beginning Balance	17	17
Additions from business combinations	0	0
Goodwill, Ending Balance	17
Health Solutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	24	24
Additions from business combinations	319	0
Goodwill, Ending Balance	343
Investment Management
Goodwill [Roll Forward]
Goodwill, Beginning Balance	286	31
Additions from business combinations	0	255
Goodwill, Ending Balance	286
Corporate
Goodwill [Roll Forward]
Goodwill, Beginning Balance	0	0
Additions from business combinations	102	$ 0
Goodwill, Ending Balance	$ 102

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount		$ 350	$ 350
Finite-life intangibles, Gross Carrying Amount	$ 1,369		1,369		$ 1,728
Finite-life intangibles, Accumulated Amortization	470		470		1,097
Finite-life intangibles, Net Carrying Amount	$ 900		900		631
Amortization of intangible assets			$ 63	$ 36
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	17 years		17 years
Finite-life intangibles, Gross Carrying Amount	$ 190		$ 190		741
Finite-life intangibles, Accumulated Amortization	13		13		554
Finite-life intangibles, Net Carrying Amount	$ 177		$ 177		187
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	8 years		8 years
Finite-life intangibles, Gross Carrying Amount	$ 325		$ 325		135
Finite-life intangibles, Accumulated Amortization	124		124		111
Finite-life intangibles, Net Carrying Amount	$ 201		$ 201		24
Computer software
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	4 years		4 years
Finite-life intangibles, Gross Carrying Amount	$ 489		$ 489		502
Finite-life intangibles, Accumulated Amortization	332		332		432
Finite-life intangibles, Net Carrying Amount	$ 158		$ 158		70
Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	8 years		8 years
Finite-life intangibles, Gross Carrying Amount	$ 15		$ 15		0
Finite-life intangibles, Accumulated Amortization	1		1		0
Finite-life intangibles, Net Carrying Amount	14		14		$ 0
Customer Lists
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount		345	345
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount		$ 5	$ 5
Gross Intangibles written off	550
Accumulated amortization for intangibles written off	$ 550

Uncategorized Items - voya-2023

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 1,007,000,000